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A B S T R A C T
Background
Chronic heart failure (HF) is a growing global health challenge. People with HF experience substantial burden that includes low exercise
tolerance, poor health-related quality of life (HRQoL), increased risk of mortality and hospital admission, and high healthcare costs. The
previous (2014) Cochrane systematic review reported that exercise-based cardiac rehabilitation (CR) compared to no exercise control
shows improvement in HRQoL and hospital admission among people with HF, as well as possible reduction in mortality over the longer
term, and that these reductions appear to be consistent across patient and programme characteristics. Limitations noted by the authors
of this previous Cochrane Review include the following: (1) most trials were undertaken in patients with HF with reduced (< 45%) ejection
fraction (HFrEF), and women, older people, and those with preserved (≥ 45%) ejection fraction HF (HFpEF) were under-represented; and
(2) most trials were undertaken in the hospital/centre-based setting.
Objectives
To determine the eNects of exercise-based cardiac rehabilitation on mortality, hospital admission, and health-related quality of life of
people with heart failure.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, and three other databases on 29 January
2018. We also checked the bibliographies of systematic reviews and two trial registers.
Selection criteria
We included randomised controlled trials that compared exercise-based CR interventions with six months' or longer follow-up versus a
no exercise control that could include usual medical care. The study population comprised adults (> 18 years) with evidence of HF - either
HFrEF or HFpEF.
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Data collection and analysis
Two review authors independently screened all identified references and rejected those that were clearly ineligible for inclusion in the
review. We obtained full papers of potentially relevant trials. Two review authors independently extracted data from the included trials,
assessed their risk of bias, and performed GRADE analyses.
Main results
We included 44 trials (5783 participants with HF) with a median of six months' follow-up. For this latest update, we identified 11 new
trials (N = 1040), in addition to the previously identified 33 trials. Although the evidence base includes predominantly patients with
HFrEF with New York Heart Association classes II and III receiving centre-based exercise-based CR programmes, a growing body of studies
include patients with HFpEF and are undertaken in a home-based setting. All included studies included a no formal exercise training
intervention comparator. However, a wide range of comparators were seen across studies that included active intervention (i.e. education,
psychological intervention) or usual medical care alone. The overall risk of bias of included trials was low or unclear, and we downgraded
results using the GRADE tool for all but one outcome.
Cardiac rehabilitation may make little or no diNerence in all-cause mortality over the short term (≤ one year of follow-up) (27 trials,
28 comparisons (2596 participants): intervention 67/1302 (5.1%) vs control 75/1294 (5.8%); risk ratio (RR) 0.89, 95% confidence interval
(CI) 0.66 to 1.21; low-quality GRADE evidence) but may improve all-cause mortality in the long term (> 12 months follow up) (6 trials/
comparisons (2845 participants): intervention 244/1418 (17.2%) vs control 280/1427 (19.6%) events): RR 0.88, 95% CI 0.75 to 1.02; high-
quality evidence). Researchers provided no data on deaths due to HF. CR probably reduces overall hospital admissions in the short term
(up to one year of follow-up) (21 trials, 21 comparisons (2182 participants): (intervention 180/1093 (16.5%) vs control 258/1089 (23.7%); RR
0.70, 95% CI 0.60 to 0.83; moderate-quality evidence, number needed to treat: 14) and may reduce HF-specific hospitalisation (14 trials, 15
comparisons (1114 participants): (intervention 40/562 (7.1%) vs control 61/552 (11.1%) RR 0.59, 95% CI 0.42 to 0.84; low-quality evidence,
number needed to treat: 25). ARer CR, a clinically important improvement in short-term disease-specific health-related quality of life may
be evident (Minnesota Living With Heart Failure questionnaire - 17 trials, 18 comparisons (1995 participants): mean diNerence (MD) -7.11
points, 95% CI -10.49 to -3.73; low-quality evidence). Pooling across all studies, regardless of the HRQoL measure used, shows there may be
clinically important improvement with exercise (26 trials, 29 comparisons (3833 participants); standardised mean diNerence (SMD) -0.60,
95% CI -0.82 to -0.39; I2 = 87%; Chi2 = 215.03; low-quality evidence). ExCR eNects appeared to be consistent diNerent models of ExCR delivery:
centre vs. home-based, exercise dose, exercise only vs. comprehensive programmes, and aerobic training alone vs aerobic plus resistance
programmes.
Authors' conclusions
This updated Cochrane Review provides additional randomised evidence (11 trials) to support the conclusions of the previous version
(2014) of this Cochane Review. Compared to no exercise control, CR appears to have no impact on mortality in the short term (< 12 months'
follow-up). Low- to moderate-quality evidence shows that CR probably reduces the risk of all-cause hospital admissions and may reduce
HF-specific hospital admissions in the short term (up to 12 months). CR may confer a clinically important improvement in health-related
quality of life, although we remain uncertain about this because the evidence is of low quality. Future ExCR trials need to continue to
consider the recruitment of traditionally less represented HF patient groups including older, female, and HFpEF patients, and alternative
CR delivery settings including home- and using technology-based programmes.
P L A I N   L A N G U A G E   S U M M A R Y
Exercise-based cardiac rehabilitation for heart failure
Background
People with heart failure (HF) experience fatigue and shortness of breath. This negatively aNects their activities of daily living and health-
related quality of life. They are at increased risk of hospital admission and death.
Study characteristics
We searched the scientific literature for randomised controlled trials (experiments in which two or more interventions, possibly including a
control intervention or no intervention, are compared by randomly allocating participants to study groups). We looked at the eNectiveness
of exercise-based rehabilitation compared with no exercise in adults (over 18 years of age) with heart failure. We considered HF due to
reduced ejection fraction (HFrEF) (i.e. the chambers of the heart contract poorly, and, as a result, a smaller volume of blood is pumped
around the body). We also considered HF due to preserved ejection fraction (HFpEF) (i.e. the chambers of the heart contract normally but
do not relax eNiciently, resulting in a smaller volume of blood pumped around the body). Our search is current to January 2018.
Key results
We found 44 studies that included 5783 people with HF, mainly HFrEF. The findings of this update are broadly consistent with those of the
previous (2014) version of this Cochrane Review. They show important benefits of exercise-based rehabilitation that include a probable
reduction in the risk of overall hospital admissions in the short term, as well as the potential for reduction in heart failure admissions.
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The eNect of exercise-based rehabilitation on health-related quality of life is uncertain due to very low-quality evidence. Exercise-based
rehabilitation may make little or no diNerence in all-cause mortality in trials with follow-up less than 12 months. Further evidence is needed
to better show the eNects of exercise rehabilitation among people with HFpEF and the impact of alternative models of delivery, such as
home-based programmes.
Quality of evidence
Generally, recent trials have been better reported and are at low to moderate risk of bias. Using the GRADE method, we assessed the quality
of evidence to range from high to very low across measured outcomes. Common reasons for downgrading outcomes include that results
were inconsistent and/or imprecise.
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Summary of findings for the main comparison.   Exercise-based cardiac rehabilitation compared to usual care for heart failure
Exercise-based cardiac rehabilitation compared to usual care for heart failure
Patient or population: adults with heart failure
Setting: hospital-based, community-based, and home-based settings
Intervention: exercise-based cardiac rehabilitation
Comparison: usual care
Anticipated absolute effects*
(95% CI)
Outcomes
Risk with
usual care
Risk with all
exercise in-
terventions
Relative ef-
fect
(95% CI)
No. of partic-
ipants
(studies)
Certainty of
the evidence
(GRADE)
Comments
All-cause
mortali-
ty up to 12
months' fol-
low-up (all
studies)
Range: 6 to
12 months
58 per 1000 52 per 1000
(38 to 70)
RR 0.89
(0.66 to 1.21)
2596
(27 RCTs, 28
comparisons)
⊕⊕⊝⊝
LOWa,b
Overall. exercise-based CR may make little or no difference in all-
cause mortality in the short term (up to 12 months). Six studies
had no events in either the intervention arm or the control arm
Sensitivity analysis from studies at low risk of bias show similar
treatment effects (RR 0.9, 95% CI 0.6 to 1.34; participants = 1651;
studies = 16; I2 = 0%). From these studies, exercise-based cardiac
rehabilitation probably makes little or no difference in all-cause
mortality in the short term. Studies were downgraded due to im-
precision (small number of events < 300)
Overall, exercise-based CR has a tendency towards a slight reduc-
tion in all-cause mortality in the medium term (over 12 months)
based on the large HF-ACTION study (RR 0.88, 95% CI 0.75 to 1.02;
participants = 2845; studies = 6; I2 = 34%; high-quality evidence as
assessed via GRADE)
HF-related
mortality
- - - - - Studies did not consistently report deaths due to HF nor sudden
deaths
Hospital ad-
mission up to
12 months'
follow-up (all
studies)
237 per 1000 166 per 1000
(142 to 197)
RR 0.70
(0.60 to 0.83)
2182
(21 RCTs)
⊕⊕⊕⊝
MODERATEc
Overall exercise-based CR probably improves hospital admissions
in the short term (up to 12 months)
Sensitivity analysis from studies at low risk of bias was higher (RR
0.74, 95% CI 0.59 to 0.92; participants = 1161; studies = 9; I2 =0%)
Based on low risk of bias studies, exercise-based CR may improve
hospital admissions in the short term (up to 12 months). Studies
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Range: 6 to
12 months
were downgraded due to imprecision (small number of events <
300 and confidence intervals including potential for no benefit and
important benefit, as 95% CI crosses RR of 0.75)
Overall, we are uncertain whether exercise-based CR improves
hospital admissions in the medium term (over 12 months) (RR 0.7,
95% CI 0.47 to 1.05; participants = 2691; studies = 6; I2 = 66%; very
low-quality evidence as assessed via GRADE) (see footnotes c, d
and e for reasons for downgrade)
Hospital ad-
mission heart
failure only
(all studies)
Range: 6
months to
6.2 years
111 per 1000 65 per 1000
(46 to 93)
RR 0.59
(0.42 to 0.84)
1114
(14 RCTs, 15
comparisons)
⊕⊕⊝⊝
LOWb,f
Overall, exercise-based CR may improve hospital admissions for
heart failure only in the medium term (over 12 months)
Sensitivity analysis from studies at low risk of bias was higher (RR
0.61, 95% CI 0.36 to 1.04; participants = 588; studies = 6; I2 = 10%)
Based on low risk of bias studies, exercise-based CR may make lit-
tle or no difference in hospital admissions for heart failure only.
Studies were downgraded due to imprecision (small number of
events < 300 and confidence intervals including potential for no
benefit and important benefit, as 95% CI crosses RR of 0.75)
Health-re-
lated quali-
ty of life - ML-
WHF up to 12
months' fol-
low-up (all
studies)
Range: 6 to
12 months
Mean 18 to 56 MD 7.11 lower
(10.49 lower
to 3.73 lower)
- 1995
(17 RCTs, 18
comparisons)
⊕⊕⊝⊝
LOWf,g
Overall, exercise-based CR may improve health-related quality of
life in the short term (up to 12 months)
Sensitivity analysis from studies at low risk of bias was lower (MD
3.38 lower, 95% CI 6.95 lower to 0.19 higher; participants = 1101;
studies = 9; I2 = 71%)
Based on low risk of bias studies, exercise-based cardiac rehabili-
tation may confer little or no benefit for health-related quality of
life in the short term (up to 12 months) Studies were downgraded
due to imprecision (confidence intervals including potential for no
benefit and important clinical benefit) and inconsistency (I2 = 71%)
Overall, we are uncertain whether exercise-based CR improves
health-related quality of life in the medium term (longer than 12
months) (MD 9.49 lower, 95% CI 17.48 lower to 1.5 lower; partici-
pants = 329; studies = 3; I2 = 73%; very low-quality evidence as as-
sessed via GRADE) (see footnotes h, i, and j for reasons for down-
grade)
Health-relat-
ed quality of
life - MLWHF
and other
scales up to
12 months'
Mean 18 to 71 SMD 0.60 low-
er (0.82 lower
to 0.39 lower)
- 3833
(26 RCTs, 29
comparisons)
⊕⊕⊝⊝
LOWf,k
Overall, exercise-based CR may improve health-related quality of
life in the short term (up to 12 months)
Sensitivity analysis from studies at low risk of bias was similar
(SMD 0.42 lower, 95% CI 0.65 lower to 0.19 lower; participants =
3181; studies = 16; I2 = 84%)
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follow-up (all
studies)
Range: 6 to
30 months
Based on low risk of bias studies, exercise-based cardiac rehabili-
tation probably improves health-related quality of life in the short
term (up to 12 months). Studies were downgraded due to inconsis-
tency (I2 = 84%)
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: confidence interval; CR: cardiac rehabilitation; HF: heart failure; MD: mean difference; MLWHF: Minnesota Living With Heart Failure questionnaire; OR: odds ratio; RCT:
randomised controlled trial; RR: risk ratio; SMD: standardised mean difference.
GRADE Working Group grades of evidence.
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
aSome concerns with random sequence generation and allocation concealment; bias likely - therefore quality of evidence downgraded by one level.
bImprecise due to small numbers of events (< 300) (Ryan 2016); therefore quality of evidence downgraded by one level.
cSome concerns with random sequence generation, allocation concealment, and groups balanced at baseline; bias likely - therefore quality of evidence downgraded by one level.
dInconsistent directions of eNect and substantial statistical heterogeneity (I2 = 66%); therefore quality of evidence downgraded by one level.
eImprecise due to confidence intervals, including potential for no benefit and important benefit, as 95% CI crosses RR of 0.75; therefore quality of evidence downgraded by one
level.
f Some concerns with random sequence generation, allocation concealment, and blinding of outcome assessment; bias likely - therefore quality of evidence downgraded by
one level.
gInconsistency with considerable statistical heterogeneity (I2 = 82%); therefore quality of evidence downgraded by one level.
hSome concerns with random sequence generation, allocation concealment, blinding of outcome assessment, intention-to-treat analysis, and groups not receiving the same
intervention; bias likely - therefore quality of evidence downgraded by two levels.
iInconsistency with substantial statistical heterogeneity (I2 = 73%); therefore quality of evidence downgraded by one level.
jImprecise due to small number of participants (< 400) (Ryan 2016); therefore quality of evidence downgraded by one level.
kInconsistency with considerable statistical heterogeneity (I2 = 86%); therefore quality of evidence downgraded by one level.
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B A C K G R O U N D
Description of the condition
Chronic heart failure (HF) is a growing global health challenge
(Braunwald 2015; Ziaeian 2016), with increasing prevalence as
reported in Braunwald 2015 and an annual economic burden
predicted to grow to more than USD108 billion per annum as the
population ages (Cook 2014). Unplanned hospital admissions are a
key driver of the cost of HF (Cook 2014).
Patients with HF experience substantial burden that includes
exercise intolerance, poor health-related quality of life (HRQoL),
mortality, increased hospital admissions, and higher healthcare
costs (Braunwald 2015; Ziaeian 2016). With important gains in
mortality achieved over the past decade through pharmacological
and device therapy in patients with HF with reduced ejection
fraction (HFrEF) (Braunwald 2015), the focus is increasingly shiRing
towards HRQoL (Calvert 2007).
Heart failure has two main subcategories: HF with impaired leR
ventricular contraction, which results in a reduced ejection fraction
(< 45% to 50%), known as HF with reduced ejection fraction (HFrEF)
(ACCF/AHA 2013); and HF with preserved ejection fraction (HFpEF),
with an ejection fraction greater than 45% to 50% (Dunley 2017;
Lam 2011). Whilst epidemiological data show that approximately
half of all patients with HF have HFpEF (Dunley 2017), only more
recent trials of drug and medical device therapies have recruited
this patient subgroup. Although drug therapy and device therapy
have helped to improve outcomes in HFrEF, the prognosis in HFpEF
largely remains unchanged. No large-scale randomised trials have
demonstrated treatment benefits that alter the natural course of
HFpEF, or that lower mortality (Holland 2011; Komajda 2017).
Description of the intervention
The British Association for Cardiovascular Prevention and
Rehabilitation (BACPR) defines cardiac rehabilitation (CR) as: "the
coordinated sum of activities required to influence favourably the
underlying cause of cardiovascular disease, as well as to provide
the best possible physical, mental and social conditions, so that
the patients may, by their own eNorts, preserve or resume optimal
functioning in their community and, through improved health
behaviour, slow or reverse progression of disease" (BACPR 2017).
This definition emphasises that whilst the central component of
CR is exercise training (Piepoli 1998; Piepoli 2015), CR programmes
should be comprehensive and should provide risk factor and
lifestyle education on risk factor management plus counselling and
psychological support (Corra 2005).
Based on current evidence on clinical outcomes and costs,
national and international guidelines on the management of HF,
including those of the American College of Cardiology/American
Heart Association, the European Society of Cardiology, and the
National Institute for Health and Care Excellence (NICE) in the UK,
consistently recommend CR as an eNective and safe intervention
(ACCF/AHA 2013; ESC 2016; NICE 2018). However, surveys in the
United States and Europe have shown that the current uptake of
CR for HF remains suboptimal, with less than 20% of HF patients
receiving rehabilitation (Bjarnason-Wehrens 2010; Golwala 2015).
To improve access to and uptake of CR for HF, there have been calls
for alternative models to centre-based CR, including home-based
and technology-based provisions (Dalal 2015).
How the intervention might work
Exercise-based CR might benefit patients with HF through a variety
of mechanisms. First, for people with an ischaemic cause of HF,
exercise training improves myocardial perfusion by alleviating
endothelial dysfunction, thereby dilating coronary vessels, and
by stimulating new vessel formation by way of intermittent
ischaemia (ExTraMatch 2004). Indeed, Belardinelli and colleagues
have demonstrated that aerobic training improves myocardial
contractility and diastolic filling (Belardinelli 1998). In addition, a
meta-analysis by Haykowsky and associates shows the benefits
of exercise training for cardiac remodelling, as measured by
ejection fraction, end-diastolic volume, and end-systolic volume
(Haykowsky 2007). Regardless of the cause, HF is characterised
by important neurohormonal and musculoskeletal abnormalities.
Exercise training may reduce adrenergic tone and increase vagal
tone, as suggested by an assessment of variability in heart rate.
Skeletal muscle dysfunction and wasting may also respond to
exercise training (ExTraMatch 2004). Regular physical activity in
people with HF has been shown to stimulate vasodilation in the
skeletal muscle vasculature (Hambrecht 1998).
Why it is important to do this review
This is an update of a Cochrane review published in 2014. The
first Cochrane systematic review of exercise-based CR for HF
in 2004 concluded that exercise training improved short-term
(up to one-year follow-up) exercise capacity compared with no
exercise control (Rees 2004). However, only one of the 29 included
randomised controlled trials (RCTs) was formally powered for
hospitalisation and mortality. Few trials at that time assessed
HRQoL. Accepting the evidence for improvement in short-term
exercise capacity, the updated 2010 Cochrane Review focussed on
trials providing follow-up of six months or longer that reported
clinical events (mortality, hospitalisation) or HRQoL (Davies 2010).
The 2010 review of 19 randomised trials (3647 participants)
showed no diNerence between exercise and control in either short-
term or long-term all-cause mortality, a reduction in HF-related
hospitalisations (risk ratio (RR) 0.72, 95% confidence interval
(CI) 0.52 to 0.99), and improvement in patient-reported HRQoL
(standardised mean diNerence (SMD) 20.63, 95% CI 20.37 to 20.80)
with exercise therapy. Most of the trials included in the 2010 review
included men with New York Heart Association (NYHA) class II
to III disease. None of these trials included people with HFpEF,
and programmes were delivered only in a centre-based setting.
The 2014 review of 33 RCTs (4740 participants) presented findings
consistent with the previous (2010) version and concluded that
exercise-based CR reduced the risk of hospital admission due to HF
and led to improvements in HRQoL compared with no exercise. To
continue to promote international access and uptake of CR for HF,
the current evidence base must be updated to reflect recent trials
that are increasingly testing alternative models to centre-based CR,
such as home- and technology-based programmes (Dalal 2015).
By gathering additional RCT evidence provided since the 2014
Cochrane review, and by performing a GRADE analysis, authors of
this review update sought to reassess the eNectiveness of exercise-
based CR in terms of mortality, hospital admissions, morbidity,
and HRQoL of people with HF compared with no exercise training,
regardless of setting.
Exercise-based cardiac rehabilitation for adults with heart failure (Review)
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O B J E C T I V E S
To determine the eNects of exercise-based cardiac rehabilitation on
mortality, hospital admission, and health-related quality of life of
people with heart failure.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included RCTs of a parallel-group or cross-over design that
provided follow-up for at least six months post randomisation.
We chose this follow-up as it is likely to reflect changes in event
outcomes as well as the focus of policy makers.
Types of participants
We included adults aged 18 years or older with HF. We excluded
trials that focussed on participants who had received exercise-
based CR, as previous participant exposure to the intervention
may confound the interpretation of trials. However, if the
trial population consisted primarily of new CR patients who
predominantly had HF, we included the trial.
Types of interventions
We included exercise-based interventions given alone or as
a component of comprehensive CR (defined as programmes
with components such as health education and psychological
interventions, in addition to exercise interventions). The control
group must not have received exercise training but may
have received active intervention (i.e. education, psychological
intervention) or usual medical care alone.
Types of outcome measures
To be included, the study must have intended to assess one or more
of the following outcomes. When reported, we extracted outcome
results at two time points: up to and including 12 months' follow-
up (short-term), and longer than 12 months' follow-up (long-term).
The longest follow-up was included in each time point analysis to
assess treatment eNects.
Primary outcomes• All-cause mortality• HF mortality• Number of participants who experienced an all-cause hospital
admission• Number of participants who experienced an HF-related hospital
admission
These event outcomes reflect both potential eNicacy and harm.
Secondary outcomes• HRQoL assessed by a validated outcome measure (e.g. 36-
item Short Form (SF-36), Minnesota Living With Heart Failure
(MLWHF) questionnaire)• Costs and cost-eNectiveness
Search methods for identification of studies
To update searches from the previous Cochrane Review, we
searched the Cochrane Central Register of Controlled Trials
(CENTRAL), in the Cochrane Library, from January 2013 to 29
January 2018. We also searched MEDLINE, Embase, the Cumulative
Index to Nursing and Allied Health Literature (CINAHL), and
PsycINFO (January 2013 to 30 January 2018), without language
restrictions. We checked Web of Science and bibliographies of
systematic reviews. We examined trial registers (World Health
Organization (WHO) International Clinical Trials Registry Platform
(ICTRP) and Clinicaltrials.gov) twice, on 14 March 2018, and again
on 4 October 2018.
Electronic searches
For this update, we reran searches of the following databases on 29
January 2018 (search strategies presented in Appendix 1).
• CENTRAL, in the Cochrane Library (2017, Issue 12 of 12).• Epub Ahead of Print, In-Process & Other Non-Indexed Citations,
MEDLINE Daily, and MEDLINE (Ovid, 1946 to 29 January 2018).• Embase (Ovid, 1980 to 2018 week 5).• CINAHL (EBSCO, 1937 to 29 January 2018).• PsycINFO (Ovid, 1806 to January week 4 2018).• Web of Science: Science Citation Index - Expanded (SCI-
EXPANDED), Social Sciences CItation Index (SSCI), Arts and
Humanities Citation Index (A&HCI), Conference Proceedings
Citation Index - Science (CPCI-S), Conference Proceedings
Citation Index - Social Science and Humanities (CPCI-SSH)
(Thomson Reuters, 1900 to 29 January 2018).
We used the Cochrane sensitivity-maximising RCT filter for
MEDLINE, and we applied to our Embase search terms
recommended in the Cochrane Handbook for Systematic Reviews
of Interventions (Lefebvre 2011). We applied adaptations of this
filter to CINAHL, PsycINFO, and Web of Science. We imposed no
restrictions on language of publication.
We also conducted a search of two trial registers.
• World Health Organization International Clinical Trials Registry
Platform (WHO ICTRP; www.who.int/ictrp/en).• ClinicalTrials.gov (clinicaltrials.gov).
For the original review and the first update (Davies 2010; Rees 2004),
we searched CENTRAL, in the Cochrane Library (2001, Issue 1; 2007,
Issue 1); MEDLINE; Embase; and CINAHL (1984 to January 2008)
(see Appendix 2 and Appendix 3). The search strategy developed in
2008 for the second review update included broader terms, as this
search was part of a review strategy that sought to identify evidence
for cardiac rehabilitation that included an update of this review
and exercise-based rehabilitation for coronary heart disease (Heran
2011), as well as home- versus centre-based cardiac rehabilitation
(Taylor 2010). For the last update (Taylor 2014), we updated the
search from the previous version (Davies 2010), and we included
CENTRAL, in the Cochrane Library (2013, Issue 1); MEDLINE (Ovid,
30 January 2013 week 4); MEDLINE In-Process (Ovid, 5 February
2013); Embase (Ovid, January 2013 week 5); CINAHL (EBSCOhost, 5
February 2013); and PsycINFO (Ovid, 30 January 2013 week 5). We
made a small addition to the January 2013 search strategy to reflect
more recent use of the terms 'HFPEF' and 'HFREF'.
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Searching other resources
We handsearched the reference lists of all eligible trials and
conducted forward citation searching of all primary studies and
review articles for additional references not identified by electronic
searches. We contacted experts in the field for unpublished and
ongoing trials, and we contacted trial authors for additional
information when necessary. We also examined any relevant
retraction statements and errata for included studies.
Data collection and analysis
Selection of studies
Two review authors (LL and IM) independently screened references
identified by the search strategy by reviewing titles and abstracts
and discarded clearly irrelevant studies. To be selected, abstracts
had to clearly identify the study design, an appropriate population,
and relevant components of the intervention, as described above.
We obtained the full-text reports of all potentially relevant trials,
and two review authors (LL and IM) independently assessed them
for eligibility based on the defined inclusion criteria. We resolved
disagreements by discussion with a third review author (RST). RST
undertook data study selection in previous review versions. We
recorded the selection process in suNicient detail to complete a
PRISMA flow diagram (Figure 1).
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Figure 1.   Study flow diagram.
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Data extraction and management
We extracted relevant data regarding inclusion criteria (study
design; participants; interventions including type of exercise,
frequency, duration, intensity, and modality; comparisons; and
outcomes) and risk of bias (randomisation, blinding, attrition, and
control). Two review authors (LL and IM) independently extracted
data using a standardised data extraction form that had been
piloted on at least one of the studies included in the review.
We resolved disagreements by discussion with a third review
author (RST). We contacted study authors when necessary to seek
clarification on issues of reporting or to obtain further outcome
details. We have detailed excluded studies and reasons for their
exclusion in the Characteristics of excluded studies table.
We extracted the following study characteristics.
• Methods: study design, total duration of study, number of study
centres and locations, study setting, withdrawals, and study
dates.• Participants: N, mean age, age range, gender, severity of
condition, diagnostic criteria, inclusion criteria, and exclusion
criteria.• Interventions: intervention, comparison, and co-interventions.• Outcomes: primary and secondary outcomes and time points
reported.• Notes: trial funding and notable conflicts of interest of trial
authors, when reported.
One review author (RST) transferred data into Review Manager 5.3
(RevMan 2014), and another review author (LL) double-checked
that data were entered correctly by checking study characteristics
for accuracy against the study report.
Assessment of risk of bias in included studies
Factors considered included the quality of random sequence
generation and allocation concealment, selective outcome
reporting, incomplete outcome data, blinding of outcome
assessors, and incomplete outcome data (Higgins 2011). Two
review authors (LL and IM) assessed the risk of bias of eligible trials,
and a third review author (RST) verified the decision. RST undertook
risk of bias assessments in previous review versions. We conducted
a sensitivity analysis and stratified results by risk of bias at the study
level (presence of low risk of bias for either allocation concealment
or sequence generation).
We assessed three additional quality criteria: whether study groups
were balanced at baseline (small trials although randomised
may be subject to chance imbalances), whether intervention and
control groups received comparable care (apart from the exercise
component of the intervention, as this may confound between-
group comparisons), and analysis by intention-to-treat (as stated in
each trial). Two of these criteria (groups balanced at baseline and
groups receiving comparable treatment), agreed upon in advance
by the review authors, have not been validated but have been used
to assess quality in several of our previous Cochrane Reviews on
CR (Taylor 2010; Taylor 2014). We assessed these additional quality
criteria as follows.
Groups balanced at baseline• Low risk of bias: characteristics of participants in the intervention
and control groups at baseline are reported to be comparable or
can be judged to be comparable (e.g. baseline data reported in
Table 1) in terms of likely main prognostic factors• Unclear risk of bias: whether characteristics of participants in
the intervention and control groups are balanced at baseline
is not reported, and reported information is inadequate for
assessment (e.g. no Table 1)• High risk of bias: evidence shows substantive imbalance in the
baseline characteristics of intervention and control groups with
regard to likely major prognostic factors
Groups receiving comparable treatment (except exercise)• Low risk of bias: all co-interventions were delivered equally
across intervention and control groups• Unclear risk of bias: information was insuNicient to assess
whether co-interventions were delivered equally across groups• High risk of bias: co-interventions were not delivered equally
across intervention and control groups
Intention-to-treat analysis• Low risk of bias: the trial reports that study authors conducted
intention-to-treat analyses, and it includes all the principles of
such an analysis (e.g. keeping participants in the intervention
groups to which they were randomised, regardless of the
intervention they actually received; measuring outcome data
on all or most participants (i.e. > 80% of those randomised);
imputing all missing data in the analysis via appropriate
methods (e.g. multiple imputation)• Uncertain risk of bias: it is unclear whether investigators
performed an intention-to-treat analysis• High risk of bias: the trial does not include an intention-
to-treat analysis, or researchers reported substantive loss of
outcome data (e.g. > 20%) and performed analyses according
to imputation methods known to create bias, such as last
observation carried forward
We graded each potential source of bias as high, low, or unclear,
and we provided a quote from the study report together with
a justification for our judgement in the 'Risk of bias' table. We
summarised the 'Risk of bias' judgements across diNerent studies
for each of the domains listed. When information on risk of bias was
related to unpublished data or correspondence with a study author,
we noted this in the 'Risk of bias' table.
When considering treatment eNects, we took into account the risk
of bias for studies that contributed to those outcomes.
Measures of treatment e:ect
We processed data in accordance with the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). We expressed
dichotomous outcomes as risk ratios (RRs) and 95% confidence
intervals (CIs) for each study. For continuous variables, we
compared net changes (i.e. exercise group minus control group
to obtain diNerences) and calculated the mean diNerence (MD)
or the standardised mean diNerence (SMD) and 95% CI for each
study. We calculated SMDs when all studies assessed the same
outcome but measured it in a variety of ways (e.g. diNerent
HRQoL measures). For each trial, we sought the mean change (and
standard deviation (SD)) in outcomes between baseline and follow-
up for both exercise and control groups, and, when not available,
we instead used the absolute mean (and SD) outcome at follow-
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up for both groups. When trials reported more than one HRQoL
outcome subscale or more than one HRQoL measure, we prioritised
inclusion of data in the meta-analysis in the following manner:
(1) the overall or total HRQoL score; and (2) if not available, the
first HRQoL subscale reported. We tabulated all reported HRQoL
outcomes for all measures and all subscales at all follow-up times
included for each. When necessary, we reversed the scores of
HRQoL measures so that a negative between-group diNerence
consistently reflected improvement in HRQoL in favour of exercise-
based CR. We considered treatment eNects for HRQoL in terms
of clinically meaningful diNerences (e.g. we considered a 5-point
diNerence on the MLWHF questionnaire as clinically meaningful)
(Rector 1992).
Unit of analysis issues
For trials with more than one relevant intervention arm included
in the same analysis, we divided the number randomised in the
control group by the number of intervention arms to obtain the
denominator for data analysis. In accordance with Section 16.4
of the Cochrane Handbook for Systematic Reviews of Intervention
(Higgins 2011), if we had included data from cross-over trials,
we would have included both periods of any cross-over trials
identified, assuming that (1) there had been a washout period
considered long enough to reduce carry-over, (2) no irreversible
events such as mortality had occurred, and (3) appropriate
statistical approaches had been used. If we had included cluster
trials, we would have considered whether the reported data
analysis had appropriately taken account of the aggregate nature
of the data.
Dealing with missing data
We contacted investigators or study sponsors to verify key study
characteristics and to obtain missing numerical outcome data
when possible (e.g. when we identified a study as abstract only).
When this was not possible, and when missing data were not
thought to introduce serious bias, we explored the impact of
including such studies on the overall assessment of results by
performing a sensitivity analysis.
Assessment of heterogeneity
We explored heterogeneity among included studies qualitatively
(by comparing the characteristics of included studies) and
quantitatively (using the Chi2 test for heterogeneity and the I2
statistic).
Assessment of reporting biases
We used funnels plots and Egger tests to assess potential small-
study eNects and publication bias for those outcomes with an
adequate number of trials (more than 10) (i.e. all-cause mortality,
hospital admissions, and HRQoL) (Egger 1997; Higgins 2011).
Data synthesis
We processed data in accordance with the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011), and we
undertook meta-analyses when these were meaningful (i.e. when
treatments, participants, and the underlying clinical question were
similar enough for pooling to make sense). We pooled data from
each study using a fixed-eNect model, except when we identified
substantial statistical heterogeneity (I2 statistic > 50%), in which
case we applied a random-eNects model, which provided a more
conservative statistical comparison of the diNerence between
intervention and control, because a confidence interval around a
random-eNects estimate is wider than a confidence interval around
a fixed-eNect estimate. We completed data synthesis and analysis
using Review Manager 5.3 soRware (RevMan 2014).
'Summary of findings' table
Two review authors (LL and IM) independently employed
the Grading of Recommendations Assessment, Development
and Evaluation (GRADE) approach to interpret study results
(Schünemann 2011). We used the five GRADE considerations (study
limitations, consistency of eNect, imprecision, indirectness, and
publication bias) to assess the quality of a body of evidence as
it related to studies that contributed data to the meta-analyses
and narrative summaries for pre-specified outcomes. We resolved
any discrepancies in judgement through discussion. One review
author (LL) used GRADEproGDT soRware (GRADEpro GDT 2015)
to import data from Review Manager to create a 'Summary of
Findings' table that included the following pre-specified outcomes:
all-cause mortality; all-cause hospital admissions; heart failure
hospital admissions; and HRQoL.
Subgroup analysis and investigation of heterogeneity
We explored potential heterogeneity in exercise-based
rehabilitation via two approaches: (1) within-trial subgroup
analyses (supported by subgroup × intervention/control
interaction terms), and (2) between-trial analyses via meta-
regression. We used meta-regression to examine the association
between eNects of exercise on all-cause mortality, all-cause
hospitalisation, and HRQoL (MLWHF or other measures) up to 12
months, as these three outcomes were reported by the greatest
number of trials. The meta-regression included the following
specific study co-variates.
• Mean per cent leR ventricular ejection fraction (LVEF).• Dose of aerobic exercise (calculated as overall number of weeks
of training × mean number of sessions per week × mean duration
of sessions in minutes).• Type of exercise (aerobic training alone or aerobic plus
resistance training).• Mean age.• Sex (per cent male).• Setting (hospital only, home only, both hospital and home).• Type of rehabilitation (exercise only vs comprehensive).• Overall risk of bias ('low', i.e. absence of bias in allocation
concealment and/or sequence generation).• Single centre versus multi-centre.• Publication date.
We added year of publication as an additional study level factor
(pre- vs post-2000) to assess the potential eNect of a change in
the standard of usual care over time, that is, to reflect when
beta blockers, angiotensin-receptor blockers, and angiotensin-
converting enzyme inhibitors became established therapies for HF
(Shekelle 2003). Given the relatively small ratio of trials to co-
variates, we limited meta-regression to univariate analysis (Higgins
2011). We used the permute option in STATA to allow for multiple
testing in meta-regression. Due to the risks of multiple testing, we
used a conservative cut-oN of P < 0.01.
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Sensitivity analysis
We compared the results of meta-analysis including all studies
versus meta-analysis including only those studies judged to have
overall low risk of bias (low risk of allocation concealment or
sequence generation).
R E S U L T S
Description of studies
We have presented the details of studies included in this review
in the Characteristics of included studies table, and reasons for
exclusion in the Characteristics of excluded studies table. We
have detailed the status of ongoing trials in the Characteristics
of ongoing studies table, and we have provided information on
studies awaiting classification in the Characteristics of studies
awaiting classification table.
Results of the search
The electronic search for this update yielded a total of 20,416
titles and abstracts. We identified 11 additional studies through
additional searches. ARer de-duplication, we found that 12,944
studies were eligible for screening. Following screening, we
formally evaluated 92 studies for inclusion or exclusion by
retrieving the full-text publications. We newly included a total
of 11 RCTs (29 publications) in the review, bringing the total of
included studies to 44 (75 publications). Backwards and forwards
searching of the reference lists of eligible publications did not reveal
additional publications for inclusion. We identified three ongoing
trial protocols (NCT01914315; NCT02196038; NCT03041376). We
have summarised the study selection process in the PRISMA flow
diagram (Figure 1).
Included studies
The 2004 and 2010 versions of this Cochrane review contributed
eight (Rees 2004),11 (Davies 2010), and 14 trials to this latest update
(Taylor 2014). We excluded from the 2010 review several trials
included in the 2004 review, as their follow-up was less than six
months, or investigators reported only exercise capacity outcomes.
For this update, we identified 11 additional trials - 13 comparisons
in patients with HF (Antonicelli 2016; Chen 2018; Cowie 2014; Dalal
2018; Dehkordi AH 2015; Du 2018; Giallauria 2008; Kaltsatou 2014;
Lang 2018; Mehani 2013; Reeves 2017). We have summarised the
study selection process in the PRISMA flow diagram shown in Figure
1.
The 44 included trials (75 publications) randomised 5783
participants predominantly with HFrEF and NYHA classes II and
III heart failure. Six trials included an (undefined) proportion of
people with HFpEF (Antonicelli 2016; Davidson 2010; Gary 2010;
Nilsson 2008; Reeves 2017; Wall 2010). Most trials were small,
single-centre studies, and one large trial contributed ˜40% (2331
participants) of all included participants (HF ACTION 2009). The
mean age of participants across the included studies ranged from
51 to 81 years. Studies recruited predominantly men (median 79%),
although evidence shows that recent trials recruited more women.
Only 10 trials reported on ethnicity. Seven trials reported follow-up
in excess of 12 months (Austin 2005; Belardinelli 1999; Belardinelli
2012; Cowie 2014; HF ACTION 2009; Jónsdóttir 2006a; Mueller 2007).
Four trials included more than one exercise intervention arm, and
each contributed two separate comparative arms for the purpose of
the meta-analysis (Cowie 2014; Gary 2010; Kaltsatou 2014; Klocek
2005).
All trials evaluated an aerobic intervention, and 14 studies
(15 comparisons) also included resistance training (Austin 2005;
Chen 2018; DANREHAB 2008; Dracup 2007; Jolly 2009; Jónsdóttir
2006a; Kaltsatou 2014; Koukouvou 2004; McKelvie 2002; Norman
2012; Pozehl 2008; Reeves 2017; Witham 2005; Witham 2012).
Researchers most commonly delivered exercise training in an
exclusively centre-based setting or in a centre-based setting in
combination with some home exercise sessions. Ten studies (13
comparisons) were conducted in a largely home-based setting
(Cowie 2014; Dalal 2018; Dracup 2007; Du 2018; Gary 2010; Jolly
2009; Kaltsatou 2014; Lang 2018; Passino 2006; Wall 2010). The
dose of exercise training ranged widely across studies, with session
duration of 10 to 120 minutes, one to seven sessions per week,
intensity of 40% to 80% maximal heart rate to 50% to 85%
maximal oxygen uptake (VO2 max) to Borg rating 11 to 18, over a
period of eight to 120 weeks. In addition to exercise training, 14
trials included other ('comprehensive rehabilitation') elements that
consisted of educational and psychological interventions (Chen
2018; Cowie 2014; Dalal 2018; DANREHAB 2008; Davidson 2010;
Gary 2010; Jolly 2009; Jónsdóttir 2006a; Lang 2018; Mueller 2007;
Myers 2000; Nilsson 2008; Pozehl 2008; Witham 2012).
All included studies included a no formal exercise training
intervention comparator. However, a wide range of comparators
were seen across studies that included active intervention (i.e.
education, psychological intervention) or usual medical care alone.
All but 18 studies reported their funding sources (Belardinelli
1999; Bocalini 2008; Chen 2018; Davidson 2010; Giallauria 2008;
Giannuzzi 2003; Gielen 2003; Gottlieb 1999; Hambrecht 1995;
Jónsdóttir 2006a; Klocek 2005; Koukouvou 2004; McKelvie 2002;
Mehani 2013; Nilsson 2008; Norman 2012; Passino 2006; Witham
2005). Two studies were funded by the pharmaceutical industry (HF
ACTION 2009; Keteyian 1996).
We have provided details of the studies included in this review in
the Characteristics of included studies table.
Excluded studies
We excluded 63 studies identified in the search for this update
for reasons listed in the Characteristics of excluded studies table.
The most common reason for exclusion was follow-up less than six
months.
In total, we excluded 124 studies (63 studies from this update and
61 studies from the previous review) for the following reasons: 18
(14.5%) studies were not RCTs; one (0.8%) study was a duplicate;
three (2.4%) studies were not conducted in adults with heart failure;
35 (28.2%) studies did not report relevant outcomes; 12 (9.7%)
studies provided an inappropriate intervention; four (3.2%) studies
provided an inappropriate comparator; eight (6.45%) studies
generated no usable data; and 43 (34.7%) studies reported follow-
up less than six months. See Characteristics of excluded studies and
Figure 1.
Ongoing studies and studies awaiting classification
Three clinical trials were still ongoing when we completed this
update (NCT01914315; NCT02196038; NCT03041376).
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Seven studies were completed and are awaiting classification
(ACTR12608000263392; ISRCTN86879094; NCT01033591;
NCT01785121; NCT02078947; NCT02696486; NCT02903225). Two
studies included patients with HFrEF and HFpEF (NCT01785121;
NCT03041376). See Characteristics of ongoing studies and
Characteristics of studies awaiting classification.
Risk of bias in included studies
The overall risk of bias in included trials was generally low or
unclear, and the level of reporting improved in more recent trials
(Figure 2 and Figure 3). Study authors reported particularly poorly
the details of generation and concealment of random allocation
sequence and blinding.
 
Figure 2.   Methodological quality graph: review authors' judgements about each methodological quality item
presented as percentages across all included studies.
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Figure 3.   Methodological quality summary: review authors' judgements about each methodological quality item
for each included study.
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Figure 3.   (Continued)
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Figure 3.   (Continued)
 
Allocation
We judged Austin 2005, Cowie 2014, Dalal 2018, DANREHAB 2008,
Davidson 2010, Dehkordi AH 2015, Du 2018, Hambrecht 2000, HF
ACTION 2009, Jolly 2009, Kaltsatou 2014, Lang 2018, McKelvie 2002,
Reeves 2017, Witham 2005, Witham 2012, and Yeh 2011 to be at low
risk of bias for allocation concealment and/or sequence generation.
All studies randomly allocated participants to study conditions. We
deemed that 27 studies had unclear risk of bias and 16 studies
had low risk of bias in the method used to generate randomisation
sequence. Mehani 2013 had high risk of bias in the method used to
generate randomisation sequence.
A total of 34 studies had unclear risk of bias and 10 studies had low
risk of bias in the methods used to conceal participant allocation.
Blinding
Given the nature of an exercise intervention, it is not possible
to blind participants and carers. However, we judged only three
studies to be at high risk of bias for blinding of outcome assessment
(Austin 2005; Jolly 2009; Norman 2012).
Incomplete outcome data
When reported, losses to follow-up and rates of dropout were
relatively high, ranging from 5% to 40% across studies. We judged
37 studies to be at low risk of bias, as they described the numbers
of and reasons for dropouts, which were balanced across groups.
We judged four studies to be at high risk of bias (Bocalini 2008;
Cowie 2014; Du 2018; Willenheimer 2001). Bocalini provided data
at follow-up for only 42 of 53 (79%) participants. Du had a high
dropout rate in the intervention group (24%) compared to the
control group (14%) and provided no explanation for diNerences
between the two groups. Cowie provided follow-up data for only 46
of 60 participants (77%). Willenheimer reported outcome data for
only 43 of 54 participants (80%) randomised at 10 months' follow-
up. We undertook no imputation or sensitivity analysis to assess
eNects of loss to follow-up in that study, and its authors stated that
participants available at 10 months' follow-up are representative.
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Selective reporting
We judged the risk of selective reporting to be unclear in seven
studies (Antonicelli 2016; Dehkordi AH 2015; Giallauria 2008;
Kaltsatou 2014; McKelvie 2002; Mehani 2013; Passino 2006). We
considered the risk of bias to be high in one additional study
because researchers did not report the outcome 'number of
hospitalisations' and we obtained the data from the study's lead
investigator (Cowie 2014).
Other potential sources of bias
With the exception of three studies (Cowie 2014; Dalal 2018; Lang
2018), all included studies did not provide objective evidence of
imbalance in baseline characteristics. Most studies performed an
intention-to-treat analysis, comparing exercise and control group
outcomes according to the initial random allocation. Because
some studies did not report co-intervention details for both
exercise and control groups, they may be prone to performance
bias (Belardinelli 1999; Giannuzzi 2003; Gielen 2003; Hambrecht
1995; Hambrecht 2000; Keteyian 1996; Klecha 2007; Klocek 2005;
McKelvie 2002; Nilsson 2008; Pozehl 2008).
E:ects of interventions
See: Summary of findings for the main comparison Exercise-
based cardiac rehabilitation compared to usual care for heart
failure
All-cause mortality
A total of 27 studies (28 comparisons; 2596 participants) reported
all-cause mortality at up to 12 months' follow-up. Several trials
reported no deaths in either the exercise or the control arm
(Dehkordi AH 2015; Gielen 2003; Kaltsatou 2014; Klecha 2007; Lang
2018; Reeves 2017). Results show no diNerence in pooled mortality
at up to 12 months' follow-up between groups (intervention
67/1302 (5.1%) vs control 75/1294 (5.8%) events: risk ratio (RR) 0.89,
95% confidence interval (CI) 0.66 to 1.21; P = 0.47; I2 = 0%; Chi2
= 15.85; P = 0.96; fixed-eNect analysis) (Analysis 1.1). We assessed
the evidence to be of low quality via the GRADE method because
of concerns about risk of bias (random sequence generation and
allocation concealment) and concerns about imprecision (small
number of events at < 300) (Ryan 2016).
Austin 2005, Belardinelli 1999, HF ACTION 2009, Jónsdóttir
2006a, and Mueller 2007 reported mortality at 60, 26, 30, 28,
and 74 months, respectively. Although not reported in their
original publication, we obtained mortality data at 10 years from
Belardinelli 2012 by contacting the study authors. We found high-
quality evidence towards a slight reduction in all-cause mortality
when pooled across the longest follow-up point of the six trials (six
comparisons; 2845 participants) with more than 12 months' follow-
up (intervention 244/1418 (17.2%) vs control 280/1427 (19.6%)
events): RR 0.88, 95% CI 0.75 to 1.02; P = 0.09; I2 = 34%; Chi2 =
7.54; P = 0.18; fixed-eNect analysis) (Analysis 1.2). HF ACTION 2009
dominated this eNect estimate. We assessed the evidence to be of
high quality using GRADE.
HF mortality
Studies did not consistently report deaths due to HF.
All-cause hospital admissions
Exercise-based rehabilitation probably reduces the number of
people experiencing all-cause hospital admissions at up to 12
months' follow-up (21 trials; 21 comparisons; 2182 participants)
(intervention 180/1093 (16.5%) vs control 258/1089 (23.7%) events:
RR 0.70, 95% CI 0.60 to 0.83; P = 0.0001; I2 = 19%; Chi2 = 24.56; P =
0.21; fixed-eNect analysis) (Analysis 1.3). Using GRADE, we assessed
the evidence to be of moderate quality because of concerns about
risk of bias (random sequence generation, allocation concealment,
and groups balanced at baseline).
We are uncertain whether exercise-based rehabilitation reduced
all-cause hospital admissions in trials with more than 12
months' follow-up (six trials; seven comparisons; 2691 participants)
(intervention 772/1348 (57.2%) vs control 825/1343 (61.4%) events:
RR 0.70, 95% CI 0.47 to 1.05; P = 0.08; I2 = 66%; Chi2 = 17.81; P
= 0.007) (Analysis 1.4). Using GRADE, we assessed the evidence
to be of very low quality because of concerns about risk of
bias (random sequence generation, allocation concealment, and
groups balanced at baseline), as well as high levels of statistical
heterogeneity and imprecision (confidence intervals including
potential for important harm or benefit).
HF hospital admissions
Exercise-based rehabilitation may reduce HF-specific hospital
admissions (14 trials; 15 comparisons; 1114 participants)
(intervention 40/562 (7.1%) vs control 61/552 (11.1%) events: RR
0.59, 95% CI 0.42 to 0.84; P = 0.003; I2 = 11%; Chi2 = 15.81; P =
0.32) (Analysis 1.5). Using GRADE, we assessed the evidence to
be of low quality because of concerns about risk of bias (random
sequence generation, allocation concealment, and blinding of
outcome assessment) and imprecision due to small numbers of
events (< 300) (Ryan 2016). None of the studies reported HF hospital
admissions at longer than 12 months' follow-up.
Health-related quality of life
Of the 44 included trials, 29 (31 comparisons) reported a validated
HRQoL measure (Table 1). Most studies reported disease-specific
quality of life using the MLWHF questionnaire; HF ACTION 2009
used the Kansas City Cardiomyopathy Questionnaire (KCCQ).
Investigators also assessed generic HRQoL using the EuroQoL
Group Quality of Life Questionnaire based on 5 dimensions (EQ-5D),
the SF-36, the Psychological General Wellbeing index (PGWB),
the Patient's Global Assessment of Quality of Life (PGAQoL),
and Spritzer's Quality of Life Index (QLI). Gottlieb 1999 reported
HRQoL values at follow-up for the exercise group but not for
the control group. Of the 31 comparisons, 18 (55%) reported
statistical superiority in one or more HRQoL domains following
exercise-based CR compared with control. No trials reported a
lower HRQoL domain score with CR than with control.All included
studies included HRQoL outcome at ≥ six months follow up except
Belardinelli 1999 and Reeves 2017 that were reported at around
three months follow up.
Lower MLWHF questionnaire scores indicate better patient HRQoL.
We found evidence of high levels of statistical heterogeneity in the
exercise-control diNerence in MLWHF scores at follow-up across
studies. When pooled across the 17 trials (18 comparisons; 1995
participants) that reported the total MLWHF score up to 12 months'
follow-up, results may show clinically important improvement with
exercise (mean diNerence (MD) -7.11, 95% CI -10.49 to -3.73; P <
Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
18
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
0.0001; I2 = 82%; Chi2 = 93.22; P < 0.00001; random-eNects analysis)
(Analysis 1.6). Using GRADE, we assessed the evidence to be of low
quality because of concerns about risk of bias (random sequence
generation, allocation concealment, and blinding of outcome
assessment) and inconsistency with considerable heterogeneity.
Pooling across all studies, regardless of the HRQoL measure used,
shows there may be clinically important improvement with exercise
at up to 12 months' follow-up (26 trials; 29 comparisons; 3833
participants) (standardised mean diNerence (SMD) -0.60, 95% CI
-0.82 to -0.39; P < 0.0001; I2 = 87%; Chi2 =215.03; P < 0.0001;
random-eNects analysis) (Analysis 1.7). As advised in the Cochrane
Handbook for Systematic Reviews of Interventions, we excluded
McKelvie 2002 from this SMD analysis, as it reported the diNerence
in HRQoL between baseline and follow-up, while all other included
studies were based on final HRQoL outcome scores.
Using GRADE, we assessed this evidence to be of low
quality because of concerns about risk of bias (random
sequence generation, allocation concealment, and blinding of
outcome assessment) and inconsistency along with considerable
heterogeneity. However, it is notable that when considering
evidence from studies at low risk of bias for this outcome, we
judged that exercise-based CR probably improved HRQoL. We are
uncertain whether exercise-based CR improves HRQoL because of
the very low quality of the evidence.
The three trials (three comparisons; 329 participants) that
reported MLWHF score at follow-up greater than 12 months show
improvement compared with control (MD -9.49, 95% CI -17.48
to -1.50; P = 0.02; I2 = 73%; Chi2 = 7.33; P = 0.03; random-
eNects analysis) (Analysis 1.8). Using GRADE, we assessed this
evidence to be of very low quality because of concerns about
risk of bias (random sequence generation, allocation concealment,
blinding of outcome assessment, intention-to-treat analysis, and
groups not receiving the same intervention), inconsistency with
considerable heterogeneity, and imprecision due to small numbers
of participants (< 400) (Ryan 2016).
Costs and cost-e:ectiveness
Six included trials reported economic data, with two undertaking
a full cost-eNectiveness analysis (Georgiou 2001; HF ACTION 2009),
and four reporting costs (Cowie 2014; Dalal 2018; Lang 2018;
Witham 2012) (Table 2). Based on data reported in Belardinelli
1999, Georgiou and colleagues estimated an additional mean
healthcare cost in the exercise training group compared with the
control group of USD3227 per person (Georgiou 2001). Researchers
calculated this cost by subtracting the averted hospitalisation cost
- USD1336/person - from the cost of exercise training and wages
lost due to exercise training - estimated at USD4563/person. Based
on exponential survival modelling to 15.5 years, the estimated
increment in life expectancy with exercise was 1.82 years/person
compared with control, and the incremental cost-eNectiveness
ratio was USD1773/life-year saved. The HF ACTION group estimated
a mean gain in quality-adjusted life-years (QALYs) of 0.03 at an
additional mean cost of USD1161 per person at 2.5 years' follow-
up (HF ACTION 2009). Although they did not report an incremental
cost-eNectiveness ratio, study authors stated that there was an
89.9% probability that exercise training was more cost-eNective
than usual care at a maximum willingness to pay threshold of
USD50,000. Witham and colleagues reported that mean costs in
the exercise group were lower (by £477.85 per person) than in the
control group at six months' follow-up (Witham 2012). This cost
diNerence was primarily the result of a reduction in the days of
hospital admission in the exercise group compared with the control
group. None of the between-group diNerences in costs or outcomes
across these three studies achieved statistical significance at P =
0.05 or less. Cowie 2014 reported that CR programmes incurred
similar costs, whether delivered in the patient's home (£196.53 per
patient) or in a supervised hospital setting (£221.58 per patient).
Meta-regression
We examined predictors of all-cause mortality, all-cause
hospitalisation, and HRQoL intervention eNects (follow-up of 12
months or less) using univariate meta-regression. The no evidence
of signficant association (at P<0.05) between outcomes and study
level covariates with the expection of study risk of bias (Table 3).
The eNect size for HRQoL and hospiatlisation for studies at high risk
of bias were larger than for studies at low risk of bias.
Within-trial subgroup analyses
Several study authors reported that they had undertaken subgroup
analyses. However, most of these analyses were not based on
a formal subgroup interaction test with the intervention eNect
but instead on a cross-sectional association between particular
participant characteristics and outcomes (e.g. association between
participant age at baseline and mortality (regardless of exercise
or control group allocation)) (Austin 2005; Belardinelli 1999;
Belardinelli 2012; Davidson 2010; Klocek 2005). Two studies
reported subgroup analyses when the methods were unclear
(Pozehl 2008; Yeh 2011). Only the large HF ACTION trial undertook
pre-defined formal interaction tests of diNerences in intervention
eNects between subgroups. HF ACTION study authors reported no
evidence of diNerences in intervention eNects as assessed for either
the primary outcome (all-cause mortality or hospitalisation) or
HRQoL (Kansas City Cardiomyopathy Questionnaire (KCCQ) overall
score) across several participant-defined subgroups (Table 4). The
HF ACTION group also undertook a large post hoc observational
analysis of people assigned to exercise training (Keteyian 2012).
This analysis shows that the volume of exercise undertaken by
participants was associated with the risk for clinical events, and
moderate levels (3 to 7 metabolic equivalent (MET) hours per week)
of exercise were needed to derive clinical benefit.
Small-study bias
We found no evidence of funnel plot asymmetry for all-cause
mortality or hospitalisations, nor for all HRQoL scores (Egger test P
> 0.05) (Figure 4 Figure 5 Figure 6 and Figure 7). However, we found
evidence of asymmetry for MLWHF measures (Egger test P < 0.0001)
(Figure 8).
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Figure 4.   Funnel plot of comparison: 1 All exercise interventions versus usual care, outcome: 1.1 All-cause mortality
up to 12 months' follow-up.
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Figure 5.   Funnel plot of comparison: 1 All exercise interventions versus usual care, outcome: 1.3 Hospital admission
up to 12 months' follow-up.
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Figure 6.   Funnel plot of comparison: 1 All exercise interventions versus usual care, outcome: 1.5 Hospital admission
heart failure only.
 
 
Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
22
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Figure 7.   Funnel plot of comparison: 1 All exercise interventions versus usual care, outcome: 1.6 Health-related
quality of life - MLWHF up to 12 months' follow-up.
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Figure 8.   Funnel plot of comparison: 1 All exercise interventions versus usual care, outcome: 1.7 Health-related
quality of life - MLWHF and other scales up to 12 months' follow-up.
 
D I S C U S S I O N
Summary of main results
This review update shows that, based on low-quality evidence,
when compared with no exercise control, exercise-based cardiac
rehabilitation (CR) may have little or no eNect on the risk of
short-term (up to 12 months' follow-up) all-cause mortality. The
included studies did not provide data on heart failure (HF)-related
mortality. High-quality evidence shows a slight reduction in all-
cause mortality in trials on exercise-based CR with follow-up in
excess of 12 months. Low-quality evidence suggests a reduction in
hospital admissions related to HF. Because evidence is of very low
quality, we are uncertain about the eNects of exercise-based CR on
health-related quality of life (HRQoL). It is important to note that
statistical heterogeneity was substantial among studies assessing
HRQoL. Although studies support the cost-eNectiveness of exercise-
based CR compared to control, available evidence is sparse.
Overall completeness and applicability of evidence
The generalisability of the previous version of this review was
limited as most included studies recruited only low- to moderate-
risk younger men. However, with inclusion of more women, older
patients, and people with HF with preserved ejection fraction
(HFpEF) in recent trials, and with more trials of CR delivered in
a home-based setting, the findings of this updated review have
potentially greater external validity and applicability.
Quality of the evidence
The general lack of reporting of methods used in the included
trials makes it diNicult to assess their methodological quality; we
therefore judged them to be at unclear risk of bias. Evidence of
a large treatment eNect for HRQoL outcomes in studies judged
to be at overall high risk of bias compared with studies at low
risk of bias suggests that risk of bias may be a major driver of
the substantive statistical heterogeneity seen across trials for this
outcome. Improvement in the quality of reporting is apparent in
more recent trials.
Using the GRADE method, we assessed the quality of evidence to
range from high to very low across outcomes. We downgraded
outcomes for hospital admissions (both all-cause over 12 months'
follow-up and HF-related admissions) for risk of both bias
and imprecision. In addition, we downgraded all-cause hospital
admissions over 12 months' follow-up for inconsistency. We
downgraded all-cause re-admissions at up to 12 months only for
risk of bias. We downgraded all HRQoL outcomes for risk of bias
and inconsistency, with HRQoL measured by the Minnesota Living
With Heart Failure questionnaire (MLWHF) over 12 months' follow-
up downgraded for imprecision, in addition to risk of bias and
inconsistency. We downgraded all-cause mortality up to 12 months
for risk of bias and imprecision; we considered evidence for all-
cause mortality over 12 months to be of high quality and did not
downgrade it based on any GRADE criteria.
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Potential biases in the review process
We believe this is the most comprehensive systematic review to
date of randomised controlled trial (RCT) evidence on the impact
of exercise-based CR for people with HF. However, our review has
some limitations. The overall risk of bias of included trials was
generally low or unclear, although evidence shows improvement
in the level of reporting in trials published over the last five to ten
years. However, details of generation and concealment of random
allocation sequence and blinding of outcome assessments were
particularly poorly reported and therefore were subject to bias.
Funnel plot asymmetry for HRQoL is indicative of small-study
bias and possible publication bias. Although a specific goal of
this updated review was to clarify the impact of exercise training
programmes on clinical events, many included trials were relatively
small and provided short-term follow-up (< 12 months), so that
the numbers of deaths and hospitalisations reported by most trials
were small. Indeed, for many studies, we located event data in the
trial descriptions of losses to follow-up and exclusions rather than
as reported outcomes per se. All included studies included a no
formal exercise training intervention comparator. However, a wide
range of comparators were seen across studies that included active
intervention (i.e. education, psychological intervention) or usual
medical care alone.
Agreements and disagreements with other studies or
reviews
The individual patient data (IPD) meta-analysis (Exercise Training
Meta-Analysis of Trials for Chronic Heart Failure - ExTraMATCH)
was origjnally published in 2004 (ExTraMatch 2004); recently the
ExTraMATCH II collaboration updated this IPD meta-analysis based
on RCTs included in the 2014 Cochrane review (ExTraMATCH
II; Taylor 2014). The ExTraMATCH II events analysis included
data obtained from 18 trials including 3912 participants with
HF with reduced ejection fraction (HFrEF). Collaboration authors
reported that, compared to control data, they found no statistically
significant diNerences in pooled time to event estimates in favour
of ExCR, although confidence intervals (CIs) were wide (all-cause
mortality: hazard ratio (HR) 0.83, 95% CI 0.67 to 1.04; HF-specific
mortality: HR 0.84, 95% CI 0.49 to 1.46; all-cause hospitalisation:
HR 0.90, 95% CI 0.76 to 1.06; and HF-specific hospitalisation: HR
0.98, 95% CI 0.72 to 1.35). Lack of statistically significant impact
of CR on all-cause mortality is consistent with the findings of this
updated Cochrane Review. However, the finding of no reduction
in all-cause or HF hospitalisations with CR contrasts with the
information provided in this update and in the 2014 version of
this Cochrane Review. A possible explanation for this diNerence is
that the ExTraMATCH II authors were not able to obtain participant
data from all trial authors, and that not all included trials collected
hospitalisation data as a time-to-event outcome. The ExTraMATCH
II authors also noted a limitation of their analysis, which showed
lack of consistency in how our included trials with IPD defined
and collected clinical event outcome data. As noted in recent
commentaries on clinical events, in HF trials, with the exception of
all-cause mortality, the collection and reporting of other outcomes
including cause-specific mortality and hospitalisation can be prone
to confounding and bias (Zannad 2013). In accord with this
Cochrane Review update, ExTraMATCH II found no strong evidence
of diNerential eNects of CR across patient characteristics (i.e.
age, sex, ethnicity, New York Heart Association (NYHA) functional
class, ischaemic aetiology, ejection fraction, exercise capacity) on
mortality or hospitalisation outcomes.
Our findings are consistent with those of other systematic reviews/
meta-analyses of RCTs for CR for HF published since the 2014
version of this review. Zhang and colleagues collated trial-level
data from 2533 patients with HF enrolled in 28 published RCTs
(Zhang 2018). Based on the MLWHF questionnaire, study authors
reported a similar magnitude of pooled improvement in HRQoL
(mean -6.8, 95% CI -3.9 to -9.7; P < 0.0001). Similarly, based on eight
RCTs including 317 participants with HFpEF, Chen and colleagues
reported a pooled improvement in MLWHF score of -6.8 (95% CI -9.7
to -3.8; P < 0.0001) (Chen 2018). Finally, in accord with our updated
Cochrane Review, Vromen 2018 found in a meta-regression analysis
that CR exercise programme characteristics of frequency, intensity,
and session duration were not predictive of CR outcomes. However,
exercise programmes with higher overall energy expenditure did
lead to better exercise capacity outcomes.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
Results of this update review show that CR results in clinical
improvement in HRQoL and reduces risk of hospitalisation, and
that these benefits appear to be consistent across ExCR programme
characteristics (including centre and home CR settings) and
support the recommendations provided in current international
clinical guidelines that the oNer of exercise-based CR should be
made taking account of patient's preference for CR setting (ACCF/
AHA 2013; ESC 2016; NICE 2018).
Implications for research
Despite clinical guidelines stating support of exercise-based CR
for management of HF, internationally the provision and uptake
of rehabilitation in HF remain poor (Bjarnason-Wehrens 2010;
Golwala 2015). Further robust randomised trials are needed to
assess the clinical eNectiveness and economic value (costs and
cost-eNectiveness) of alternative models of exercise-based CR
delivered as conventional centre-based programmes, as well as
home- and technology-based programmes. Future trials must
consider the generalisability of trial populations (women, older
people, and people with HFpEF remain under-represented in trial
populations); application of interventions to enhance long-term
maintenance of exercise training and outcomes (Karmali 2014); and
costs and cost-eNectiveness of exercise-based CR programmes.
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C H A R A C T E R I S T I C S   O F   S T U D I E S
Characteristics of included studies [ordered by study ID]
 
Methods Parallel-group RCT
Participants N randomised: 343 (exercise 170, control 173)
Diagnosis (% of pts):
Aetiology: ischaemic 49%, hypertension 36%, valvular 15%
LVEF: total 48.4 ± 13.4%, exercise 47.9 ± 13.3%, control 49 ± 13.4%
NYHA: not reported
Case mix: not reported
Age (mean ± SD), years: total 76.9 ± 5.67, exercise 76.21 ± 5.21, control 77.6 ± 6.02
Percentage male: total 56.9%, exercise 60.6%, control 53.2%
Percentage white: not reported
Inclusion/exclusion criteria:
Inclusion: inpatients or outpatients > 70 years of age, CHF from any cause with reduced or preserved
ejection fraction (EF), NYHA functional class ≥ II, Mini Mental State Examination score > 24
Exclusion: survival prognosis < 6 months, severe uncontrolled diabetes, acute heart decompensation
in previous 2 months, severe chronic obstructive pulmonary disease, severe liver failure with survival
prognosis < 12 months; severe chronic kidney disease with glomerular filtration rate < 15 mL/min/1.73
m2, severe disabling systemic disease, severe cognitive impairment, inability to perform ET
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: aerobic (cycling)
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Frequency: 3 sessions/week (for 24 weeks)
Duration: 50 minutes (30 minutes on cycle ergometer)
Intensity: 20 minutes intense exercise on cycle ergometer per exercise session (60 rpm, achieving 60%
to 70% maximum predicted heart rate)
Modality: cycle ergometer
Settings: hospital and home
Other: supervised (face-to-face by physiotherapist in hospital and remotely by nurse via telemonitoring
at home)
Control group / Comparison:
Usual care (medication, education/advice on discharge from hospital); GP appointment within 2 weeks
of discharge and hospital cardiologist appointment at 12 months
Outcomes All-cause hospital admissions; HRQoL (MLWHF)
Country and setting Italy
Single centre
Follow-up 3 months and 6 months
Notes Exercise group received heart failure education
Source of funding: strategic project grant of the Italian Ministry of Health, 2007: "Modelli riabilitativi
multi-disciplinari: i nuovi farmaci per il paziente anziano con scompenso cardiaco cronico?". Part of the
2007 I.N.R.C.A. Strategic Program, RFPS-2007-6-654027: "Assessment of biological parameter changes
induced by the rehabilitation program in elderly patients with congestive heart failure". This work was
also supported by grants from TERPAGE project POR Marche FESR 2007-2013 Italy to RA and FO; and
Universita Politecnica delle Marche, Italy, to FO
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk No description of the randomisation process provided
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Unclear risk No protocol identified
Intention-to-treat analy-
sis?
Low risk Although the term ITT was not stated, it appears from the CONSORT diagram
that ITT analysis was undertaken
Incomplete outcome da-
ta?
Low risk All withdrawals and dropouts were described
Exercise: 20/170 (11.8%) lost to follow-up
Control: 10/173 (5.8%) lost to follow-up
Antonicelli 2016  (Continued)
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Groups balanced at base-
line?
Low risk "There were no differences between the two groups at baseline"
Groups received same in-
tervention?
Low risk All participants continued with usual medication and received education/ad-
vice before discharge from the hospital
Antonicelli 2016  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 200 (exercise 100, control 100)
Diagnosis (% of participants):
Aetiology: ischaemia 77%, hypertension 15.5%, DCM 5.5%, other 2%
NYHA: Class II 51.5%, Class III 48.5%
LVEF: 40% to 35%: 16.5%; < 35% to 30%: 45%; < 30%: 38.5%
Case mix: 100%, as above
Age, years: exercise 71.9 (SD 6.3), control 71.8 (SD 6.8)
Male: 43%
White: not reported
Inclusion/exclusion criteria:
Inclusion: age > 60 years, NYHA Class II or III, LVSD < 40% as confirmed by echocardiography
Exclusion: diastolic dysfunction, significant co-morbidity preventing entry into the study because of
terminal disease or inability to exercise (e.g. severe musculoskeletal disorder, unstable IHD, advanced
valvular disease), resident outside the catchment area or in a long-term care establishment
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: aerobic endurance training and low resistance training/high repetitive muscu-
lar strength work
Frequency: 2 sessions/week (for 8 weeks), 1 session/week (for 16 weeks) plus 3 sessions/week at home
Duration: 2.5-hour class (for 8 weeks) and 1-hour class (for next 16 weeks)
Intensity: not reported
Modality: not reported
Settings: hospital and home
Other: none
Control group / Comparison:
Standard care group (including monitoring of clinical status, explanation of HF and its treatment, self-
monitoring, dietary advice, and contact details of clinical nurse specialist)
Outcomes HRQoL (MLWHF questionnaire and EuroQol/EQ-5D); healthcare utilisation (length of stay in hospital,
admissions arising from heart disease, prescribed HF medication); mortality
Austin 2005 
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Country and setting UK
Single centre
Follow-up 6 months and 5 years (after randomisation)
Notes Source of funding: Nevill Hall Coronary and Research Thrombosis Fund, North Gwent Cardiac After
Care Charity, Gwent Healthcare Trust, University of Glamorgan
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "A computer was used to generate a list of random numbers"
Allocation concealment
(selection bias)
Low risk "The numbers, placed in plain sealed envelopes by a university colleague pri-
or to patient recruitment, were allocated to the participants by a hospital col-
league unconnected with the study. The allocation schedule was not broken
until the trial was completed"
Blinding (performance
bias and detection bias) 
All outcomes
High risk Not for HRQoL; data on deaths, admissions from hospital records department
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk Although the term ITT was not stated, it appears from the CONSORT diagram
that ITT analysis was undertaken
Incomplete outcome da-
ta?
Low risk CONSORT diagram was presented, showing participant flow. No imputation or
sensitivity analysis was done to assess the impact of loss to follow-up
Groups balanced at base-
line?
Low risk "There are no significant differences in the baseline parameters of the stan-
dard care and experimental groups"
Groups received same in-
tervention?
Low risk Yes, both groups received usual medical care; the only difference between
groups was the exercise intervention provided
Austin 2005  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 99 (exercise 50, control 49)
Diagnosis (% of participants):
Aetiology: ischaemic cardiomyopathy 85%, idiopathic DCM 15%
NYHA: Class II 49%, Class III 34%, Class IV 17%
LVEF: exercise 28.4 (SD 6), control 27.9 (SD 5)
Case mix: see above
Age, years: exercise 56 (SD 7), control 53 (SD 9)
Belardinelli 1999 
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Male: 89%
White: not reported
Inclusion/exclusion criteria:
Inclusion: HF, LVEF < 40%, sinus rhythm, diagnosis of CHF based on clinical symptoms and signs with or
without radiological evidence of pulmonary congestion
Exclusion: unstable angina, recent acute MI, decompensated congestive HF, haemodynamically signifi-
cant valvular heart disease, significant chronic pulmonary illness, uncontrolled hypertension, renal in-
sufficiency (serum creatinine > 2.5 mg/dL), orthopaedic or neurological limitations
Interventions Exercise:
Total duration: 14 months; 8 weeks supervised, then 12 months maintenance
Aerobic/resistance/mix: aerobic
Frequency: 2 to 3 sessions/week
Duration: 40 minutes/session
Intensity: 60% max VO2
Modality: cycling
Setting: hospital-based programme
Other: all sessions were supervised by a cardiologist
Control group / Comparison:
Standard medical care
Outcomes HRQoL (MLWHF questionnaire); mortality; morbidity; cost-effectiveness
Country and setting Italy
Single centre
Follow-up 14 months and 26 months (after randomisation)
Notes Source of funding: none reported.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Belardinelli 1999  (Continued)
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Intention-to-treat analy-
sis?
Unclear risk Not reported
Incomplete outcome da-
ta?
Low risk Losses to follow-up were reported
Groups balanced at base-
line?
Low risk "The baseline characteristics of the study population are shown in Table 1.
The 2 groups were well balanced with respect to most characteristics, includ-
ing peak VO2, New York Heart Association functional class, and leR ventricular
ejection fraction. There were no differences in type and doses of medications,
blood chemistry, and previous cardiac events"
Groups received same in-
tervention?
Unclear risk Not reported
Belardinelli 1999  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 123 (exercise 63, control 60)
Diagnosis (% of participants):
Aetiology: ischaemic 80%, non-ischaemic 20%
NYHA: Class II 59%, Class III 41%
LVEF: 37 (SD 8)
Case mix: see above
Age, years: 59 (SD 14)
Male: 78%
White: not reported
Inclusion/exclusion criteria
Inclusion: clinical stability for 3 months before enrolment, LVEF < 40%, ability to exercise
Exclusion: haemodynamically significant valvular heart disease, uncontrolled DM and hypertension, or-
thopaedic or neurological problems, renal insufficiency (creatinine > 2.5 mg/dL)
Interventions Exercise:
Total duration: 10 years; 8 weeks' supervised, then 12 months' maintenance
Aerobic/resistance/mix: aerobic
Frequency: 2 to 3 sessions/week
Duration: 40 minutes/session
Intensity: 60% max VO2 for first 2 months, thereafter at 70% max VO2
Modality: cycling
Settings: hospital and home
Belardinelli 2012 
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Other: trained participants were encouraged to exercise without supervision at home at least a third
time, performing aerobic activities at the same HR as the other 2 supervised sessions
Exercise sessions held at the hospital were supervised by cardiologists. Study authors emphasise that
the supervised element was maintained over 10 years of follow-up
Control group / Comparison:
Standard medical care. Participants were instructed to continue with their usual home daily physical
activities, avoiding exercise training in a supervised environment. They were free to perform aerobic
activities such as walking, cycling (home or outside), and swimming, avoiding a duration longer than
30 minutes. Study authors advised control group participants to walk and perform usual physical activ-
ities
Outcomes HRQoL (MLWHF questionnaire); mortality; morbidity (including hospitalisation); cost-effectiveness
Country and setting Italy
Single centre
Follow-up 10 years (every 12 months) (after randomisation)
Notes Every 6 months, participants exercised at the hospital, then returned to a coronary club, where they ex-
ercised the rest of the year
Source of funding: no external funding
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk "All analyses were performed with an intention-to-treat principle"
Incomplete outcome da-
ta?
Low risk Losses to follow-up were reported
Dropout rate was 3% on average in the exercise group. 2/63 did not complete
the protocol - 1 because of a car accident and the other for personal reasons.
3/60 in the control group decided to withdraw from the study for reasons unre-
lated to their clinical status
Groups balanced at base-
line?
Low risk "The baseline characteristics of the study population are shown in Table 1. The
2 groups were well balanced with respect to most characteristics, including
peak VO2, New York Heart Association functional class, leR ventricular ejec-
tion fraction. There were no difference in type and doses of medication, blood
chemistry, and previous cardiac events"
Belardinelli 2012  (Continued)
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Groups received same in-
tervention?
Low risk Both groups appeared to receive the same interventions apart from the CR in-
tervention
Belardinelli 2012  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 53 (exercise 28, control 25)
Diagnosis (% of participants):
Aetiology: MI 45.2%, systemic hypertension 19%, dilated Chagas' cardiomyopathy 11.9%, DM 4.8%, oth-
er 19.1%
NYHA: Class II or III
LVEF: ≤ 45%
Case mix: 100%, as above
Age, years: exercise 61 (SD 12), control 60 (SD 11)
Male: 88%
White: not reported
Inclusion/exclusion criteria:
Inclusion: EF < 45%, symptoms of NYHA functional Class II or III, optimised pharmacological therapy es-
tablished at least 4 weeks before inclusion in the study, compensated HF state at least 2 months before
Exclusion: age < 50 years, NYHA functional Class IV, clinical instability in the preceding 2 months, non-
optimised therapy, uncontrolled arrhythmias, MI within the last 2 months, surgery-associated car-
diomyopathy, pulmonary disease or other co-morbid conditions that limit physical exercise, accentuat-
ed severe cardiac symptoms (hypotension, complex ventricular arrhythmia, progressive worsening of
dyspnoea, and significant ischaemia at low rates) during ergometric tests, regular participation in some
exercise programme within the last 6 months, frequency in the training protocol < 80%
Interventions Exercise: Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: 90 minutes
Intensity: target HR (50% of work at maximum HR)
Modality: walking on a treadmill
Setting: not reported
Other: relaxation and stretching exercises before and after every session
Control group / Comparison:
Usual medical therapy - individual dietary guidance and pharmacological therapy
Outcomes HRQoL (shortened version of World Health Organization Quality of Life questionnaire); hospitalisation
Country and setting Brazil
Bocalini 2008 
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Single centre
Follow-up 6 months (after randomisation)
Notes Initially randomised 53 participants; excluded data from participants who withdrew, were lost to fol-
low-up, etc.; hence analysed 42 participants
Although setting was not reported, the exercise programme was described as "supervised"
Source of funding: none reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
High risk "During the follow-up, medicine doses were not modified except for those that
presented impairment of symptoms and, consequently, these patients were
excluded from the analysis"
Incomplete outcome da-
ta?
High risk Only 42/53 (79%) provided data at follow-up
Groups balanced at base-
line?
Low risk Table 1 of the publication shows that groups were well balanced
Groups received same in-
tervention?
Low risk "All patients continued with pharmacological therapy and individual dietary
guidance"
Bocalini 2008  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 62 (exercise 31, control 31)
Diagnosis (% of participants):
Aetiology: coronary artery disease 41.9%, cardiomyopathy 35.5%, rheumatic heart disease 9.7%, hyper-
tension 6.5%, valvular 6.5%
NYHA: Class II to IV
LVEF: mean 43.5%, SD 13.8
Case mix: 100%, as above
Chen 2018 
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Age, years: exercise 61 (SD 14), control 62 (SD 15)
Male: 59.7%
White: not reported
Inclusion/exclusion criteria:
Inclusion: heart failure diagnosis, NYHA class II to IV, > 18 years old
Exclusion: cognitive impairment, unable to be contacted by telephone or home visit, included in other
study, COPD, life expectancy < 1 year, other diagnosis limiting activity
Interventions Exercise:
Total duration: 26 weeks
Aerobic/resistance/mix: mix
Frequency: up to 3 sessions/week
Duration: 20 to 40 minutes/session
Intensity: as tolerated by participant
Modality: walking
Setting: hospital
Other: education, depression therapy, home visits
Control group / Comparison:
Standard of care (telephone call at 2 weeks, 2 clinic reviews at 90 and 180 days), mortality, hospitalisa-
tion
Outcomes HRQoL (MLWHF questionnaire and Short Physical Performance Battery - SPPB)
Country and setting China
Single centre
Follow-up 6 months
Notes Source of funding: none reported.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "A computer generated randomization list was created by a statistician for pa-
tient randomization"
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Data collectors (nurses) were blinded to randomisation; whether they were
blinded to outcomes is not clear
Selective reporting (re-
porting bias)
Low risk All outcomes were reported (no protocol publication is available)
Chen 2018  (Continued)
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Intention-to-treat analy-
sis?
Low risk Although the term ITT was not stated, it appears that groups were analysed ac-
cording to initial random allocation
Incomplete outcome da-
ta?
Low risk Only 2 deaths were reported; no other losses to follow-up were described
Groups balanced at base-
line?
Low risk "Baseline demographic and clinical characteristics were not significantly dif-
ferent between the SC group and MDMP group (Table 1)"
Groups received same in-
tervention?
Low risk "Medications recommended by the 2013 American College of Cardiology Foun-
dation/American Heart Association Guideline for the Management of Heart
Failure.50 were prescribed for all the patients in this study at optimal dosage if
there was no contradiction"
Chen 2018  (Continued)
 
 
Methods Parallel-group RCT - 2 arms
Participants N randomised: 46; 15 hospital, 15 home, 16 control
Diagnosis (% of pts):
Aetiology: not reported
NYHA: Class II: exercise (home 60%, hospital 53.3%), control 56.3%
NYHA: Class III: exercise (home 40%, hospital 46.7%), control 43.7%
LVEF: not reported (severe LVSD: exercise (home 60%, hospital 53.3%), control 56.3%)
Case mix: 100%, as above
Age, years: exercise (home 63.3, hospital 69.2), control 60.4
Percentage male: 91.3%(total), exercise (home 86.7%, hospital 86.7%), control 100%
Percentage white: not reported
Inclusion/exclusion criteria:
Inclusion: leR ventricular systolic dysfunction on echocardiography, clinically stable for at least 1
month, receiving optimised medication
Exclusion: significant ischaemic symptoms at low workloads, uncontrolled diabetes, acute systemic ill-
ness/fever, recent embolism, active pericarditis or myocarditis, moderate to severe aortic stenosis, re-
gurgitant valvular heart disease requiring surgery, myocardial infarction within past 3 weeks, new-on-
set atrial fibrillation, signs and symptoms of decompensation, other co-morbidities (life-threatening,
uncontrolled, infectious, or exacerbated by exercise)
Interventions Exercise:
Total duration: 8 weeks
Aerobic/resistance/mix: aerobic
Frequency: 2 sessions/week
Duration: 60 minutes
Intensity: not specified
Cowie 2014 
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Modality: circuit training
Setting: hospital-based (intervention 1) and home-based (intervention 2)
Other: hospital group with a senior cardiac rehabilitation physiotherapist, a physiotherapy technical in-
structor, and a senior cardiac nurse present at each class; home group monitored by a senior cardiac
rehabilitation physiotherapist by telephone, twice during their 8-week intervention (estimated as two
20-minute calls, plus 10-minute documentation, i.e. 1 hour per participant)
Control group / Comparison:
Usual care, which included specialist HF nursing input
Outcomes Hospitalisations; costs
Country and setting United Kingdom
Follow-up 5.2 years
Notes Source of funding: NHS Ayrshire and Aaran's Coronary Heart Disease Managed Clinical Network
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk No details of randomisation sequence generation process were provided
Allocation concealment
(selection bias)
Low risk Concealed envelopes were used
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk The researcher collating and analysing data was blind to participants' ran-
domisation groups when measuring long-term activity levels, but blinding was
unclear for outcomes
Selective reporting (re-
porting bias)
High risk Number of hospitalisations was not reported (obtained from study lead inves-
tigator)
Intention-to-treat analy-
sis?
Low risk Although the term ITT was not stated, it appears that groups were analysed ac-
cording to initial random allocation
Incomplete outcome da-
ta?
High risk 46/60 (77%) provided follow-up data
Groups balanced at base-
line?
Unclear risk Hospital group participants were almost 10 years older than control partici-
pants and so were at high risk of bias, whereas the home group and the con-
trol group were similar and so were at low risk of bias
Groups received same in-
tervention?
Low risk Usual care was standard in all 3 groups
Cowie 2014  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 216; 107 exercise, 109 control
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Diagnosis (% of pts):
Aetiology: ischaemic intervention 45%, control intervention 46%
Female: intervention 24%, control 19%
NYHA: Class II: intervention 59%, control 58%; Class III: intervention 19%, control 24%
LVEF: mean 34%
Case mix: 100%, as above
Age: intervention mean 69.7 (SD 10.9), control mean 69.9 (SD 11.0)
Percentage male: 78% (total); intervention 76, control 81%
Percentage white: 100%
Inclusion/exclusion criteria
Inclusion: men and women aged ≥ 18 years with a confirmed diagnosis of HFrEF on echocardiography
or angiography (leR ventricular ejection fraction < 45% within the preceding 5 years), no deterioration
of HF symptoms in prior 2 weeks resulting in hospitalisation or alteration of HF medication
Exclusion: cardiac rehabilitation (CR) within the past 12 months; received an intracardiac defibrillator
(ICD); cardiac re-synchronisation therapy (CRT) or combined CRT/ICD device in prior 6 months; con-
traindications to exercise testing or exercise training; in a long-term care establishment or unwilling or
unable to travel to research assessments, or to accommodate home visits; unable to understand study
information or unable to complete outcome questionnaires
Interventions Exercise:
Total duration: 12 weeks
Aerobic/resistance/mix: aerobic
Frequency: 2 to 3 times/week
Duration: 12 weeks
Intensity: not reported
Modality: not reported
Setting: home-based
Participants received the REACH-HF Manual (including a choice of 2 exercise programmes); a partici-
pant ‘Progress Tracker’ booklet to record symptoms, physical activity, and other actions related to self-
care; support for caregivers and facilitation by cardiac nurses or physiotherapists, including assessing
individual participant and caregiver needs and concerns and tailoring the intervention content to ad-
dress these; this element was supported by a 3-day training course for facilitators on how to deliver the
intervention using a patient-centred style of communication
Control group / Comparison:
Usual care ("...intervention and control group patients received usual medical management for HF ac-
cording to current guidelines")
Outcomes Primary outcome: MLWHF questionnaire
Secondary outcomes: death; hospitalisation; HeartQoL; EQ-5D-3L; costs
Country and setting United Kingdom
Multi-centre (4 sites)
Dalal 2018  (Continued)
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Follow-up 4, 6, and 12 months
Notes Funding source: National Institute for Health Research (NIHR) under its Programme Grants for Applied
Research Programme (Grant Reference Number RP-PG-1210-12004)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "Participants were randomly allocated in a 1:1 ratio, stratified by investigator
site and baseline plasma N-terminal proB-type natriuretic peptide (NT-pro-
BNP) levels (≤2000 vs >2000 pg/mL), using minimisation to facilitate balance
between the groups. Randomisation numbers were computer generated and
assigned in strict sequence at the point of randomisation"
Allocation concealment
(selection bias)
Low risk "To maintain concealment, the Peninsula Clinical Trials Unit used a password
protected, web based randomisation system to allocate participants after
completion of consent and entry of baseline assessment data"
Blinding (performance
bias and detection bias) 
All outcomes
Low risk Outcome assessors and statistician were blinded
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported as in the published protocol
Intention-to-treat analy-
sis?
Low risk "Primary analyses were based on ITT complete case analyses"
Incomplete outcome da-
ta?
Low risk All participants were accounted for in a CONSORT flow diagram
Groups balanced at base-
line?
High risk "Patient level characteristics at baseline were well balanced between the
groups, apart from more frequent cardiac comorbidity (history of myocardial
infarction and atrial fibrillation) and, consequently, a higher Charlson comor-
bidity score in the control group (table 1). Mean baseline MLHFQ scores for
the REACH-HF group were higher (poorer) than for the control group, but sec-
ondary baseline outcomes were similar for the two groups"
Groups received same in-
tervention?
Low risk Both groups received usual care
Dalal 2018  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 91 (exercise 45, control 46)
Age, years: exercise median 66 (range 33 to 91), control median 65 (range 29 to 94)
Male: 90%
White: not reported
Inclusion/exclusion criteria:
Inclusion: symptoms of CHF and objective findings or effect of medication
DANREHAB 2008 
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Exclusion: mental disorders and social problems (such as dementia, alcoholism, or drug addiction);
transferred to other department or hospital at discharge; severe illness, including NYHA Class IV; living
at nursing home; did not speak Danish; refused consent
Interventions Exercise:
Total duration: 12 weeks
Aerobic/resistance/mix: mix
Frequency: 3 sessions/wk
Duration: 90 minutes/session
Intensity: 50% max HR
Modality: not reported
Setting: supervised centre-based plus home-based also encouraged to continue
Other: physical exercise was conducted as a mixture of endurance and strengthening training using
various upper and lower body modalities easily implemented as activities that participants could per-
form at home. CR included participant education, exercise training, dietary counselling, smoking cessa-
tion, psychosocial support, risk factor management, and clinical assessment. All components reflected
theoretical and practical approaches followed by individual follow-up and feedback. The lifestyle inter-
vention strategy was based on the stages of change model and the self-efficacy theory. The lifestyle in-
tervention was designed as a group intervention, but individual counselling was also provided
Control group / Comparison:
Usual care participants were offered follow-up treatment prescribed by the discharging physician as
outpatient control or by the general practitioner. Pharmaceutical treatment followed routine clinical
practice based on current national guidelines. The discharging nurse or physician determined whether
participants were referred to smoking cessation and dietary counselling parallel to outpatient treat-
ment
Outcomes Primary outcomes: composite outcome measure included overall mortality, MI, or acute first-time re-
admission due to heart disease other than MI
Secondary outcomes: collected data based on an adapted standardised interview questionnaire and
a postal questionnaire (e.g. SF-36, HADS); clinical examination; blood tests
Country and setting Demark
Single centre
Follow-up 12 months
Notes HF subset of 770 participants were randomised; this study included other participants without HF
(coronary heart disease and individuals ar high risk but no diagnosed disease). Only data on HF pa-
tients used in this review. Randomisation was stratified by indication.
Funding source: Copenhagen Hospital Corporation Research Council, Danish Heart Foundation, Dan-
ish Pharmacy Foundation of 1991, Danish Research Council, Danish Centre for Evaluation and Health
Technology Assessment, Danish Ministry of the Interior and Health, Development Fund of Copenhagen
County, Villadsen Family Foundation, Eva and Henry Fraenkel's Memorial Foundation, Builder LP Chris-
tensen's Foundation, Danish Animal Protection Foundation, Bristol-Myers Squibb, Merck Sharp and
Dohme, and AstraZeneca
Risk of bias
Bias Authors' judgement Support for judgement
DANREHAB 2008  (Continued)
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Random sequence genera-
tion (selection bias)
Low risk "Patients who gave informed consent were randomized using a centralized
randomization procedure administered by the Copenhagen Trial Unit. The
randomization was stratified according to risk group (CHF, IHD, or HR) based
on a random-permuted multiblock within-stratum method"
Allocation concealment
(selection bias)
Low risk As above
Blinding (performance
bias and detection bias) 
All outcomes
Low risk "Because of the nature of CR, the interventions were open to the investigators
and the patients. Investigator independent outcome data from registries were
chosen to ensure blinded assessment and outcome analysis"
Selective reporting (re-
porting bias)
Low risk All outcomes listed in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk ITT analysis was stated
Incomplete outcome da-
ta?
Low risk 81% overall follow-up at 12 months
Groups balanced at base-
line?
Low risk "Patients were well matched at entry"
Groups received same in-
tervention?
Low risk Both groups received control care
DANREHAB 2008  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 105 (exercise 53, control 52)
Diagnosis (% of participants):
Aetiology: not reported
NYHA: Class I: exercise 2%, control 0%; Class II: exercise 38%, control 33%; Class III: exercise 60%, con-
trol 67%; Class IV: exercise 0%, control 0%
LVEF: not reported
Case mix: as above
Age, years: exercise 71.6 (SD not reported), control 73.9 (SD not reported)
Male: 67%
White: not reported
Inclusion/exclusion criteria:
Inclusion: patients of any age with diagnosis of HF of any aetiology and NYHA Class I to IV. All partici-
pants were cleared by their physician to participate in the exercise group
Exclusion: participants with unstable angina pectoris were ineligible to participate
Interventions Exercise:
Davidson 2010 
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Total duration: 12 weeks
Aerobic/resistance/mix: aerobic
Frequency: 1 session/week
Duration: 30 to 50 minutes
Intensity: not reported
Modality: gymnasium: treadmills, stationary cycles, recumbent cycles
Home-based: hall walks, stairs, and sporting activities such as lawn bowls
Setting: supervised gymnasium, home-based programme tailored to participant's needs
Other: also attended a nurse-co-ordinated CR clinic with emphasis on self-management. A group-
based educational session was conducted for study participants and their families. The exercise group
attended the nurse-co-ordinated CR clinic, where comprehensive assessment was performed by the
physiotherapist, the CR co-ordinator, and the occupational therapist
Control group / Comparison:
Information session, then usual medical care
Outcomes HRQoL (MLWHF questionnaire); all-cause and cardiovascular-related hospital admission; mortality
Country and setting Australia
Single centre
Follow-up 12 months (after randomisation)
Notes The trial had to be stopped prematurely at 12 months following introduction of chronic and complex
care for people with CHF by the New South Wales Health Department. "In view of trends in favour of the
intervention group and emerging evidence from other studies, it was considered unethical and unten-
able to continue randomization in view of the policy mandate. When the trial was stopped there were
53 participants in the intervention group and 52 participants in the usual care group"
Source of funding: none reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "Participants were randomized to either the intervention or control group by
means of a computer-generated program"
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Low risk "The randomization technique was blinded to the investigators until the close
of the study"
Selective reporting (re-
porting bias)
Low risk All outcomes were described and all methods were reported
Intention-to-treat analy-
sis?
Low risk Although this was not reported as an ITT analysis, groups did appear to be
analysed according to original randomised allocation
Davidson 2010  (Continued)
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Incomplete outcome da-
ta?
Low risk "No participants were lost to follow-up"
Groups balanced at base-
line?
Low risk "…there were few differences between intervention and usual care groups, in-
dicating success of randomization. The most important difference on clinical
variable was that a significantly greater proportion of people in the interven-
tion group were taking spironolactone at baseline"
Groups received same in-
tervention?
Low risk Both groups appeared to receive the same interventions apart from the CR in-
tervention
Davidson 2010  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 61 (exercise 30, control 31)
Diagnosis (% of pts):
Aetiology: ischaemic cardiomyopathy 67.2%, hypertension 26.2%, dilated cardiomyopathy 4.9%
NYHA: Class I: exercise 0, control 0
Class II: exercise 20%, control 19.33%
Class III: exercise 83%, control 81%
LEVF: exercise 32 ± 4%; control 33 ± 5%
Case mix: as above
Age (mean ± SD), years: exercise 60 ± 4.25, control 58 ± 4.22
Percentage male: 67.2% (exercise 60%, control 74%)
Percentage white: not reported
Inclusion/exclusion criteria:
Inclusion: patients admitted to hospital with diagnosis of heart failure, with LVEF ≤ 40%, and in sinus
rhythm
Exclusion: difficulty with movement; no heart transplant 3 months after exercise programme; no ad-
vanced heart failure; available throughout the study; coronary bypass surgery during the study; oth-
er neurological, orthopaedic, peripheral vascular, or pulmonary disease, making it impossible to com-
plete exercise; unwilling to co-operate
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: aerobic only (walking)
Frequency: 3 sessions/week
Duration: 40 minutes
Intensity: in short term (up to 6 weeks), < 3 MET (simple walking until heart rate reaches 60% of heart
rate reserve); in longer term (≥ 6 weeks), heart rate 70% of heart rate reserve
Modality: walking
Dehkordi AH 2015 
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Setting: hospital sport facility or gymnasium (supervised)
Control group / Comparison:
Usual care (medication and lifestyle advice)
Outcomes HRQoL (MacNew Questionnaire)
Country and setting Iran, hospital
Follow-up 6 months
Notes Exercise group supervised by nurse or cardiologist; control group supervised by physician
Source of funding: Research and Technology Deputy of Shahrekord University of Medical Sciences
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk The randomisation code was developed with a computer random-number
generator
Allocation concealment
(selection bias)
Unclear risk Method of allocation was not described
Blinding (performance
bias and detection bias) 
All outcomes
Low risk HRQoL assessment was self-administered
Selective reporting (re-
porting bias)
Unclear risk No protocol was identified
Intention-to-treat analy-
sis?
Low risk Although the term ITT was not stated, it appears from the CONSORT diagram
that ITT analysis was undertaken
Incomplete outcome da-
ta?
Low risk No loss to follow-up was reported in either arm
Groups balanced at base-
line?
Low risk No differences were noted between groups
Groups received same in-
tervention?
Low risk Medications were unchanged in both groups
Dehkordi AH 2015  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 173 (exercise 86, control 87)
Diagnosis (% of participants):
Aetiology: ischaemic; idiopathic; valvular; DCM; other
NYHA: Class II to IV
LVEF: 26.4 (SD 6.8)
Dracup 2007 
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Case mix: 100%, as above
Age, years: 54 (SD 12.5)
Male: 71.7%
White: 60.1 
Inclusion/exclusion criteria:
Inclusion: English-speaking, age 18 to 80 years, NYHA II to IV, and LVSD with LVEF < 40% as documented
by echocardiogram or radionuclide ventriculography within 6 months, and sinus rhythm
Exclusion: MI or recurrent angina within 3 months, orthopaedic impediments to exercise, severe ob-
structive pulmonary disease with forced expiratory volume < 1 L in 1 second as measured by spirome-
try, stenotic valvular disease as measured by echocardiogram, history of uncontrolled ventricular tach-
yarrhythmias (documented by electrophysiology study or 24-hour Holter monitor), or absence of an
implantable cardioverter-defibrillator despite a history of sudden cardiac death
Interventions Exercise:
Total duration: unclear (6 months or 1 year)
Aerobic/resistance/mix: mix
Frequency: 4 sessions/week
Duration: 10 to 45 minutes
Intensity: 40% to 60% max HR
Modality: walking
Setting: home-based
Other: "After six weeks resistive training component involved both upper and lower extremity
strengthening. Resistance training was prescribed at 80% of one repetition maximum, which is the
maximal weight lifted one time, for 2 sets of 10 repetitions using seated biceps curls to strengthen the
arms & seated lateral raises to strengthen shoulders. A second set of 10 repetitions at 80% of one repe-
tition maximum was also prescribed…"
Control group / Comparison:
Maintained usual level of daily activities; no exercise component
Outcomes HRQoL (MLWHF questionnaire); mortality; hospitalisation
Country and setting USA
Single centre
Follow-up 6 months and 12 months (after randomisation)
Notes Home-based exercise programme
Subgroup analysis reported: Evangelista 2010
Source of funding: American Heart Association Western Division (NCR 133-09)
Risk of bias
Bias Authors' judgement Support for judgement
Dracup 2007  (Continued)
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Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Blinding reported for physical activity (accelerometer) outcome but not re-
ported for other outcomes
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk Although not reported as ITT analysis, groups did appear to be analysed ac-
cording to original randomised allocation
Incomplete outcome da-
ta?
Low risk "Two patients (one from the experimental and one from the control group)
were lost to follow-up within the first three months of enrollment. One was in-
carcerated and the second leR the geographic area with no forwarding infor-
mation. The remaining 173 patients compose the final study"
Groups balanced at base-
line?
Low risk Current version: "There were no differences between the control and exercise
groups at baseline with respect to sociodemographic variables (Table I) and
most clinical characteristics. However, patients in the exercise group had a sig-
nificantly higher likelihood of having a history of coronary heart disease and
taking antiplatelet medication than in the control group"
Our version: "There were no significant differences in any of baseline char-
acteristics between the 2 groups, except for angiotensin-converting enzyme
(ACE) inhibitor; adherers were more likely to use ACE inhibitors than nonad-
herers (84% vs 60%; P = 0.039)"
Groups received same in-
tervention?
Low risk "Research nurses made home visits weekly for the first two weeks and then
monthly to assess protocol adherence, correct use of the pedometer, and tol-
erance to the exercise program. The home visits also served as a form of atten-
tion control in the care- as-usual group. All clinical questions were referred to
the patient's cardiologist"
Dracup 2007  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 132 (exercise 67, control 65)
Diagnosis (% of participants):
Aetiology: ischaemic: total 60 (45%), exercise 33 (49%), control 27 (42%)
NYHA: Class II: total 92 (70%), exercise 49 (73%), control 43 (66%); Class III: total 40 (30%), exercise 18
(27%), control 22 (34%)
LVEF: total 32.6 (SD 12.5), exercise 32 (SD 11.6), control 33 (SD 13.5)
Case mix: 100%, as above
Age, years: total 60 (SD 15); exercise 62 (SD 15), comparator 58 (SD 15)
Male: total 104 (78.8%); exercise 56 (83.6%), control 48 (73.8%)
Du 2018 
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White: not reported
Inclusion/exclusion criteria:
Inclusion: symptomatic heart failure, NYHA II to III
Exclusion: unstable angina pectoris, unexplained syncope in previous 3 months, resting heart rate > 120
beats/min, participating in any structured exercise programme, inability to give informed consent, sig-
nificant cognitive impairment
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: aerobic
Frequency: 1 session/week
Duration: 6 minutes/session
Intensity: tailored to individual
Modality: walking (home heart walk)
Setting: home-based
Other: usual care
Control group / Comparison:
Usual care consisting of bedside education, cardiology appointments
Outcomes HRQoL (SF-36 and MLWHF questionnaire)
Country and setting Australia
Multi-centre
Follow-up 3 months and 6 months
Notes Australain New Zealand Clinical Trial Registry 12609000437268. Participants in this study were younger
than the average age of the heart failure population
Source of funding: Australian Department of Health and Ageing, as part of the Sharing Health Care Ini-
tiative
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "Participants were randomized at a 1:1 ratio through a central phone random-
ization centre using computer generated random numbers"
Allocation concealment
(selection bias)
Low risk "Participants were randomized at a 1:1 ratio through a central phone random-
ization centre using computer generated random numbers"
Blinding (performance
bias and detection bias) 
All outcomes
Low risk A blinded assessor conducted outcome assessments at follow-up (3 months
and 6 months)
Selective reporting (re-
porting bias)
Low risk No differences were noted between the protocol and the study
Du 2018  (Continued)
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Intention-to-treat analy-
sis?
Low risk "Data were analysed according to the intention-to-treat principle"
Incomplete outcome da-
ta?
High risk 16/67 were lost to follow-up in the exercise group
9/65 were lost to follow-up in the control group
All reasons for losses to follow-up were reported but no explanation was given
for differences between groups
Groups balanced at base-
line?
Low risk Tables 1 and 2
Groups received same in-
tervention?
Low risk Both groups received usual care
Du 2018  (Continued)
 
 
Methods Parallel-group RCT - 2 arms
Participants N randomised: total 65; intervention 1 (comp): 28 (CBT 10; CBT and exercise 18); intervention 2 (ex
alone): 37 (exercise alone 20; control 17)
Diagnosis (% of participants):
Aetiology: not reported
NYHA: Class II 43.3%; Class III 56.7% (as a whole)
LVEF: ≥ 15%
Case mix: 100%, as above
Age, years: 65.8 (SD 13.5)
Male: 41.9%
White: not reported
Inclusion/exclusion criteria:
Inclusion: documented medical diagnosis of HF; LVEF ≥ 15% documented within the last year by
echocardiogram, cardiac catheterisation, ventriculography, or radionuclide ventriculography; receiv-
ing therapy for HF according to guidelines published by the American College of Cardiology/American
Heart Association recommendations (angiotensin-converting enzyme inhibitors, diuretics, beta block-
ers, angiotensin receptor blockers, hydralazine and nitrate combination, etc.); Hamilton Rating Scale
for Depression (HAM-D) score ≥ 11; positive results on the Mini International Neuropsychiatric Interview
(Mini) for minor or major depression; DSM-IV diagnosis for depression for 14 days, or for 7 days if histo-
ry of major depressive disorder in the last 6 months. Participants also had to be English speaking; liv-
ing independently (non-institutionalised) within 100 miles of Atlanta, Georgia; able to respond to ques-
tions appropriately; able to hear adequately to respond to verbal questions; not involved in any struc-
tured exercise programme or walking 3 times/week for a minimum of 20 minutes; not participating in
any psychotherapy; and not hospitalised within the last 60 days
Exclusion: suicide ideation according to psychiatric assessment or Mini evaluation; major psychiatric
co-morbidity such as schizophrenia, personality disorder, or dementia; planned surgery; not given a di-
agnosis of HF in the past 3 months; renal insufficiency (serum creatinine > 2.5 mg/dL); uncontrolled hy-
pertension; acute bereavement or loss of significant other within the last month or currently involved
Gary 2010 
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in family crisis such as divorce; any disorder interfering with independent ambulation; and terminal ill-
ness such as cancer
Interventions Exercise:
Total duration: 12 weeks
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: 30 to 45 minutes/session, maximum 1 hour
Intensity: Borg < 15 ('moderate')
Modality: walking
Setting: home-based
Other: exercise + CBT group also received 12 weeks of weekly 1-hour sessions of CBT for 12 weeks. No
other co-interventions were mentioned
Control group / Comparison:
Usual care
"Participants assigned to the UC [usual care] group received no information or counselling from their
health care provider other than that normally provided"
Outcomes HRQoL (MLWHF questionnaire); mortality
Country and setting USA
Single centre
Follow-up 24 weeks (after randomisation)
Notes Exercise group participants had 12 weekly face-to-face home visits by a research nurse to monitor
walking progress and to tailor the exercise prescription. "At the first home visit for EX, the research
nurse (1) educated the patient on the rationale for EX in HF; (2) instructed on self-monitoring of symp-
toms [dyspnoea, heart rate (HR), fatigue] during walking; (3) provided the patient with a Polar monitor
and instruction on how to use it; (4) provided patient with EX logs and instructions; (5) instructed on
use of the 6- to 20-point Borg's rate of perceived exertion (RPE) scale; (6) provided patient with blood
pressure cuN and weight scale, if not available; and (7) observed participant response to walking out
side home"
Source of funding: Southeast Affiliate of the American Heart Association Beginning Grant-in-Aid, At-
lanta Clinical and Translational Science Institute at Emory University School of Medicine
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Low risk "Data collectors were blinded to group assignment"
Gary 2010  (Continued)
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Selective reporting (re-
porting bias)
Low risk Outcome were described in the Methods and were reported in the Results
Intention-to-treat analy-
sis?
Low risk Although not stated, CONSORT diagram suggests that groups were analysed
according to initial randomised allocation
Incomplete outcome da-
ta?
Low risk QUORUM diagram and details of losses to follow-up were reported. In exercise
group, 1 patient died and 3 withdrew at 24 weeks. In usual care group, 2 par-
ticipants and 1 participant withdrew at 12 and 24 weeks, respectively. In com-
bined CBT/exercise group, 2 withdrew at 12 weeks. 1 was lost to follow-up and
1 withdrew at 24 weeks. In CBT group, 1 withdrew at 12 weeks and 24 weeks. 1
died and 1 was lost to follow-up at 24 weeks
Groups balanced at base-
line?
Low risk "There were no BL differences between groups on any demographic or out-
come variables"
Groups received same in-
tervention?
Low risk Groups appeared to receive the same care other than exercise and CBT inter-
ventions
Gary 2010  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 61 (exercise 30, control 31)
Diagnosis (% of participants):
Aetiology: anteroseptal acute MI: total 55.7%, exercise 60%, control 55%
NYHA: exercise 2.7 ± 0.7, control 2.6 ± 0.5
LVEF: exercise 41.6 ± 11.3%, control 42.0 ± 7.6%
Case mix: 100%, as above
Age (mean ± SD), years: exercise 55.9 ± 3.1, control 55.1 ± 3.7
Male: total 72.1%, exercise 73.3%, control 71%
White: not reported
Inclusion/exclusion criteria:
Inclusion: consecutive patients immediately post STEMI
Exclusion: residual myocardial ischaemia, severe ventricular arrhythmias, atrioventricular block, valvu-
lar disease requiring surgery, pericarditis, severe renal dysfunction (i.e. creatinine > 2.5 mg/dL)
Interventions Exercise:
Total duration: 12 weeks
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: 40 minutes (30 minutes plus 5 minutes of warm-up and 5 minutes of cool-down)
Intensity: tailored to individual (target 60% to 70% of VO2 peak achieved at initial symptom-limited car-
diopulmonary exercise test)
Giallauria 2008 
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Modality: cycling
Setting: hospital (supervised)
Other: usual care co-interventions
Control group / Comparison:
Usual care (generic instructions re exercise and diet plus a visit at 6 months)
Outcomes Hospital admissions
Country and setting UK
Single centre
Follow-up 6 months
Notes Source of funding: study authors state there was no conflict of interest related to sponsorship
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Unclear whether clinician prescribing hospitalisation following dyspnoea was
blinded
Selective reporting (re-
porting bias)
Unclear risk No protocol available
Intention-to-treat analy-
sis?
Unclear risk Not stated whether intention-to-treat analysis was performed, but looks as if
groups were analysed to original random allocation
Incomplete outcome da-
ta?
Low risk All participants were accounted for
Groups balanced at base-
line?
Low risk No differences between groups were noted (Table 1)
Groups received same in-
tervention?
Low risk Medications were uptitrated to maximal in both groups
Giallauria 2008  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 90; 45 each group
Diagnosis (% of participants):
Aetiology: HF secondary to idiopathic DCM; ischaemic heart disease; valvular disease
Giannuzzi 2003 
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NYHA: Class II to III
LVEF: exercise 25% (SD 4), control 25% (SD 4)
Case mix: 100%
Age, years: exercise 60 (SD 7), control 61 (SD 7)
Male: not reported
White: not reported
Inclusion/exclusion criteria
Inclusion: HF secondary to idiopathic DCM, ischaemic heart disease, or valvular disease; echocardio-
graphic ejection fraction < 35%; clinical stability for at least 3 months under optimised therapy; NYHA
functional Class II to III; peak oxygen uptake (VO2) < 20 mL/kg/min; echocardiographic images of ade-
quate quality for quantitative analysis
Exclusion: any systemic disease limiting exercise; hypertrophic cardiomyopathy; valvular disease re-
quiring surgery; angina pectoris; sustained ventricular arrhythmias; severe hypertension; excess vari-
ability (> 10%) at baseline cardiopulmonary exercise test; inability to participate in a prospective study
for any logistical reason 
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: aerobic
Frequency: 3 to 5 sessions/week
Duration: 30 minutes
Intensity: 60% peak VO2
Modality: exercise cycle, daily brisk walk, calisthenic. In addition, requested to take brisk daily walk for
> 30 minutes
Setting: supervised cycling sessions at rehabilitation centre; unsupervised sessions at home
Other: not reported
Control group / Comparison:
Educational support but no formal exercise protocol was provided
Outcomes Mortality; morbidity
Country and setting Italy
Multi-centre (15 CR units)
Follow-up 6 months (after randomisation)
Notes Source of funding: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Giannuzzi 2003  (Continued)
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Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk Although not stated, it is clear from the CONSORT diagram that 2 groups were
analysed according to ITT
Incomplete outcome da-
ta?
Low risk 45/45 (100%) in exercise training group, 44/45 (98%) available at 6 months' fol-
low-up
Groups balanced at base-
line?
Low risk "No significant differences were observed between the 2 groups with respect
to demographic and clinical data, including age, weight, cause of heart failure,
or New York Heart Association functional class. Furthermore, there was no dif-
ference between the 2 groups in the medications received during the 6-month
period of the study"
Groups received same in-
tervention?
Unclear risk Not clearly stated whether co-treatments (i.e. cardiovascular medication) in
the 2 groups were the same
Giannuzzi 2003  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 20 (exercise 10, control 10)
Diagnosis (% of participants):
Aetiology: IHD, DCM
NYHA: Class II 90%, Class III 10%
LVEF: exercise mean 26.1% (SD 6), control mean 24.7% (SD 8)
Case mix: 100%, as above
Age, years: exercise 55 (SD 6), control 53 (SD 9)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: age < 70 years with CHF (NYHA II to III) as a result of DCM or IHD as assessed by cardiac
catheterisation. All had clinical, radiological, and echocardiographic signs of CHF and an LVEF of 40%
as assessed by ventriculography and clinically stable condition for > 3 months before enrolment
Exclusion: significant valvular heart disease, uncontrolled hypertension, peripheral vascular disease,
pulmonary disease, musculoskeletal abnormalities precluding exercise training
Interventions Exercise:
Total duration: 2 weeks inpatient followed by 6 months outpatient
Gielen 2003 
Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
66
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Aerobic/resistance/mix: aerobic
Frequency: 7 sessions/week
Duration: 20 minutes/session
Intensity: 70% symptom-limited VO2 max
Modality: cycle ergometers
Setting: supervised sessions at hospital and home-based unsupervised sessions
Other: expected to participate in 1 group training session (walking, calisthenics, and non-competitive
ball games) of 60 minutes each week. Participants were asked to exercise for 20 minutes/d at home
Control group / Comparison:
Continued sedentary lifestyle and remained on individually tailored cardiac medication supervised by
private physicians
Outcomes Mortality
Country and setting Switzerland
Single centre
Follow-up 26 weeks (after randomisation)
Notes Source of funding: none reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk Although ITT analysis not reported, groups do appear to be analysed accord-
ing to original randomised allocation
Incomplete outcome da-
ta?
Low risk No loss to follow-up
Groups balanced at base-
line?
Low risk "Patients in the training group and in the control group showed a significantly
reduced leR ventricular ejection fraction (training group: 26.1 ±3.1%, control
group: 24.7± 2.4%; NS [not significant]) and exercise capacity as determined by
peak oxygen uptake (training group: 20.3 ± 1.0 ml/kg min, control group: 17.9 ±
1.6 ml/kg min; P NS)"
Gielen 2003  (Continued)
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Groups received same in-
tervention?
Unclear risk Details of co-interventions not reported
Gielen 2003  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 33
Diagnosis (% of participants):
Aetiology: ischaemic or primary
NYHA: Class II or III
LVEF: exercise 22% (SD 8), control 25% (SD 10)
Case mix: 100%, as above
Age, years: exercise 67 (SD 7), control 64 (SD 10)
Male: exercise 15/16 (94%), control 11/14 (79%), total 87%
White: not reported
Inclusion/exclusion criteria:
Inclusion: NYHA Class II to III for at least 3 months and on stable medications for the past 1 month. All
participants were on maximal medical therapy with angiotensin-converting enzyme inhibitors, diuret-
ic, and digoxin. All participants had EF < 40% by nuclear ventriculography. No participants had obstruc-
tive valvular disease, MI within 3 months, or limitation of exercise secondary to angina or new arrhyth-
mias
Exclusion: not reported
Interventions Exercise:
Total duration: 3 months
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: 30 minutes
Intensity: Borg 12 to 13
Modality: bike and treadmill
Setting: supervised sessions at medical centre by a nurse or an exercise physiologist
Other: care provided by a specialist HF physician
Control group / Comparison:
Usual medical care
Other: care provided by specialist HF physicians
Outcomes HRQoL (MLWHF questionnaire and MOS SF-36 questionnaire); mortality; morbidity
Country and setting USA
Gottlieb 1999 
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Single centre
Follow-up 6 months (after randomisation)
Notes MLWHF, MOS, SF-36 results not reported for the control group
Source of funding: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Unclear risk Not reported
Incomplete outcome da-
ta?
Low risk Yes, QUORUM flow diagram reported
Unclear how loss to follow-up, dropout, and cross-over were dealt with
Groups balanced at base-
line?
Low risk "There were no differences at baseline between patients randomised to the
control group and those randomised to the exercise program"
Groups received same in-
tervention?
Low risk "Medical follow-up of both the control and intervention patient groups was
provided by specialized heart failure physicians"
Gottlieb 1999  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 22 (exercise 12, control 10)
Diagnosis (% of participants):
Aetiology: DCM 86%, ischaemic heart disease 14%
NYHA: Class II (55%), Class III (45%)
LVEF: exercise 26% (SD 9), control 27% (SD 10)
Case mix: 100%, as above
Age, years: exercise 50 (SD 12), control 52 (SD 8)
Male: 100%
White: not reported
Hambrecht 1995 
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Inclusion/exclusion criteria:
Inclusion: EF < 40% as assessed by radionucleotide scintigraphy and reduced fractional shortening <
30% as assessed by echocardiography; willingness to participate in the study for the next 6 months;
permanent residence within 25 km of the training facility; physical work capacity at baseline > 25 watts
without signs of myocardial ischaemia (i.e. angina or ST segment depression); clinically stable > 3
months 
Exclusion: exercise-induced myocardial ischaemia or ventricular tachyarrhythmias (> Lown Class IVa),
valvular heart disease, uncontrolled hypertension, peripheral vascular disease, COPD, orthopaedic or
other conditions precluding regular participation in exercise sessions
Interventions Exercise:
Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 4 to 6 sessions/week
Duration: 10 to 60 minutes/session, 1 hour at home
Intensity: 70% VO2 max
Modality: cycling, walking, ball games, and calisthenics
Setting: first 3 weeks supervised hospital-based training; thereafter, home-based
Other: none
Control group / Comparison:
After discharge, medical therapy was continued and participants were supervised by private physician
Outcomes Morbidity and mortality
Country and setting Germany
Single centre
Follow-up 6 months (after randomisation)
Notes Source of funding: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Hambrecht 1995  (Continued)
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Intention-to-treat analy-
sis?
Unclear risk Not reported
Incomplete outcome da-
ta?
Low risk Dropouts and clinical events were fully reported for both groups. No imputa-
tion was undertaken
Groups balanced at base-
line?
Low risk "There were no significant differences in baseline variables between the train-
ing and control groups"
Groups received same in-
tervention?
Unclear risk The exercise group had a 3-week hospital stay; the control group stayed only
3 days. Control group followed up with private physician. No comment was in-
cluded on follow-up of the intervention group
Hambrecht 1995  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 20 (exercise 10, control 10)
Diagnosis (% of participants):
Aetiology: IHD 35%, DCM 65%
NYHA: Class II 65%, Class III 35%
LVEF: exercise mean 24% (SD 13), control mean 23% (SD 10%)
Case mix: as above
Age, years: exercise 54 (SD 9), control 56 (8)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: age < 70 years, with CHF as a result of DCM or IHD; LVEF < 40%
Exclusion: DM, hypertension, overt atherosclerotic PVD, hypercholesterolaemia, ventricular tachycar-
dia, COPD, primary valvular disease
Interventions Exercise:
Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 2 to 6 sessions/d
Duration: 10 to 20 minutes/session
Intensity: 70% VO2 max
Modality: bike ergometer
Setting: supervised hospital-based sessions and unsupervised home-based sessions
Other: not reported
Control group / Comparison:
Hambrecht 1998 
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Stayed on previous medication, continued sedentary lifestyle, and supervised by private physicians
Outcomes Mortality
Country and setting Germany
Single centre
Follow-up 6 months (after randomisation)
Notes Source of funding: Grant Ha 2155/3-2 from the Deutsche Forschungsgemeinschaft (DFG), Bonn, Ger-
many
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk It appears that groups were analysed according to original randomised alloca-
tion
Incomplete outcome da-
ta?
Low risk Detailed description of losses to follow-up and dropouts was provided
Groups balanced at base-
line?
Low risk "At baseline, patients in the control group did not differ significantly from
those in the training group with respect to age, aetiology of heart failure, NYHA
functional class, duration of heart failure, LVEF (leR ventricular ejection frac-
tion) or LVEDD (leR ventricular end diastolic diameter)"
Groups received same in-
tervention?
Low risk "Patients were on angiotensin-converting enzyme inhibitors (100% in both
groups), diuretics (training group 82%, control 70%), and digoxin (training
73%, control 70%, P5NS). Drug treatment did not change between 4 weeks be-
fore enrolment and study termination"
Hambrecht 1998  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 73 (exercise 36, control 37)
Diagnosis (% of participants):
Aetiology: IHD 16%, DCM 84%
NYHA: Class I and II 74%, Class III 26%
Hambrecht 2000 
Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
72
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
LVEF: 29% (SD 9)
Case mix: 100%, as above
Age, years: exercise 54 (SD 9), control 54 (SD 8)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: documented HF by signs, symptoms, and angiographic evidence of reduced leR ventricular
function (LVEF < 40%) as a result of DCM or IHD; physical work capacity at baseline > 25 watts; clinical
stability ≥ 3 months before study start
Exclusion: significant valvular heart disease, uncontrolled hypertension, DM, hypercholesterolaemia,
PVD, pulmonary disease, musculoskeletal abnormalities precluding exercise training
Interventions Exercise:
Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 6 or 7 sessions/week
Duration: 10 to 20 minutes/session
Intensity: 70% of peak VO2
Modality: cycle ergometer
Setting: first 2 weeks in hospital, remainder home based
Other: plus group sessions 1 hour twice weekly, walking, ball games, and calisthenics
Control group / Comparison:
Continued individually tailored cardiac medications, supervised by physicians
Outcomes Mortality
Country and setting Germany
Single centre
Follow-up 6 months (after randomisation)
Notes Source of funding: Grant Ha 2155/3-2, from the Deutsche Forschungsgemeinschaft (DFG), Bonn, Ger-
many
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "Patients were randomly assigned to either a training group or an inactive
group using a list of random numbers"
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
Unclear risk Not reported
Hambrecht 2000  (Continued)
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All outcomes
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk Not reported
Incomplete outcome da-
ta?
Low risk QUORUM diagram and details of losses to follow-up were reported
Groups balanced at base-
line?
Low risk "No significant differences were observed between the two groups with regard
to demographic or clinical data, including age, weight, LVEF, LVEDD (leR ven-
tricular end diastolic diameter), NYHA or maximum oxygen uptake"
Groups received same in-
tervention?
Unclear risk Co-interventions in the control group were not reported
Hambrecht 2000  (Continued)
 
 
Methods Parallel group RCT
Participants N randomised: 2331 (exercise 1159, control 1172)
Diagnosis (% of participants):
Aetiology: IHD 51%
NYHA: Class II 63%, Class III 35%, Class IV 1%
LVEF: 25% (SD not reported)
Case mix: 100%, as above
Age, years: exercise 59 (SD not reported), control 59 (SD not reported)
Male: 72%
White: 62%
Inclusion/exclusion criteria:
Inclusion: LVEF < 35%; NYHA Class II to IV HF for previous 3 months despite a 6-week period of treat-
ment; optimal HF therapy at stable doses for 6 weeks before enrolment or documented rationale for
variation, including intolerance, contraindication, participant preference, and personal physician's
judgement; sufficient stability, by investigator judgement, to begin an exercise programme
Exclusion: (selected) age < 18 years; co-morbid disease or behavioural or other limitations that inter-
fere with performing exercise training or preventing the completion of 1 year of exercise training; major
cardiovascular event or cardiovascular procedure, including implantable cardioverter-defibrillator use
and cardiac re-synchronisation, within previous 6 weeks
Interventions Exercise:
Total duration: 30 months
Aerobic/resistance/mix: aerobic
Frequency: 3 to 5 sessions/week
Duration: 15 to 35 minutes/session
HF ACTION 2009 
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Intensity: 60% to 70% HR reserve
Modality: cycling or walking
Setting: first 36 sessions were supervised, then participant was advised to follow a 5 days/week home-
based exercise programme
Other: none reported
Control group / Comparison:
Usual care: all participants, regardless of group allocation, received self-management educational ma-
terials consistent with guidelines of American College of Cardiology and American Heart Association
Outcomes Mortality, hospitalisation, HRQoL (KCCQ), cost-effectiveness
Country and setting USA
Multi-centre
Follow-up Median 30.1 months (after randomisation)
Notes Study authors were contacted for further details of outcome findings, but no information was provided
Source of funding: Study authors were funded by various bodies, including National Institutes of
Health and various pharmaceutical companies, particularly GE Medical and Roche
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "The trial uses a permuted block randomization scheme stratified by center
and by the etiology of the patient's heart failure (ischemic vs nonischemic)"
Allocation concealment
(selection bias)
Low risk "Patients are randomized at the enrolling centers using an interactive voice re-
sponse"
Blinding (performance
bias and detection bias) 
All outcomes
Low risk Event outcomes were blinded
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk "Statistical comparisons of the treatment arms with respect to clinical out-
comes were performed according to the intention-to-treat principle"
Incomplete outcome da-
ta?
Low risk QUORUM diagram and details of losses to follow-up were reported
Groups balanced at base-
line?
Low risk Table 1 of the publication shows that the 2 groups were well balanced
Groups received same in-
tervention?
Low risk "All patients, regardless of group allocation, received self-management educa-
tional materials...consistent with guidelines of American College of Cardiology
and American Heart Association"
HF ACTION 2009  (Continued)
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Methods Parallel-group RCT
Participants N randomised: 169 (exercise 84, control 85)
Diagnosis (% of participants):
Aetiology: data not available
NYHA: Class I 6%, Class II 74%, Class III 20%
LVEF: ≤ 40%
Age, years: exercise 65.9 (SD 12.5), control 70 (SD 12.5)
Male: 75%
White: 85.1%
Inclusion/exclusion criteria:
Inclusion: LVEF ≤ 40% on echocardiogram and severity of at least NYHA group II in the previous 24
months; had to have been clinically stable for 4 weeks and in receipt of optimal medical treatment and
in care of a specialist HF nurse team from 2 acute hospital trusts and 1 primary care trust, not consid-
ered high-risk for a home-based exercise programme
Exclusion: NYHA Class IV; MI or re-vascularisation within past 4 months; hypotension; unstable angina;
ventricular or symptomatic arrhythmias; obstructive abortive valvular disease; COPD; hypertrophic ob-
structive cardiomyopathy; severe musculoskeletal problems preventing exercise; case note-reported
dementia or current severe psychiatric disorder
Interventions Exercise:
Total duration: 6-month programme progressive with aim that participants would achieve the follow-
ing:
- Aerobic/resistance/mix: mix
- Frequency: 5 times/week
- Duration: 20 to 30 minutes
- Intensity: 70% peak VO2 or Borg 12 to 13
Modality: aerobic and resistance elements (upper and lower limb exercises)
Setting: first 3 sessions supervised centre-based followed by home-based programme with home visits
by nurse at 4, 10, and 20 weeks and telephone support at 6, 15, and 24 weeks; intervention manual pro-
vided
Other: specialist HF nurse care
Control group / Comparison:
Specialist HF nurse care
Outcomes HRQoL (MLWHF questionnaire); composite of death, hospital admissions, generic quality of life (EQ-5D)
Country and setting UK
West Midlands, community
Follow-up 6-Month and 12-month follow-up (after randomisation)
Notes Source of funding: Department of Health's Policy Research Programme, as part of a joint DH/British
Heart Foundation Heart Failure research initiative
Risk of bias
Jolly 2009 
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "An independent clinical trials unit using a computerized programme under-
took randomization after each patient had consented and undergone the
baseline tests and questionnaire"
Allocation concealment
(selection bias)
Low risk "An independent clinical trials unit using a computerized programme under-
took randomization after each patient had consented and undergone the
baseline tests and questionnaire"
Blinding (performance
bias and detection bias) 
All outcomes
High risk "…, the nurse undertaking the assessment was blinded to the treatment allo-
cation of the patient, but owing to staNing issues, this occurred in only 62% of
participants followed up at 6 months"
Selective reporting (re-
porting bias)
Low risk All primary outcomes and most secondary outcomes described in the methods
were reported
Stated in the methods that blood pressure and incremental shuttle walking
test were not collected at 12 months
Intention-to-treat analy-
sis?
Low risk "...between- and within-group analyses for primary and secondary outcomes
at 6 and 12 months were performed according to intention to treat"
Incomplete outcome da-
ta?
Low risk Dropouts and clinical events were fully reported
Outcomes available for 161 (95%) participants at 6 months and for 157 (92%)
participants at 12 months. Non-imputed data were reported, and sensitivity
analysis was undertaken to examine the impact of missing data
Groups balanced at base-
line?
Unclear risk "Baseline characteristics were broadly comparable, the exception being that
the exercise group was somewhat younger and had higher HADS depression
scores and a lower systolic blood pressure"
Groups received same in-
tervention?
Low risk "Both groups received specialist heart failure nurse input in primary and sec-
ondary care through clinic and home visits that included the provision of infor-
mation about heart failure, advice about self-management and monitoring of
their condition, and titration of beta-blocker therapy"
Jolly 2009  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 43 (exercise 21, control 22)
Diagnosis (% of participants):
Aetiology: ischaemic 79%, AF 12%, valvular 7%, hypertension 2%
NYHA: Class II and III
LVEF: exercise 41.5 (SD 13.6), control 40.6% (SD 13.7)
Case mix: as above
Age, years: exercise 68 (SD 7), control 69 (SD 5)
Male: 79%
White: not reported
Jónsdóttir 2006a 
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Inclusion/exclusion criteria:
Inclusion: CHF diagnosis; on CHF medication; clinical symptoms of CHF; clinically stable > 3 months be-
fore study entrance; fulfilling 1 of the following criteria: previous MI, hospitalised because of CHF, lung
oedema, and cardiac enlargement on X-ray
Exclusion: chronic obstructive lung disease, orthopaedic disabilities, psychiatric disabilities, cancer, se-
nility, age > 80 years
Interventions Exercise:
Total duration: 5 months
Aerobic/resistance/mix: mix
Frequency: 2 sessions/week
Duration: 45 minutes
Intensity: not reported
Modality: cycling, free weights, and elastic rubber bands (Thera-bands)
Setting: hospital outpatients, supervised by physiotherapists
Other: training group given 3 educational lectures about nutrition, physical activity, and relaxation, in
addition to the exercise programme
Control group / Comparison:
Usual medical care (continued previous level of physical activity, which varied from performing little
physical activity to taking a daily walk outdoors)
Outcomes Rehospitalisation; mortality
Country and setting Iceland
Single centre
Follow-up 12 months and 28 months (after randomisation)
Notes Source of funding: none reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Jónsdóttir 2006a  (Continued)
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Intention-to-treat analy-
sis?
Low risk Although not reported as an ITT analysis, groups did appear to be analysed ac-
cording to the original randomised allocation
Incomplete outcome da-
ta?
Low risk No losses to follow-up
Groups balanced at base-
line?
Low risk Table 2 of the publication suggests that the 2 groups were well balanced
Groups received same in-
tervention?
Low risk Yes, both groups appeared to receive the same interventions apart from the CR
intervention
Jónsdóttir 2006a  (Continued)
 
 
Methods Parallel-group RCT - 2 arms
Participants N randomised: 57 (dance 19, formal exercise 19, control 19)
Diagnosis (% of participants):
Aetiology: coronary artery disease 29.8%, hypertension 24.6%, valvular heart disease 24.6%, arrhyth-
mia 21.1%
NYHA: not reported
LVEF: dance 49.3 ± 3.4%, formal exercise 49.1 ± 2.4%, control 49.6 ± 3.5%
Case mix: as above
Age, years: dance 67.2 (SD 4.2), formal exercise 67.1 (SD 7.2), control 67.2 (SD 5)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: NYHA II/III, heart failure with at least 3 months' clinical stability, no participation in any form
of regular exercise
Exclusion: unstable angina, myocardial infarction within last 5 months, uncontrolled hypertension,
chronic obstructive pulmonary disease, insulin-dependent diabetes mellitus, severe neurological or or-
thopaedic problems that would hinder the patient's participation in the exercise programme
Interventions Exercise:
Total duration: 32 weeks
Aerobic/resistance/mix: mix (resistance training included in the formal exercise group)
Frequency: 3 sessions/week
Duration: 60 minutes
Intensity: moderate: exercise perceived exertion 13 to 14 (somewhat hard) on the Borg 6 to 20 category
scale
Modality: dancing, cycling, or treadmill
Setting: home setting (supervised training at a public gym)
Kaltsatou 2014 
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Other: not reported
Control group / Comparison:
Usual care (no formal intervention was provided, and participants were asked to continue with usual
sedentary lifestyle)
Outcomes HRQoL (Greek version of SF-36)
Country and setting Greece
Single centre
Follow-up 8 months
Notes Formal exercise was structured by a group of experienced exercise trainers specialising in cardiac reha-
bilitation. Dance intervention was designed by a dance teacher with experience in rehabilitation
Source of funding: no specific grant from any funding agency in public, commercial, or not-for-profit
sectors
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "simple random allocation (drawing lots)"
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Low risk "All tests were conducted and interpreted by the same researcher blinded to
the identity of the subjects"
Selective reporting (re-
porting bias)
Unclear risk No protocol available
Intention-to-treat analy-
sis?
Low risk Although the term ITT was not stated, it appears from the CONSORT diagram
that ITT analysis was undertaken
Incomplete outcome da-
ta?
Low risk Loss to follow-up comparable and low in all groups, with reasons reported
In the dance group, 1/19 were lost to follow-up
In the formal exercise group, 3/19 were lost to follow-up
In the control group, 2/19 were lost to follow-up
Groups balanced at base-
line?
Low risk No differences between groups
Groups received same in-
tervention?
Low risk "The participants had to be in a clinically stable condition for at least three
months before entering the study and remained in a stable medication regi-
men and diet during the study"
Kaltsatou 2014  (Continued)
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Methods Parallel-group RCT
Participants N randomised: 40 (exercise 21, control 19)
Diagnosis (% of participants):
Aetiology: DCM 40%, IHD 60%
NYHA: Class II 67.5%, Class III 32.5%
LVEF: 21% (SD 7)
Case mix: 100%, as above
Age, years: 56 (SD 11)
Male: 100%
White: 62.5% (remainder black)
Inclusion/exclusion criteria:
Inclusion: NYHA Class II or III, resting EF < 35% measured by echocardiography or gated equilibrium ra-
dionuclide angiography, no change in medical therapy ≥ 30 days before randomisation
Exclusion: AF, acute MI 3 months, angina pectoris at rest or induced by exercise, current enrolment in
another clinical trial, current participation in a regular exercise programme (at least twice weekly)
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week (rate of perceived exertion 12 to 14)
Duration: 33 minutes
Intensity: 60% to 80% peak HR
Modality: treadmills, stationary cycles, rowing machines, arm ergometers  
Setting: outpatient clinic
Other: none reported
Control group / Comparison:
Usual medical care.
Participants were instructed to maintain their normal daily activity habits and not to begin an exercise
regimen
Outcomes Mortality, hospital admissions
Country and setting North America
Single centre
Follow-up 6 months (after randomisation)
Notes Study authors were contacted for further details of outcome findings but provided no information.
Each participant's physician was asked to not change the drug regimen during the study, if possible
Source of funding: Astra Merck
Keteyian 1996 
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "Patients were randomly assigned to the exercise group or the control group"
Allocation concealment
(selection bias)
Unclear risk "Each patient's assignment was sealed in an envelope until completion of the
second exercise test"
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk "Of the 40 patients entered into the study, only those who also completed the
exercise tests at weeks 12 and 24 were considered in the data analysis"
Incomplete outcome da-
ta?
Low risk "Fifteen patients in the exercise group completed the study. Two patients
dropped out because of noncardiac medical conditions (progressive, limiting
arthritis in one patient and newly diagnosed cancer in the other) that devel-
oped within 1 month of the start of the exercise program. One patient devel-
oped atrial fibrillation between week 12 and week 24; 3 other patients stopped
exercising for personal reasons before week 12 and refused follow-up test-
ing. Fourteen of the 19 patients in the control group completed the study. Two
dropped out for personal reasons and refused follow-up testing, one devel-
oped atrial fibrillation between week 12 and week 24, one was hospitalized at
week 22 for an acute myocardial infarction, and one died suddenly"
Groups balanced at base-
line?
Low risk "Among patients who completed the study, no differences in demographic
characteristics were seen between the two study groups after randomization"
Groups received same in-
tervention?
Unclear risk Co-interventions in the control group were not reported
Keteyian 1996  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 50 (exercise 25, control 25)
Diagnosis (% of participants):
Aetiology: IHD 100%
NYHA: Class II: exercise 56%, control 60%; Class III: exercise 44%, control 40%
LVEF: exercise mean 27.4% (SD 5.7), control mean 28.5% (SD 5.2)
Case mix: 100%, as above
Age, years: exercise 59.6 (SD 10.2), control 61.2 (SD 9.5)
Male: exercise 80%, control 72%
White: not reported
Klecha 2007 
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Inclusion/exclusion criteria:
Inclusion: ischaemic HF in NYHA Classes II and III > 6 months, clinically stable > 6 weeks, LVEF < 35%
Exclusion: uncontrolled arterial hypertension; history of major ventricular arrhythmias, acute coronary
syndrome, percutaneous coronary intervention, or brain event 3 months before the study; AF or other
arrhythmia making it impossible to perform MRI; previous coronary artery bypass grafting; implantable
cardioverter-defibrillator; permanent pacemaker or presence of metal parts in the body; signs of os-
teoarticular dysfunction excluding participation in physical training; DM; COPD; anaemia
Interventions Exercise:
Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: 25 minutes/session
Intensity: 80% predicted HR at VO2 max
Modality: cycling
Setting: centre-based
Other: none reported
Control group / Comparison:
Standard medical care only
Outcomes Mortality
Country and setting Poland
Single centre
Follow-up 26 weeks (after randomisation)
Notes Source of funding: KBN (The Polish State Committee for Scientific Research), grant no. 3 PO5D 047 23
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk Not implicit, but numbers used suggest that groups were analysed according
to randomised allocation
Klecha 2007  (Continued)
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Incomplete outcome da-
ta?
Low risk No participants were lost to follow-up
Groups balanced at base-
line?
Low risk "At baseline the groups did not differ significantly in clinical characteristics.
The only exception was smoking, the training group consisted of significantly
more ex-smokers"
Groups received same in-
tervention?
Unclear risk Not reported
Klecha 2007  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 42 (exercise group A 14, exercise group B 14, control group 14)
Diagnosis (% of participants): 
Exercise group A
Aetiology: ischaemic 100%
NYHA: Class II/III exercise group A 55%, control group 100%
LVEF: exercise group A mean 33.6% (SD 3.6), control group 33.2% (SD 3.8)
Exercise group B
Aetiology: ischaemic 100%
NYHA: Class II/III exercise group B 75%, control group 100%
LVEF: exercise group B mean 34.2% (SD 4.2), control group 33.2% (SD 3.8)
Case mix: 100%, as above
Age, years: exercise group A 54 (SD 7), control group 55 (SD 9), exercise group B 57 (SD 8), control 55
(SD 9)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: stable CHF, LVEF < 40% on echocardiography ≤ 1 month before inclusion, age < 65 years
Exclusion: moderate or severe pulmonary disease; orthostatic blood pressure fall (> 20 mmHg); MI, un-
stable angina, heart surgery, or coronary angioplasty within 3 months before inclusion as well as inabil-
ity to perform bicycle training
Interventions Exercise:
Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: group A: 20 minutes/session (4 minutes constant workload with 1 minute rest repeated 5
times)
Klocek 2005 
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Intensity: group A: 60% max HR
Duration: group B: 25 minutes/session (exercise workload gradually increased after each 5-minute
training period to a total of 25 minutes)
Intensity: group B: up to 75% max HR
Modality: cycle ergometer
Setting: CR, outpatient unit under supervision of the physician and the rehabilitation specialist
Other: none reported
Control group / Comparison:
Controls were asked to not change their degree of physical activity during the study
Outcomes HRQoL (Psychological General Wellbeing Index)
Country and setting Poland
Single centre
Follow-up 26 weeks (after randomisation)
Notes Source of funding: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk "Results of baseline QoL examinations were not known to the patients and
their physicians or to the persons performing the randomisation"
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk It appears that groups were analysed according to initial random allocation
Incomplete outcome da-
ta?
Unclear risk No information was presented on loss to follow-up nor dropouts
Groups balanced at base-
line?
Low risk "At baseline there were no significant differences in between groups in leR
ventricular ejection fraction and other basic parameters of leR ventricular
function"
"At the start of the study, mean PGWB [Psychological General Wellbeing Index]
total index was similar in groups A and B. Controls had lower total index than
patients in group B"
Groups received same in-
tervention?
Unclear risk Details of co-interventions were not reported, although the degree of fol-
low-up was stated to be equivalent
Klocek 2005  (Continued)
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Methods Parallel-group RCT
Participants N randomised: 26 (exercise 16, control 10)
Diagnosis (% of participants):
Aetiology: DCM 7%, ischaemic 100%
NYHA: Class II 58%, Class III 42%
LVEF: < 40%
Case mix: 100%, as above
Age, years: exercise 52 (SD 9), control 53 (SD 11)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: aetiology of CHF either ischaemic heart disease or DCM; diagnosis of CHF mainly based on
clinical signs (NYHA Class II and III), radiological findings, and echocardiographically determined EF <
40% and shortening fraction < 30%
Exclusion: recent MI or unstable angina; aortic stenosis; DM; uncontrolled hypertension; musculoskele-
tal limitations or other contraindications for participating in an exercise training programme; docu-
mented exercise-induced severe ischaemia or serious arrhythmias, or both
Interventions Exercise:
Total duration: 6 months
Aerobic/resistance/mix: mix
Frequency: 3 or 4 sessions/week
Duration: 60 minutes/session
Intensity: 50% to 75% peak VO2
Modality: cycle ergometer, walking or jogging, stair climber, and step-aerobics
- Plus 'light' resistance exercise (not defined)
Setting: supervised exercise training programme at institution
Other: none reported
Control group / Comparison:
Not reported
Outcomes HRQoL (MLWHF questionnaire and Spritzer Quality of Life Index)
Country and setting Greece
Single centre
Follow-up 6 months (after randomisation)
Koukouvou 2004 
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Notes Source of funding: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Low risk "The psychological tests were assessed from all patients in the first week of ad-
mission, before randomization to study groups and the end of the study by the
same physician, who was not familiar with the patients"
Selective reporting (re-
porting bias)
Low risk All outcomes outlined in the methods were reported
Intention-to-treat analy-
sis?
Low risk Not stated explicitly, but analysis appears to be done according to initial group
allocation
Incomplete outcome da-
ta?
Unclear risk Losses to follow-up, dropouts not reported
Groups balanced at base-
line?
Low risk "The two groups of patients participating in the study were similar as regards
their clinical data"
Groups received same in-
tervention?
Unclear risk Not reported
Koukouvou 2004  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 50 (exercise 25, control 25)
Diagnosis (% of participants):
Aetiology: ischaemic Intervention 32%, control 64%
NYHA: Class II: intervention 60%, control 64%; Class III: intervention 36%, control 32%
LVEF: ≥ 45%
Case mix: 100%, as above
Age, years: exercise 71.8 (SD 9.9), control 76.0 (SD 6.6)
Male: exercise 36%, control 56%
White: not reported
Inclusion/exclusion criteria:
Inclusion: LVEF ≥ 45% within 6 months of randomisation
Exclusion: cardiac rehab within 6 months, contraindication to exercise
Lang 2018 
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Interventions Exercise:
Total duration: 12 weeks
Aerobic/resistance/mix: aerobic
Frequency: 2 to 3 times/week
Duration: not reported
Intensity: not reported
Modality: walking or chair-based
Setting: home-based
The REACH-HF Manual; a participant ‘Progress Tracker’ booklet to record symptoms, physical activity,
and other actions related to self-care; support for caregivers; and facilitation by cardiac nurses or phys-
iotherapists, including assessment of individual patient and caregiver needs and concerns and tailor-
ing of the intervention content to address these were provided; this element was supported by a 3-day
training course for facilitators on how to deliver the intervention using a patient-centred style of com-
munication
Control group / Comparison:
Usual care ("...intervention and control group patients received usual medical management for HF ac-
cording to current guidelines")
Outcomes Primary outcome: MLWHF questionnaire
Secondary outcomes: mortality, hospitalisation, Heart-QoL, EQ-5D-3L, costs
Country and setting United Kingdom
Single centre
Follow-up 4 months and 6 months
Notes Funding source: National Institute for Health Research (NIHR) under its Grants for Applied Research
Programme (Grant Reference No. RP-PG-1210-12004)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "Participants will be randomly allocated in a 1:1 ratio to either intervention
or control group arms without stratification or minimisation. Randomisation
numbers will be computer generated and assigned in strict sequence. At the
point of randomisation, participants will be assigned the next randomisation
number in the sequence. To maintain concealment and minimise selection
bias, randomisation will be performed after the baseline visit by a member of
Peninsula Clinical Trials Unit (CTU), independent from investigator teams, us-
ing a secure, web-based randomisation system"
Allocation concealment
(selection bias)
Low risk As above
Blinding (performance
bias and detection bias) 
All outcomes
Low risk "We assessed the fidelity of blinding by asking outcome assessors at each fol-
low-up visit to guess patient group allocation. Unblinding of groups did not
take place until after data analysis and the blinded results had been presented
to the Trial Management Group and interpretation of results was agreed"
Lang 2018  (Continued)
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Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported as in the published protocol
Intention-to-treat analy-
sis?
Low risk "All analyses are based on the intention to treat principle (patients are
analysed according to their original random allocation) using observed data
only"
Incomplete outcome da-
ta?
Low risk All participants were accounted for in a CONSORT flow diagram
Groups balanced at base-
line?
High risk "There was evidence of imbalance between intervention and control group
patients in terms of their baseline demographic characteristics (see Table 1).
Compared with the control group, the intervention group included a higher
proportion of females, and lower proportions of patients with an ischaemic di-
agnosis, with atrial flutter/atrial fibrillation, and with chronic renal failure; al-
so, the intervention group had a younger mean age"
Groups received same in-
tervention?
Low risk Both groups received usual care
Lang 2018  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 181 (exercise 90, control 91)
Diagnosis (% of participants):
Aetiology: ischaemic 76%, hypertensive 7%, valvular 5%, other 12%
NYHA: Class I to III
LVEF: < 40%
Case mix: 100%, as above
Age, years: exercise 64.8 ± 1.1 (SD 10.5), control 66.1 (SD 9.4)
Male: control 80, exercise 82
White: not reported
Inclusion/exclusion criteria:
Inclusion: documented clinical signs and symptoms of HF; LVEF < 40%; NYHA functional class I to III; 6-
minute walk test distance < 500 m
Exclusion: inability to attend regular exercise training sessions; exercise testing limited by angina or
leg claudication; abnormal blood pressure response to exercise testing (systolic blood pressure dur-
ing exercise > 250 mmHg or diastolic blood pressure response > 15 mmHg, systolic blood pressure re-
sponse decrease > 20 mmHg after normal increase or decrease below the resting level); cerebrovascu-
lar or musculoskeletal disease preventing exercise testing or training; respiratory limitation (forced ex-
pired volume in 1 second, or vital capacity < 60% of predicted, or both); poorly controlled cardiac ar-
rhythmias; any non-cardiac condition affecting regular exercise training or decreasing survival
Interventions Exercise:
Total duration: 9 months (3 supervised, 6 home-based)
Aerobic/resistance/mix: mix
McKelvie 2002 
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Frequency: 2 sessions/week
Duration: aerobic; 30 minutes/session
Intensity: aerobic: 60% to 70% max HR. Resistance: 40% of 1-repetition maximum, with 10 repetitions
for arm exercises and 15 repetitions for leg exercises, with an increase over 5 weeks to an intensity of
60% for 1-repetition maximum and a total of 3 sets of each exercise per session
Modality: aerobic: cycle, treadmill, and arm ergometry exercise. Resistance: arm curl, knee extension,
and leg press performed individually with each limb.
After 3 months of supervised training, participants in the exercise group were provided an exercise cy-
cle and a set of free weights with instructions to continue training at home 3 times/week for the re-
mainder of the study
Setting: supervised for 3 months at rehabilitation centre and unsupervised for 9 months at home
Other: none reported
Control group / Comparison:
Usual medical care. Control participants were not provided a formal exercise prescription but were en-
couraged to continue their usual level of physical activity and were not discouraged from regular physi-
cal activity
Outcomes HRQoL (MLWHF questionnaire); mortality; composite of mortality and hospital admission for HF
Country and setting Canada
Multi-centre
Follow-up 12 months (after randomisation)
Notes Source of funding: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "The predetermined allocation sequence was based on a stream of comput-
er-generated pseudorandom numbers from a uniform distribution stratified
by center and with a blocking factor of 4"
Allocation concealment
(selection bias)
Low risk "Eligible patients were registered in a log and treatment group determined by
opening the next sequential study allocation envelope"
Blinding (performance
bias and detection bias) 
All outcomes
Low risk "Outcome measures were performed in a blinded fashion. Individuals respon-
sible for supervising and recording the results of the outcome measurements
were unaware of the patients group assignment"
Selective reporting (re-
porting bias)
Unclear risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk Although ITT analysis was not reported, groups appear to have been analysed
according to the original randomised allocation
Incomplete outcome da-
ta?
Low risk "In the control group, 83 patients completed 3 months of follow-up (reasons
for incompletion: death 3; other problems 4; worsening heart failure 1) and 75
patients completed 12months of follow-up (reasons for incompletion: death 8;
withdrawal 2; other problems 3; worsening heart failure 2; refused testing 1).
For the exercise group, 80 patients completed 3 months of follow-up (reasons
McKelvie 2002  (Continued)
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for incompletion: death 1; withdrawal 5; other problems 1; worsening failure 2;
refused testing 1) and 64 patients completed 12 months of follow-up (reasons
for incompletion: death 9; withdrawal 6; other problems 7; worsening heart
failure 3; refused testing 1)"
No imputation nor sensitivity analysis was undertaken to assess the impact of
loss to follow-up
Groups balanced at base-
line?
Low risk "There were no differences between the control and exercise training groups
with respect to age, resting ejection fraction, New York Heart Association class,
cause of heart failure, or duration of heart failure"
Groups received same in-
tervention?
Unclear risk "All patients were reviewed monthly throughout the study"
McKelvie 2002  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 40 (exercise 20, control 20)
Diagnosis (% of participants):
Aetiology: ischaemic 76%, hypertensive 7%, valvular 5%, other 12%
NYHA: Class I to III
LVEF: exercise 33.09 ± 4.77%, comparator 35.8 ± 6.87%
Case mix: 100%, as above
Age, years: exercise 56.4 (SD 5.829), control 54.6 (SD 9.264)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: > 8 months' history of DCM with 3 months' clinical stability on optimal medical therapy
Exclusion: significant coronary disease by history or angiography to exclude ischaemic causes; evi-
dence for secondary causes of cardiomyopathy as long-standing or uncontrolled hypertension; prima-
ry valvular disease; atrial fibrillation (AF); severe functional mitral regurgitation (MR); clinical evidence
of pulmonary disease (chronic obstructive lung disease, moderate to severe pulmonary hypertension)
Interventions Exercise:
Total duration: 28 weeks
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: aerobic; 45 minutes/session
Intensity: aerobic: maximal 80% of heart rate reserve
Modality: aerobic: circuit training (stairmaster, bicycle, treadmill)
Setting: hospital (supervised)
Other: none reported
Mehani 2013 
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Control group / Comparison:
Usual care (2 weekly physician visits with medication adjustments)
Outcomes Hospital admissions, mortality
Country and setting Iran
Single centre
Follow-up 7 months
Notes Source of funding: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk "the patients were randomly assigned into two groups (training and control
groups) by arrangement into numerical numbers from 1 to 40, then odd num-
bers were allocated as a training group and the even numbers were allocated
as a control group"
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk HRQoL assessment was self-administered. Blinding was not reported for other
outcomes
Selective reporting (re-
porting bias)
Unclear risk No protocol was available
Intention-to-treat analy-
sis?
Low risk Although the term ITT was not stated, it appears from the CONSORT diagram
that an ITT analysis was undertaken
Incomplete outcome da-
ta?
Low risk Loss to follow-up similar across groups, with reasons given
Exercise: 5/20 were lost to follow-up
Control: 5/20 were lost to follow-up
Groups balanced at base-
line?
Low risk "At baseline, there were no statistical significant differences between both
groups as regards to age, body mass index, NYHA classification, leR ventricular
internal dimensions at diastole and systole"
Groups received same in-
tervention?
Low risk With the exception of the exercise-based intervention, all participants under-
went the same visits, except for exercise, and received the same disease infor-
mation
Mehani 2013  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 50 (exercise 25, control 25)
Diagnosis (% of participants):
Mueller 2007 
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Aetiology: ischaemic, DCM (% not reported)
NYHA: not reported
LVEF: < 40% (% not reported)
Case mix: 100%, as above
Age, years: 55 (SD 10)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: CHF documented by clinical, angiographic, or echocardiographic criteria; resting EF < 40%
Exclusion: not reported
Interventions Exercise:
Total duration: 1 month
Aerobic/resistance/mix: aerobic
Frequency: 5 sessions/week
Duration: 30 minutes/session cycling, 90 minutes walking each day
Intensity: Borg 12 to 14 (60% to 80% max HR)
Modality: cycling and walking
Setting: indoor cycling sessions were supervised directly by a medical resident; outdoor walking ses-
sions were supervised by exercise physiologists
Other: resided at the rehabilitation centre for 1 month; programme also included education and low-
fat meals prepared daily by the centre's cook
Control group / Comparison:
Usual medical care
Outcomes Morbidity, mortality
Country and setting Switzerland
Single centre
Follow-up 6.2 years (after randomisation)
Notes Source of funding: RAHN-Medizinfonds, Zurich; Schweizerische Herzstiftung, Switzerland
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Mueller 2007  (Continued)
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Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk Outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk ITT was not stated explicitly; however, groups appear to have been analysed
according to the original allocation
Incomplete outcome da-
ta?
Low risk "Data from one patient in the control group was not available at the two-
month evaluation due to refusal to complete testing." "Among subjects in the
exercise group, 9 died, and one refused repeat testing. Among patients in the
control group, 12 died and two refused repeat testing. Therefore, 14 and 13 pa-
tients performed six-year evaluations in the exercise and control groups, re-
spectively"
QUORUM diagram reported and detailed text provided; no imputation under-
taken
Groups balanced at base-
line?
Low risk "No differences were observed between the exercise and control groups ini-
tially in clinical or demographic data, including age, height, weight, pulmonary
function or medication status"
Groups received same in-
tervention?
Unclear risk "Patients in the exercise group resided at the rehabilitation centre for one
month. Control subjects received usual clinical care, including verbal encour-
agement to remain physically active"
Mueller 2007  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 25 (exercise 12, control 13)
Diagnosis (% of participants):
Aetiology: ischaemic 100%
NYHA: not reported
LVEF: exercise 31.5% (SD 7), control 33.3% (SD 6)
Case mix: 100%, as above
Age, years: exercise 56 (SD 5), control 55 (SD 7)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: MI, diagnosis of HF and stable symptoms, LVEF < 40%
Exclusion: pulmonary disease
Interventions Exercise:
Total duration: 2 months
Myers 2000 
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Aerobic/resistance/mix: aerobic
Frequency: walking: 2 sessions daily; cycling: 4 sessions/week
Duration: walking: 1 hour; cycling: 45 minutes
Intensity: walking: not reported; cycling: 60% to 70% peak VO2
Modality: walking and cycling
Setting: centre-based; supervised by physicians
Other: exercise groups received educational sessions and low-fat meals prepared 3 times daily
Control group / Comparison:
Usual clinical follow-up
Outcomes Hospitalisation, mortality
Country and setting Switzerland
Single centre
Follow-up 2 months and 12 months (after randomisation)
Notes "After the initial 2-months exercise training or control period, both groups were encouraged to remain
physically active over the subsequent 10 months, although no formal program was implemented"
Source of funding: supported in part by a grant from Schweizerische Herzstiftung, Switzerland
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk Although not explicit, participants appeared to be analysed according to the
initial random allocation
Incomplete outcome da-
ta?
Low risk Losses to follow-up were reported
Groups balanced at base-
line?
Low risk "No differences were observed between the 2 groups initially in clinical or de-
mographic data, including age, height, weight, resting blood pressure, pul-
monary function, ejection fraction, or maximal oxygen uptake"
Groups received same in-
tervention?
Low risk Yes, both groups appeared to receive the same interventions, apart from the
CR intervention
Myers 2000  (Continued)
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Methods Parallel-group RCT
Participants N randomised: 80 (exercise 40, control 40)
Diagnosis (% of participants):
Aetiology: ischaemic cardiomyopathy 69%, idiopathic DCM 18%, hypertensive HF 13%
NYHA: Class II 47%, Class III 35%
LVEF: exercise 31% (SD 8), control 31% (SD 9)
Case mix: 100%, as above
Age, years: 70.1 (SD 7.9)
Male: 79%
White: not reported
Inclusion/exclusion criteria:
Inclusion: stable CHF and LVEF < 40% or ≥ 40% with clinical symptoms of diastolic HF
Exclusion: acute MI within 4 weeks; unstable angina pectoris; serious rhythm disturbance; symptomatic
PVD; severe COPD, with forced expiratory vital capacity < 50% of expected measured by spirometry; 6-
minute walking distance > 550 m; workload on the cycle ergometer test > 110 watts; significant co-mor-
bidities that would prevent entry into the study due to terminal disease or inability to exercise (e.g. se-
vere musculoskeletal disorder, advanced valvular disease); in long-term care establishment
Interventions Exercise:
Total duration: 4 months
Aerobic/resistance/mix: aerobic
Frequency: 2 sessions/week
Duration: 50 minutes
Intensity: 15 to 18 on Borg scale
Modality: fast walking, side-stepping, and leg liRs in combination with overhead arm reaches
Setting: hospital outpatient department
Other: 15 to 30 minutes of counselling with CHF nurse for participants in the exercise group (4 hours in
total)
Control group / Comparison:
Control group was not provided with exercise prescriptions and was encouraged to continue usual lev-
els of physical activity
Outcomes HRQoL (MLWHF questionnaire); mortality
Country and setting Norway
Single centre
Follow-up 12 months (after randomisation)
Nilsson 2008 
Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
96
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Notes All training sessions were supervised by a physiotherapist - a specialist in heart rehabilitation
Source of funding: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "computer-generated table of random numbers"
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Low risk "Three physicians and 3 nurses who were blinded to the clinical data and
group assignments of the patients carried out all the follow-up tests. Patients
were told not to reveal to which groups they belonged"
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk "Intention-to-treat analyses were performed"
Incomplete outcome da-
ta?
Low risk 35/40 (88%) in the exercise training group and 37/40 (93%) in the control group
were available at 12 months
Groups balanced at base-
line?
Low risk Table 1 of the publication suggests no differences between the 2 groups
Groups received same in-
tervention?
Low risk Yes
Nilsson 2008  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 42 (exercise 22, control 20)
Diagnosis (% of participants):
Aetiology: ischaemic 50%, non-ischaemic 50%
NYHA: Class II: exercise 64%, control 45%; Class III: exercise 36%, control 55%
LVEF: exercise: mean 33% (SD 7), control: mean 32% (SD)
Age, years: exercise 57 (SD 12), control 63 (SD 15)
Male: 57.5%
White: not reported
Inclusion/exclusion criteria:
Inclusion: age ≥ 21 years with HF; oriented to person, place, and time; able to speak and read English;
resting LVEF ≤ 40% and stable on optimal medical therapy for at least 30 days
Norman 2012 
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Exclusion: clinical evidence of decompensated HF; unstable angina pectoris; MI; coronary artery by-
pass surgery; biventricular pacemaker < 3 months ago; orthopaedic or neuromuscular limitations pre-
venting participation in aerobic or resistance exercise training; participation in an aerobic exercise pro-
gramme during the past 12 months
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: mix
Frequency: aerobic 3 days/week, resistance 2 days/week
Duration: aerobic: 30 minutes/session (30 minutes' warm-up); resistance: 8 to 10 exercises (upper and
lower extremities) performed for 1 set of 10 to 15 repetitions
Intensity: aerobic: 40% to 70% HR reserve, or Borg 11 to 14; resistance: not reported
Modality: aerobic: not reported; resistance: weight machines, free weights, or elastic bands based on
exercise performance
Setting: 3 weeks: supervised, 21 weeks: hospital's wellness centre or home
Other: group meetings that addressed the same educational topics as were addressed in the control
group but also information on problem-solving barriers to exercise, relapse management, and symp-
toms experienced during exercise
Control group / Comparison:
"Attention control"
Instructions to continue with normal level of activity; no instructions given to withhold or stop activity
Outcomes HRQoL (KCCQ); SF-36; mortality
Country and setting USA
Single centre
Follow-up 24 weeks (after randomisation)
Notes Study conducted in 2 sequential 12-week phases
Phase 1: separate weekly group meetings of both groups during weeks 1 to 3, then separate biweekly
meetings during weeks 4 to 12
Phase 2: following the groups for an additional 12 weeks without group sessions
Other trial report:
Pozehl B, Duncan K, Hertzog M, Norman JF. Heart failure exercise and training camp: effects of a mul-
ticomponent exercise training intervention in patients with heart failure. Heart Lung 2010;39(6 Sup-
pl):S1-13
Source of funding: R-15 AREA Grant from the National Institute of Health (# NR0092 15-01)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Norman 2012  (Continued)
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Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
High risk "Research assistants who were blinded to group assignment assisted in some
of the data collection. However, because of budget constraints, the investiga-
tors who were not blinded to group assignment were also involved in data col-
lection"
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk Not stated, but groups were analysed according to randomised allocation
Incomplete outcome da-
ta?
Low risk Due to mortality and dropout, KCCQ scores were available for 37 participants
(88%) at 24 weeks
Groups balanced at base-
line?
Low risk "…no significant difference noted between groups"
Groups received same in-
tervention?
Low risk Both groups received group sessions (attention control), so the only difference
between groups was the exercise-based intervention
Norman 2012  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 85 (training 44, control 41)
Diagnosis (% of participants)*:
Aetiology: ischaemic 59%, DCM 41%
NYHA: Class I 16%, Class II 69%, Class III 34%
LVEF: training 35% (SD 9.3), control 32.3 (SD 14.1)
Case mix: 100%, as above
Age, years: exercise 60 (SD 13), control 61 (SD 13)
Male: 87%
White: not reported
Inclusion/exclusion criteria:
Inclusion: impaired leR ventricular systolic function (EF < 45%) and exercise capacity (peak VO2 < 25 mL/
min/kg)
Exclusion: NYHA Class IV; MI or unstable angina < 6 months before the examination; exercise-limiting
disease; severe pulmonary or renal disease
*Baseline data available for only 85 participants
Interventions Exercise:
Total duration: 9 months
Aerobic/resistance/mix: aerobic
Passino 2006 
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Frequency: > 3 sessions/week
Duration: 30 minutes/session
Intensity: 65% max VO2
Modality: cycle
Setting: home-based
Other: not reported
Control group / Comparison:
Not reported
Outcomes HRQoL (MLWHF questionnaire)
Morbidity
Country and setting Italy
Not reported
Follow-up 9 months (after randomisation)
Notes Source of funding: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Exercise test assessor was blinded
Selective reporting (re-
porting bias)
Unclear risk Not reported
Intention-to-treat analy-
sis?
Low risk Although ITT was not stated, groups appear to have been analysed according
to the original randomisation
Incomplete outcome da-
ta?
Low risk Outcomes described in the methods were reported in the results
Groups balanced at base-
line?
Low risk "The two groups did not differ as to age, gender, NYHA functional class, EF,
pharmacologic treatment, or HF etiology (Table 1)"
 
Groups received same in-
tervention?
Low risk "Patients in [control] group underwent follow-up visits at the third and ninth
month to exclude changes in their usual lifestyle and physical activity"
Passino 2006  (Continued)
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Methods Parallel-group RCT
Participants N randomised: 21 (exercise 15, control 6)
Diagnosis (% of participants):
Aetiology: ischaemic 71%, non-ischaemic 29%
NYHA: Class II 39%, Class III 52%, Class IV 9%
LVEF: exercise 27.9% (SD 7.0), control 29.7% (SD 8.7)
Case mix: 100%, as above
Age, years: exercise 66.3 (SD 9.6), control 66 (SD 12.6)
Male: 90%
White: 100%
Inclusion/exclusion criteria:
Inclusion: ability to speak and read English; stable NYHA Class II to IV; no change in medical therapy for
30 days; resting LVEF < 40% as measured by echocardiography or gated equilibrium radionuclide an-
giography; medical diagnosis of HF ischaemic or non-ischaemic; standard pharmacological therapy for
HF (diuretics, angiotensin-converting enzyme inhibitors, and beta blockers)
Exclusion: participation in a formal exercise programme < 30 days before this study; clinical evidence of
decompensated HF; any of the following medical conditions: AF, acute MI < 3 months, unstable angina
pectoris, end-stage renal disease, or orthopaedic impediments to exercise
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: mix
Frequency: 3 sessions/week
Duration: 30 minutes aerobic, 20 minutes resistance
Intensity: 60% to 85% max VO2, 12 to 14 Borg scale
Modality: aerobic: treadmill, stationary bike, rower, arm ergometer; resistance: light upper body exer-
cises (military press, biceps curl, lateral deltoid raises), and lower body exercises (knee extension, side
hip raise, hip extension) with 1 to 10 lb hand and ankle weights. Wall push-ups, abdominal curl-ups,
pelvic tilts, or a combination
Setting: first 12 weeks at the hospital and remaining sessions were unsupervised at the rehabilitation
centre
Other: strategies from social learning theory (goal-setting, feedback, problem-solving guidance)
utilised to facilitate, improve adherence to the training programme
Control group / Comparison:
Usual medical care
Outcomes Mortality
Country and setting USA
Single centre
Pozehl 2008 
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Follow-up 6 months (after randomisation)
Notes Source of funding: American Heart Association #9806406S and University of Nebraska Medical Center
#OC-10-98
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk Outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk Although not stated, groups appear to have been analysed according to the
initial randomised allocation
Incomplete outcome da-
ta?
Low risk "One subject in the control group died of myocardial infarction and one sub-
ject in the exercise training group was diagnosed with cancer and unable to
continue the exercise training"
No imputation undertaken
Groups balanced at base-
line?
Low risk "Subjects did not differ in fatigue or dyspnea by type of HF (ischemic vs. nonis-
chemic) or years since diagnosis of HF (length of time since diagnosis)"
Groups received same in-
tervention?
Unclear risk Not reported
Pozehl 2008  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 27 (exercise 15, control 12)
Diagnosis (% of participants):
Aetiology: preserved EF: exercise 42%, control 40%
NYHA: not reported
LVEF: exercise 40 ± 13%, control 34 ± 18%
Case mix: 100%, as above
Age, years: exercise 72.7 (SD 10.8), control 71.8 (SD 9.1)
Male: exercise 47%, control 33%
White: 47% in exercise group, 42% in control group
Reeves 2017 
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Inclusion/exclusion criteria:
Inclusion: ADHF diagnosed by acute worsening of HF symptoms; at least 1 sign of HF and change in
medical treatment consistent with HF; aged ≥ 60 years; independence with basic activities of daily liv-
ing before hospitalisation; achievement of clinical stability allowing study participation; ability to am-
bulate at least 4 m; planned return home post discharge
Exclusion: acute coronary syndrome, severe aortic stenosis, end-stage HF requiring advanced therapies
or home intravenous inotropic therapy, functional status limited by condition other than HF at the time
of enrollment, advanced chronic kidney disease defined as estimated glomerular filtration rate 20 mL/
min/1.73 m2, terminal illness other than HF, active participation in supervised exercise training before
hospitalisation, inability or unwillingness to adhere with the study protocol
Interventions Exercise:
Total duration: 12 weeks
Aerobic/resistance/mix: mix
Frequency: 3 sessions/week
Duration: 60 minutes
Intensity: individually tailored: initially low intensity, rising to 13 ("somewhat hard") on self-reported
score
Modality: endurance and strength training
Setting: hospital (supervised) and home (unsupervised)
Other: components of exercise include static and dynamic balance training (e.g. standing with narrow
base of support, standing and reaching); mobility training (e.g. dynamic start and stop, changing direc-
tion while walking); functional strength training focused on lower extremities (e.g. chair rise; step-ups);
endurance training (sustained walking preferred)
Control group / Comparison:
Usual care (regular physician visits with medication adjustments) plus regular contact with study per-
sonnel
Outcomes All-cause hospital admissions
Country and setting USA
Multi-centre
Follow-up 6 months
Notes Exercise was individually tailored and was delivered by trained internationalists in hospital over 12
weeks along with a home exercise prescription (unsupervised low-intensity walking at usual pace for
up to 30 minutes and simple functional strengthening exercises)
Source of funding: NIH Grants R01AG045551 and R01AG18915; The Claude D. Pepper Older Americans
Independence Centre of Wake Forest School of Medicine Winston-Salem, NC, NIH Grant P30AG021332;
the Kermit Glenn Phillips II Endowed Chair in Cardiology; Dean's Faculty Achievement, Jefferson Glenn
Philips II Endowed Chair in Cardiology; Dean's Faculty Achievement Award, Jefferson College of Health
Professions, Philadelphia, PA; and Oristano Family Research Fund
Risk of bias
Bias Authors' judgement Support for judgement
Reeves 2017  (Continued)
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Random sequence genera-
tion (selection bias)
Low risk "Participants were randomized using a computer-generated list SAS software"
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Low risk "Follow-up assessments were collected by trained, blinded assessors accord-
ing to standardized protocols"
Selective reporting (re-
porting bias)
Low risk  
Intention-to-treat analy-
sis?
Low risk "Intention-to-treat analysis performed for all-cause hospital admissions, with
comparisons made using analysis of covariance with heart failure category
(ejection fraction <45% or ≥45%)"
Incomplete outcome da-
ta?
Unclear risk Three dropouts from total (N = 24) but no further details or reasons given
Groups balanced at base-
line?
Low risk "Baseline characteristics were balanced between the study arms"
Groups received same in-
tervention?
Low risk Control group received "attention" consisting of at least monthly contact with
study personnel via scheduled phone calls and follow-up assessments
Reeves 2017  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 19 (exercise 9, control 10)
Diagnosis (% of participants):
Aetiology: not reported
NYHA: mean exercise 2 (SE 0), mean control 2.13 (SE 0.13)
LVEF: ≤ 60%
Case mix: as above
Age, years: exercise 69 (SD 4.44), control 70 (SD 4.05)
Male: 58%
White: 100%
Inclusion/exclusion criteria:
Inclusion: diagnosis of NYHA Class I to III congestive HF; EF ≤ 60%; systolic dysfunction; physician ap-
proval; ability to complete a minimum of 3 minutes of a modified Bruce protocol stress test
Exclusion: failure to meet any of the inclusion criteria; inability to speak English; noticeable cognitive
impairment
Interventions Exercise:
Total duration: 12 months
Wall 2010 
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Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: > 15 minutes
Intensity: not reported
Modality: treadmill
Lifestyler® treadmill provided for 1 year of in-home use; 3 supervised exercise sessions at hospital with
CR specialist. Weekly in-home exercise visits with CR specialist, month 1. Monthly in-home exercise vis-
its with CR specialist, months 2 to 12. Also received comprehensive disease management programme
Setting: 3 hospital based; the remainder at home
Other: not reported
Control group / Comparison:
Comprehensive disease management - by dedicated case manager (participant education on nutrition,
medications, and disease management; an oximetry assessment; constant monitoring of symptomatic
changes and disease status)
Outcomes Disease-specific HRQoL (Chronic Heart Failure Questionnaire), mortality
Country and setting USA
Single centre
Follow-up 12 months (after randomisation)
Notes Source of funding: ATPM/CDC/ATSDR Cooperative Agreement No. U50/CCU300860
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported
Intention-to-treat analy-
sis?
Low risk Although not stated, it is clear from the CONSORT diagram that 2 groups were
analysed according to ITT
Incomplete outcome da-
ta?
Low risk QUORUM flow diagram report suggests that 19 were included in the analysis
15 participants (79%) completed final follow-up measures at month 12
Groups balanced at base-
line?
Low risk Table 3 of the publication suggests there is no difference between the 2 groups
(except dyspnoea score)
Wall 2010  (Continued)
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Groups received same in-
tervention?
Low risk Both groups received comprehensive disease management
Wall 2010  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 54 (exercise 27, control 27)
Diagnosis (% of participants):
Aetiology: ischaemic 80%, non-ischaemic 20%
NYHA: exercise 2.1 (SD 0.7), control 2.4 (0.7)
LVEF: exercise 35% (SD 12), control 38% (SD 10)
Case mix: 100%, as above
Age, years: exercise 64 (SD 5), control 64 (SD 9)
Male: exercise 73%, control 70%
White: not reported
Inclusion/exclusion criteria:
Inclusion: 8 points on Boston heart failure criteria; LVEF 0.45 at the most recent radionuclide or echocar-
diographic examination (not older than 1 year at inclusion); age 75 years
Exclusion: change in clinical status or medication (or both) within 4 weeks before inclusion; MI, heart
surgery, or coronary angioplasty within 3 months before inclusion; inability to perform a bicycle test;
exercise-terminating angina pectoris, ST depressions (> 2 mm in > 1 lead), blood pressure fall (>.10 mm
Hg), or arrhythmia (e.g. ventricular tachycardia/fibrillation, ventricular extrasystoles, supraventricu-
lar tachycardia > 170 bpm) at the most recent maximal exercise test (including the baseline test); pul-
monary disease judged to be the main exercise-limiting factor or peak expiratory flow rate < 50% of
age- and sex-adjusted reference values, or both; NYHA Class IV; clinically significant aortic stenosis
Interventions Exercise:
Total duration: 4 months
Aerobic/resistance/mix: aerobic/interval
Frequency: 2 to 3 sessions/week
Duration: 15 minutes/session, increasing to 45 minutes/session
Intensity: 80% peak VO2, or 15 on Borg score
Modality: cycle ergometry
Setting: group sessions supervised by physiotherapist
Other: none
Control group / Comparison:
Control participants were asked to not change their degree of physical activity during the active study
period. Neither training participants nor controls were instructed regarding physical activity during the
6-month extended follow-up
Willenheimer 2001 
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Outcomes HRQoL (Patient's Global Assessment of Quality of Life); mortality
Country and setting Sweden
Single centre
Follow-up 10 months (after randomisation)
Notes Source of funding: Swedish Society for Patients With Heart and Lung Diseases
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Low risk Outcome assessors blinded; participants, clinical carers not blinded
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk Although ITT is not implicit, it appears that groups were analysed according to
the original randomised allocation
Incomplete outcome da-
ta?
High risk Outcomes were available for only 43/54 (80%) participants randomised at 10
months' follow-up. No imputation or sensitivity analysis was undertaken to as-
sess effects of loss to follow-up. Study authors stated that participants avail-
able at 10 months' follow-up are representative
Groups balanced at base-
line?
Low risk "There was no difference between training (n = 22) and control (n = 27) pa-
tients as regards baseline variables"
Groups received same in-
tervention?
Low risk "No change in medication allowed during study"
Willenheimer 2001  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 82 (exercise 41, control 41)
Diagnosis (% of participants):
Aetiology: IHD 66%
NYHA: Class II 56%, Class III 44%
LVEF: not reported
Case mix: as above
Witham 2005 
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Age, years: exercise 80 (SD 6), control 81 (SD 4)
Male: 55%
White: not reported
Inclusion/exclusion criteria:
Inclusion: age ≥ 70 years with clinical diagnosis of CHF according to European Society of Cardiology
guidelines; NYHA Class II or III symptoms and evidence of LVSD on echocardiography, contrast ventricu-
lography, or radionuclide ventriculography; evidence of LVSD
Exclusion: uncontrolled AF, significant aortic stenosis, sustained ventricular tachycardia, recent MI, in-
ability to walk without human assistance, abbreviated mental score < 6 of 10, currently undergoing
physiotherapy or rehabilitation
Interventions Exercise:
Total duration: 6 months
Aerobic/resistance/mix: mix
Frequency: 2 to 3 sessions/week
Duration: 20 minutes
Intensity: Borg 11 to 13
Modality: walking and wrist/ankle weights
Setting: 3 months: hospital-based by senior physiotherapist; 3 months: home-based
After 3 months of supervised training, participants in the exercise group were asked to continue to per-
form exercises at home 2 or 3 times/week with the aid of video or audio cassette with demonstrations,
instructions, and music. No face-to-face contact was had with the physiotherapist during this period
Other: not reported
Control group / Comparison:
Usual medical care
Outcomes Disease-specific health-related quality-of-life (Guyatt Chronic Heart Failure Questionnaire); mortality;
hospitalisation
Country and setting UK
Single centre
Follow-up 6 months (after randomisation)
Notes Source of funding: Grant 2006/918 from The Health Foundation (formerly PPP Health Foundation),
London, United Kingdom
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "A researcher not otherwise connected with the operation of the study pre-
pared cards contained in numbered, sealed envelopes from computer-gener-
ated random number tables"
Witham 2005  (Continued)
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Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias) 
All outcomes
Low risk "An experienced research nurse who was blinded to treatment allocation per-
formed all assessments"
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk It appears from the QUORUM diagram that groups were analysed according to
the initial random allocation
Incomplete outcome da-
ta?
Low risk 75/82 (91%) and 68/82 (83%) were available at 3 months' and 6 months' fol-
low-up, respectively
Groups balanced at base-
line?
Low risk Table 1 of the publication shows that groups were well balanced
Groups received same in-
tervention?
Low risk Yes, both groups appear to have received usual medical care; the only differ-
ence between groups was the exercise intervention
Witham 2005  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 107 (exercise 53, control 54)
Diagnosis (% of participants):
Aetiology: ischaemic 62.6%
NYHA: Class II 79%, Class III 21%
LVEF: not reported
Case mix: as above
Age, years: exercise 80.4 (SD 5.8), control 79.5 (SD 4.9)
Male: exercise 35%; control 37%
White: 100%
Inclusion/exclusion criteria:
Inclusion: age ≥ 70 years with confirmed diagnosis of HF due to LVSD (NYHA Class II and III) and history
of symptoms and signs of congestive HF
Exclusion: wheelchair bound, unwilling or unable to give informed consent, aortic stenosis with peak
gradient > 30 mmHg, sustained ventricular tachycardia or ventricular fibrillation outside the context of
an acute MI, currently (within the past month) with unstable angina or AF with ventricular rate > 100/
min
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: mix
Witham 2012 
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Frequency: 2 sessions/week
Duration: ≤ 60 minutes
Intensity: not reported
Modality: home, walking
Setting: hospital and home*
Other: cognitive and behavioural techniques were incorporated into first 8-week hospital-based reha-
bilitation; resistance training with elasticised bands
Control group / Comparison:
Usual medical care (given a booklet with general advice on diet, exercise, and lifestyle); not discour-
aged from exercising if already in the habit of doing so
Outcomes Disease-specific HRQoL (MLWHF questionnaire); HRQoL (EuroQoL-5D); mortality; hospital admission;
cost
Country and setting UK
Single centre
Follow-up 24 weeks (after randomisation)
Notes *8 weeks in hospital delivered by experienced physiotherapist, 16-week home-based (telephoned
every 2 weeks for 8 weeks by physiotherapists, then monthly for the final 8 week)
Source of funding: Chief Scientist Office (Scottish Government), Grant number CZH/4/426
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "Using oN-site telephone randomization service, randomization was per-
formed without stratification and with block sizes between 8 and 16, depend-
ing on the size of each planned exercise class"
Allocation concealment
(selection bias)
Low risk "…the project coordinator passed the participants' details to the research
physiotherapist who obtained group allocation, ensuring that the project co-
ordinator remained blind to group assignments"
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk Not reported
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk Analyses were by ITT
Incomplete outcome da-
ta?
Low risk 89/104 (86%) and 87/104 (83%) were available for follow-up at 8 and 24 weeks,
respectively
Groups balanced at base-
line?
Low risk Table 1 of the publication suggests no differences between the 2 groups
Witham 2012  (Continued)
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Groups received same in-
tervention?
Low risk It appeared that both groups received the same care, except for the exercise
intervention
Witham 2012  (Continued)
 
 
Methods Parallel-group RCT
Participants N randomised: 100 (Tai Chi (exercise) 50, education (control) 50)
Diagnosis (% of participants):
Aetiology: ischaemic 54%, non-ischaemic 46%
NYHA: Class I 20%, Class II 63%, Class III 17%
LVEF: mean 29% (SD 8%)
Case mix: 100%, as above
Age, years: exercise 68.1 (SD 11.9), control 66.6 (SD 12.1)
Male: 64%
White: 86%
Inclusion/exclusion criteria:
Inclusion: EF ≤ 40% in past 2 years, stable medical regimen, NYHA Class I to III HF
Exclusion: unstable angina, MI, or major surgery in past 3 months; history of cardiac arrest in past 6
months; history of cardiac re-synchronisation therapy in the past 3 months; unstable serious ven-
tricular arrhythmias; unstable structural valve disease; current participation in conventional CR pro-
gramme; diagnosis of peripartum cardiomyopathy within preceding 6 months; inability to perform a bi-
cycle stress test; lower extremity amputation or other inability to ambulance owing to condition oth-
er than HF; severe cognitive dysfunction (Mini-Mental State Examination score ≤ 24); inability to speak
English; regular practice of Tai Chi
Interventions Exercise:
Total duration: 12 weeks
Aerobic/resistance/mix: aerobic
Frequency: 2 sessions/week (for 12 weeks) and encouraged to practice at home at least 3 times/week
Duration: 1-hour class (30 minutes' warm-up)
Intensity: not reported
Modality: Tai Chi movements
- Weeks 2 to 5: warm-up + raising the power; withdraw and push
- Weeks 6 to 9: 1 + grasp sparrow's tail, brush knee twist step
- Weeks 10 to 12: 2 + wave hands like clouds
Participants were given 45-minute instructional videotape that outlined the exercises presented in
class as an aid to practice
Participants also received the same educational pamphlets used in the education (control) group, with
a brief (< 5 minutes) explanation towards the end of 1 Tai Chi session weekly
Yeh 2011 
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Setting: centre-based and home-based
Other: none reported
Control group / Comparison:
Educational group ('attention control'): nurse practitioner-led educational session (same duration and
frequency as Tai Chi group classes)
Participants were asked to not start Tai Chi classes during the study
Outcomes HRQoL (MLWHF questionnaire); mortality; hospital admission
Country and setting USA
Multi-site
Follow-up 12 weeks and 6 months (after randomisation)
Notes Single-blind
Source of funding: ROI AT002454 Award from the National Center for Complementary and Alternative
Medicine; in part by RR 01032 from the Beth Isreal Deaconess Medical Center General Clinical Research
Center from the National Institutes of Health (NIH)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "The trial uses a permuted block randomization with variable block size to
generate treatment assignment"
Allocation concealment
(selection bias)
Unclear risk "Patients who chose to were randomly assigned to receive a 12-week tai chi
exercise program or a heart health education program (attention control)"
Blinding (performance
bias and detection bias) 
All outcomes
Low risk "We masked all the study staN performing all tests to each participant's group
allocation"
Selective reporting (re-
porting bias)
Low risk All outcomes described in the methods were reported in the results
Intention-to-treat analy-
sis?
Low risk All participants were included in the analysis regardless of their attendance
Incomplete outcome da-
ta?
Low risk Figure 1 of the publication shows 91% to 96% complete data across HRQoL
and exercise outcomes
Groups balanced at base-
line?
Low risk "The 2 groups were generally similar in demographics, clinical classification of
heart disease severity, and rates of comorbidities"
Groups received same in-
tervention?
Low risk Yes, both groups received comprehensive disease management
Yeh 2011  (Continued)
ACE: angiotensin-converting enzyme; AF: atrial fibrillation; BL: baseline; bpm: beats/min; CBT: cognitive-behavioural therapy; CHF:
chronic heart failure; CONSORT: CONsolidated Standards of Reporting Trials; COPD: chronic obstructive pulmonary disease; CR: cardiac
rehabilitation; CRT: cardiac re-synchronisation therapy; DCM: dilated cardiomyopathy; DM: diabetes mellitus; DSM-IV: Diagnostic and
Statistical Manual of Mental Disorders, 4th Edition; EF: ejection fraction; EQ-5D: EuroQoL Group Quality of Life Questionnaire based on 5
dimensions; EQ-5D-3L: EuroQoL Group Quality of Life Questionnaire based on a 3-level scale; GP: general practitioner; HADS: Hospital
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Anxiety and Depression Scale; HAM-D: Hamilton Depression Rating Scale; HF: heart failure; HFrEF: heart failure with reduced ejection
fraction; HR: heart rate; HRQoL: health-related quality of life; ICD: implantable cardioverter-defibrillator; IHD: ischaemic heart disease; ITT:
intention-to-treat; KCCQ: Kansas City Cardiomyopathy Questionnaire; LVEDD: leR ventricular end-diastolic diameter; LVEF: leR ventricular
ejection fraction; LVSD: leR ventricular systolic dysfunction; max: maximum; MDMP: XXX; MET: metabolic equivalent; MI: myocardial
infarction; MOS: Medical Outcomes Survey; MLWHF: Minnesota Living With Heart Failure questionnaire; MR: mitral regurgitation; MRI:
magnetic resonance imaging; NIH: National Institutes of Health; NIHR: National Institute for Health Research; NYHA: New York Heart
Association; PVD: peripheral vascular disease; RCT: randomised controlled trial; RPE: rate of perceived exertion; SC: subcutaneous; SD:
standard deviation; SE: standard error; SF-36: Short Form-36; SPPB: Short Physical Performance Battery; STEMI: ST-elevation myocardial
infarction; UC: usual care; VO2: oxygen consumption.
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Abreu 2015 Relevant outcomes not reported. Emailed Abreu on 18 October 2018 to clarify outcomes but re-
ceived no response
Adamopoulos 2001 Relevant outcomes not reported. Attempt to contact Adamopolous on 4 October 2018 to clarify
outcomes was unsuccessful
Agvall 2013 Not exercise-based cardiac rehabilitation intervention
Ahmad 2014 Relevant outcomes not reported. Emailed Ahmad on 18 October 2018 to clarify outcomes but re-
ceived no response
Alves 2012 Relevant outcomes not reported. Attempt to contact Alves on 4 October 2018 to clarify outcomes
was unsuccessful
Ambrosy 2016 < 6 months' follow-up
Ambrosy 2017 No usable data
Aronov 2015 Abstract - study authors contacted; no usable data provided
Ascione 2013 < 6 months' follow-up
Bachman 2015 Inappropriate intervention - hawthorn extract
Banks 2015 < 6 months' follow-up
Barrow 2008 < 6 months' follow-up
Belardinelli 2005 < 6 months' follow-up
Belardinelli 2013 Not a randomised controlled trial
Bernocchi 2016 Combined population with chronic obstructive pulmonary disease and heart failure
Bittencourt 2015 < 6 months' follow-up
Borland 2014 < 6 months' follow-up
Boyd 2015 Relevant outcomes not reported. Emailed Boyd on 18 October 2018 to clarify outcomes but re-
ceived no response
Brand 2014 Abstract - study authors contacted; no usable data provided
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Study Reason for exclusion
Briffa 2005 No heart failure
Brotons 2009 No exercise-based cardiac rehabilitation intervention
Cameron 2015 No exercise-based cardiac rehabilitation intervention - memory training
Chang 2005 Relevant outcomes not reported. Attempt to contact Chang on 4 October 2018 to clarify outcomes
was unsuccessful
Chrysohoou 2013 < 6 months' follow-up
Chrysohoou 2014 < 6 months' follow-up
Chrysohoou 2016 < 6 months' follow-up
Coats 1992 < 6 months' follow-up
Collins 2004 < 6 months' follow-up
Corvera-Tindel 2004 < 6 months' follow-up
Cowie 2011 < 6 months' follow-up
Cowie 2012 < 6 months' follow-up
Deng 2006 Relevant outcomes not reported. Attempt to contact Deng on 4 October 2018 to clarify outcomes
was unsuccessful
Dingli 2002 Relevant outcomes not reported. Attempt to contact Xu on 4 October 2018 to clarify outcomes was
unsuccessful
Doukky 2016 No exercise-based cardiac rehabilitation intervention
Duncan 2014 Relevant outcomes not reported. Emailed Duncan on 18 October 2018 to clarify outcomes but re-
ceived no response
Edelmann 2011 < 6 months' follow-up
Erbs 2003 Relevant outcomes not reported. Emailed Erbs on 4 October 2018 to clarify outcomes but received
no response
Erbs 2010 Relevant outcomes not reported. Emailed Erbs on 4 October 2018 to clarify outcomes but received
no response
ExTraMATCH 2004 Meta-analysis
Fernhall 2013 Not a randomised controlled trial
Fischer 2015 Wrong population - animal model
Franco 2006 < 6 months' follow-up
Fu 2013 < 6 months' follow-up
Galenko 2016 No usable data - assessment tool used to measure HRQoL not stated
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Study Reason for exclusion
Gary 2004 Relevant outcomes not reported. Attempt to contact Gary on 4 October 2018 to clarify outcomes
was unsuccessful
Gary 2007 < 6 months' follow-up
Gelbrich 2014 No exercise-based cardiac rehabilitation intervention
Haykowsky 2007 Meta-analysis
Hollriegal 2016 Relevant outcomes not reported. Emailed Hollriegal on 18 October 2018 to clarify outcomes but re-
ceived no response
Huang 2014 Abstract - study authors contacted; no usable data
Hwang 2015 No exercise-based cardiac rehabilitation intervention
Hwang 2016 Relevant outcomes not reported. Emailed Hwang on 18 October 2018 to clarify outcomes but re-
ceived no response
Inglis 2006 Inappropriate intervention - exercise advice only
Jónsdóttir 2006b < 6 months' follow-up
Kaltsatou 2013 Duplicate
Kelly 2016 Not a randomised controlled trial
Keteyian 2016 Not a randomised controlled trial
Kiilavuori 1999 Relevant outcomes not reported. Attempt to contact Kiilavuori on 4 October 2018 to clarify out-
comes was unsuccessful
Kitzman 2010 < 6 months' follow-up
Kitzman 2013 < 6 months' follow-up
Kitzman 2016 Not a randomised controlled trial
Kobayashi 2003 Relevant outcomes not reported. Emailed Kobayashi on 4 October 2018 to clarify outcomes but re-
ceived no response
Kolesnikova 2015 Abstract - study authors contacted; no usable data
Korzeniowska-Kubacka 2010 Not a randomised controlled trial
Koufaki 2014 Comparator contained exercise training
Koukoui 2015 Not a randomised controlled trial
Larsen 2016 Not a randomised controlled trial
Lewinter 2014 Abstract - study authors contacted; no usable data
Lloyd-Williams 2002 Meta-analysis
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Study Reason for exclusion
Masterson 2014 Relevant outcomes not reported. Attempt to contact Masterson on 18 October 2018 to clarify out-
comes was unsuccessful
McCarthy 2013 Not a randomised controlled trial
Mediano 2016 Not a randomised controlled trial
Mehralian 2014 Inappropriate intervention - education only
Mendes 2014 Not a randomised controlled trial
Meyer 2005 Relevant outcomes not reported. Emailed Meyer on 4 October 2018 to clarify outcomes but re-
ceived no response
Molloy 2006 Relevant outcomes not reported. Emailed Molloy on 4 October 2018 to clarify outcomes but re-
ceived no response
Myers 2001 Relevant outcomes not reported. Myers contacted on 4 October 2018 and confirmed no relevant
outcomes were measured
Myers 2002 Relevant outcomes not reported. Myers contacted on 4 October 2018 and confirmed no relevant
outcomes were measured
Myers 2007 Relevant outcomes not reported. Myers contacted on 4 October 2018 and confirmed no relevant
outcomes were measured
Newton 2013 Abstract - study authors contacted; no usable data
Niebauer 2005a Relevant outcomes not reported. Emailed Niebauer on 4 October 2018 to clarify outcomes but re-
ceived no response
Niebauer 2005b Relevant outcomes not reported. Emailed Niebauer on 4 October 2018 to clarify outcomes but re-
ceived no response
Oka 2000 Relevant outcomes not reported. Emailed Oka on 4 October 2018 to clarify outcomes but received
no response
Oliveira 2015 < 6 months' follow-up
Owen 2000 < 6 months' follow-up
Parnell 2002 < 6 months' follow-up
Passino 2008 Relevant outcomes not reported. Emailed Passino on 4 October 2018 to clarify outcomes but re-
ceived no response
Pinto 2015 Relevant outcomes not reported. Attempt to contact Pinto on 18 October 2018 to clarify outcomes
was unsuccessful
Piotrowicz 2015 < 6 months' follow-up
Ponikowski 1997 < 6 months' follow-up
Pozehl 2003 < 6 months' follow-up
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Study Reason for exclusion
Pu 2001 Relevant outcomes not reported. Emailed Pu on 4 October 18 to clarify outcomes but received no
response
Roscani 2016 < 6 months' follow-up
Sabelis 2004 Relevant outcomes not reported. Emailed Sabelis on 4 October 2018 to clarify outcomes but re-
ceived no response
Santos 2015 Relevant outcomes not reported. Attempt to contact Santos on 18 October 2018 to clarify out-
comes was unsuccessful
Sarullo 2006 < 6 months' follow-up
Scalvini 2016 Inappropriate comparator - control group received inpatient rehabilitation
Schuang 2014 Inappropriate intervention - education advice only
Selig 2004 < 6 months' follow-up
Senden 2005 Relevant outcomes not reported. Emailed Senden on 4 October 2018 to clarify outcomes but re-
ceived no response
Smart 2004 Meta-analysis
Smart 2007 < 6 months' follow-up
Smolis-Bak 2015 Inappropriate comparator - control group received inpatient rehabilitation
Smolis-Bak 2017 Inappropriate comparator - control group received inpatient rehabilitation
Soska 2014 < 6 months' follow-up
Stewart 1998 Inappropriate intervention - exercise advice only
Suna 2015 < 6 months' follow-up
Sviridenko 2013 < 6 months' follow-up
Takase 2015 < 6 months' follow-up
Taylor-Piliae 2004 Meta-analysis
Tyni-Lenne 2001 < 6 months' follow-up
van den Berg-Emons 2004 < 6 months' follow-up
van Tol 2006 Meta-analysis
Vasiliauskas 2007 Relevant outcomes not reported. Emailed Vasiliauskas on 4 October 2018 to clarify outcomes but
received no response
Von Oehsen 2013 < 6 months' follow-up
Wagenaar 2014 No exercise-based cardiac rehabilitation intervention
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Study Reason for exclusion
Wielenga 1998 < 6 months' follow-up
Williams 2007 Relevant outcomes not reported. Emailed Williams on 4 October 2018 to clarify outcomes but re-
ceived no response
Wisløff 2007 < 6 months' follow-up
Yasushi 2015 Relevant outcomes not reported. Attempt to contact Yasushi on 18 October 2018 to clarify out-
comes was unsuccessful
Yeh 2004 < 6 months' follow-up
Zhang 2003 < 6 months' follow-up
Zhao 2005 Relevant outcomes not reported. Attempt to contact Zhao on 2018 to clarify outcomes was unsuc-
cessful
 
Characteristics of studies awaiting assessment [ordered by study ID]
 
Methods RCT
Participants 360 adults less than or equal to 6 weeks post acute admission to hospital with symptomatic con-
gestive heart failure as dominant clinical diagnosis
Interventions A supervised exercise programme consisting of 36 one-hour sessions of gym-based aerobic and re-
sistance exercise over 6 months with active encouragement of home-based exercise, administered
in addition to an established disease management programme including education, early review,
telephone and outreach support, and optimal drug titration. Comparator is an established disease
management programme including education, early review, telephone and outreach support, and
optimal drug titration, as well as standard exercise advice
Outcomes Primary outcomes: all-cause 12-month death or re-admission
Secondary outcomes: depressive symptoms based on the Geriatric Depression Scale and the Car-
diac Depression Scale; time to first re-admission; time to first heart failure-related re-admission;
number of hospitalisations; hospital bed days occupied; days alive out of hospital; rates of adher-
ence to exercise classes and educational sessions; exercise adherence; walking capacity; function-
al decline; quality of life based on the Australian Quality of Life questionnaire; programme costs;
quality of sleep assessed by the Pittsburgh Sleep Quality Index
Notes Note: the protocol is published and the trial has concluded. Results from an associated full RCT
were published in February 2018. This falls outside our search criteria; hence we have not included
these data in this review update
ACTR12608000263392 
 
 
Methods RCT
Participants Stable symptomatic HF with preserved ejection fraction (diagnosis according to criteria of the Eu-
ropean Society of Cardiology; Paulus 2007)
ISRCTN86879094 
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Interventions Experimental intervention: individually prescribed, supervised, combined endurance/strength
training for 12 months (≥ 3 times/week)
Control intervention: usual care
Outcomes Primary:
• Combined outcome score (modified 'Packer score'; Packer 2001). This combined score classifies
participants as 1 (worsened), 0 (unchanged), or +1 (improved)
Secondary:
• Components of the primary endpoint (all-cause mortality, cardiovascular hospitalisations,
change in NYHA class, change in global self-assessment, change in peak VO2, change in E/e')• Change in echocardiographic parameters of diastolic function (leR atrial volume index, grade of
diastolic function, E/e', e', ratio between early (E) and late (atrial - A) ventricular filling velocity (E/
A), deceleration time, isovolumic relaxation time), systolic function (LVEF), leR ventricular dimen-
sions (leR ventricular end-diastolic diameter), and structure (leR ventricular mass index) after 6
months and 12 months• Change in quality of life (SF-36, Minnesota Living With Heart Failure questionnaire, Hospital Anx-
iety and Depression Scale) after 6 months and 12 months• Change in ventilatory efficacy (VE/VCO2) and submaximal exercise capacity (anaerobic threshold,
6-minute walk distance) after 6 months and 12 months• Change in neurohumoral activation (N-terminal pro brain natriuretic peptide) after 6 months and
12 months• Safety and tolerability of training intervention• Gender aspects of all primary and secondary endpoints
Notes Recruitment status: no longer recruiting. Trial shown as completed on 31.08.2015, on ISRCTN reg-
istry, but no results posted. Study author contacted for further details
ISRCTN86879094  (Continued)
 
 
Methods RCT
Participants Participants with HF with LVEF < 45%
Interventions Experimental: supervised exercise + optimised treatment according to European Society of Cardi-
ology guidelines
No intervention: control optimised treatment according to European Society of Cardiology guide-
lines
Outcomes Primary outcomes:
• Change in HRQoL (SF-36 and Minnesota Living with Heart Failure Questionnaire)
Secondary outcomes:
• Change in functional capacity (6-minute walking test)• Cardiac structural changes (B-type natriuretic peptide)• Muscle strength (dynamometer)• Body composition (fat and muscular weight)
All at 12 months
Notes Zuazagoitia A, Grandes G, Torcal J, Lekuona I, Echevarria P, Gómez MA, Domingo M, de la Torre MM,
Ramírez JI, Montoya I, Oyanguren J, Pinilla RO; EFICAR Group (Ejercicio Físico en la Insuficiencia
NCT01033591 
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Cardiaca). Rationale and design of a randomised controlled trial evaluating the effectiveness of an
exercise program to improve the quality of life of patients with HF in primary care: the EFICAR study
protocol. BMC Public Health 2010;10:33
Protocol published
Recruitment status: unknown
Estimated study completion date: January 2015, on clinicaltrials.gov, but no results posted.
Study author contacted for further details
NCT01033591  (Continued)
 
 
Methods RCT
Participants 605 participants with HF (both patients with a preserved ejection fraction (HFpEF) and those with
reduced ejection fraction (HFrEF) can be included)
Interventions Patients randomised to the active intervention (Wii group) will be introduced to the Nintendo Wii
game computer in an introduction lesson of approximately 2 hours, and the Wii will be installed
at home. During the first 3 months after inclusion, participants will be phoned after 2, 4, 8, and 12
weeks to discuss their experiences with the Wii, or to solve possible problems. Patients randomised
to the control group (motivational support only) will receive protocolised exercise advice from a
member of the HF team (nurse, cardiologist, or physiotherapist). During the first 3 months after in-
clusion, participants will be phoned after 2, 4, 8, and 12 weeks to discuss their current activity
Outcomes HRQoL (Minnesota Living With Heart Failure Questionnaire (MLWHFQ))
Notes Protocol published. Trial completed April 2018, as reported on clinicaltrials.gov, but no results
posted. Study authors contacted for additional details
NCT01785121 
 
 
Methods RCT
Participants 180 participants, 40 years of age and older, with heart failure with preserved ejection fraction
Interventions High-intensity exercise, moderate continuous exercise, or usual care
Outcomes Primary outcome measures:
Change in peak VO2 after 3 months
Secondary outcome measures:
Change in E/e' (representing diastolic filling pressure) at baseline and at 3 months
Change in E/e' at baseline and at 12 months
Change in Peak VO2 at baseline and at 12 months
Change in NTproBNP at baseline and at 3 months
Change in NTproBNP at baseline and at 12 months
Change in health-related quality of life at baseline and at 3 months
Change in health-related quality of life at baseline and at 12 months
Change in leR atrial volume index (LAVI) at baseline and at 3 months
Change in leR atrial volume index (LAVI) at baseline and at 12 months
Change in e' medial at baseline and at 3 months
Change in e' at baseline and at 12 months
NCT02078947 
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Change in submaximal exercise capacity at baseline and at 3 months
Change in submaximal exercise capacity at baseline and at 12 months
Change in VE/VCO2 slope at baseline and at 3 months
Change in VE/VCO2 slope at baseline and at 12 months
Change in flow-mediated dilation (FMD) at baseline and at 3 months
Change in flow-mediated dilation (FMD) at baseline and at 12 months
Notes Other study ID numbers: EU 602405-2; estimated study completion date: June 2018; reported on
clinicaltrials.gov, but no results posted. Study authors contacted
NCT02078947  (Continued)
 
 
Methods RCT
Participants 16 participants (55 years and older) with a diagnosis of HF with preserved ejection fraction (HFpEF)
Interventions Study participants will receive medically supervised aerobic and resistance exercise training for 1
hour per session, 3 times per week, for 6 weeks, at the Cardiac Rehab Centre, then will transition
to home-based or YMCA partnership-based exercise with staN follow-up contact for an additional 3
weeks
Outcomes Primary outcome measures:
Change in quality of life (QoL) score before and after exercise training (ET) [Time Frame: 9 weeks]
Secondary outcome measures:
Change in exercise capacity/tolerance before and after ET using cardiopulmonary exercise test-
ing [Time Frame: 9 weeks]: symptom-limited treadmill testing with expired gas measurement and
analysis; exercise capacity measured as peak VO2 (peak exercise oxygen uptake) in mL/min/kg;
continuous monitoring of 12-lead electrocardiogram and blood pressure measured every 2 min-
utes; peak VO2 defined as highest VO2 value of the last 30 seconds before termination of exercise;
exercise time and peak workload measured for exercise tolerance; demonstrated ability to co-ordi-
nate patient transition from clinic to home-based or YMCA partnership-based exercise programme
with weekly staN follow-up within the study timeline [Time Frame: 9 weeks]: captured 90-day hos-
pital re-admission data starting on study enrollment date and within participants' study timeline
[Time Frame: 90 days]
Notes Recruitment completed. Actual primary completion date reported in clinicaltrials.gov as January
2017. No results posted. Study authors contacted
NCT02696486 
 
 
Methods RCT
Participants 40 participants 18 to 80 years of age, males and females, with HF LVEF≤ 40%
Interventions Exercise training L on a 3 days/week basis over 24 weeks (68 to 74 sessions). Each session started
with a 10-minute warm-up walking period followed by 20 minutes of breathing exercises and free
non-resistance movements of limbs. This stage was followed by pedaling during 20 minutes at a
circuit resistance training protocol with a stationary cycle ergometer. Each session ended with a
cool-down period (5 minutes) including diverse stretching manoeuvres of engaged muscle groups.
The initial bicycle-ergometer workload (WL) was defined as 50% of maximum achieved in previous
stress testing
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Outcomes Primary outcome measures:
• Clinical events [Time Frame: 6 months]: change in New York Heart Association Functional Class;
numbers of hospitalisations 6 months before and after the date of enrolment; temporary or per-
manent withdrawal from the study protocol (due to persistent atrial or ventricular arrhythmias;
worsening of congestive heart failure symptoms; myocardial infarction; unstable angina; need for
cardiac interventions: pacemaker, implantable cardioverter-defibrillator, coronary re-vasculari-
sation, or cardiac transplantation; stroke or transient ischaemic attack; severe peripheral inter-
mittent claudication or death observed during training or follow-up sessions)• Mean heart rate [Time Frame: 6 months]: mean value of 12-minute electrocardiogram recordings
was considered the resting heart rate (beats per minute)• 6-Minute walk test [Time Frame: 6 months]: walking along a 20-metre-long corridor at their own
pace, with the aim of covering as much ground as possible in 6 minutes. The distance walked was
expressed in metres• LeR ventricular ejection fraction [Time Frame: 1 year]: area-length method was measured to ob-
tain biplane leR ventricle volumes. LeR ventricle ejection fraction was derived from the standard
equation (%)• Quality of life [Time Frame: 6 months]: all participants completed the Short Form-36 Health Survey
(SF-36), available in its Spanish version, for measuring physical and mental quality of life• Stress test [Time Frame: 6 months]: symptom-limited exercise testing, measured in metabolic
units (MET)• Square root of mean squared successive differences of R-R intervals (rMSSD) [Time Frame: 6
months]: short-term continuous electrocardiographic recordings were performed for heart rate
variability analysis. In the time domain, the square root of the mean squared successive differ-
ences of R-R intervals (rMSSD) was calculated. Units: ms• Heart rate power high-frequency (HF) [Time Frame: 6 months]: high frequency (HF), from 0.15 to
0.40 Hz of the power spectral analysis, was calculated. Units: ms2/Hz
Notes Recruitment completed. Study reported at ClinicalTrials.gov to be completed November 2014. No
results posted. Study authors contacted
NCT02903225  (Continued)
ET: exercise training; FMD: flow-mediated dilation; HF: heart failure; HFpEF: heart failure with preserved ejection fraction; HFrEF: heart
failure with reduced ejection fraction; HRQoL: health-related quality of life; LAVI: leR atrial volume index; LVEF: leR ventricular ejection
fraction; MET: metabolic equivalent; MLWHFQ: Minnesota Living With Heart Failure Questionnaire; NTproBNP: N-terminal prohormone of
brain natriuretic peptide; NYHA: New York Heart Association; QoL: quality of life; RCT: randomised controlled trial; rMSSD: mean squared
successive diNerences of R-R intervals; SF-36: Short Form-36; VE: ventilatory eNicacy; VCO2: carbon dioxide production; VO2: oxygen uptake;
WL: workload.
 
Characteristics of ongoing studies [ordered by study ID]
 
Trial name or title Rehabilitation Program in Heart Failure With Preserved Ejection Fraction
Methods RCT
Participants 1100 participants
Interventions Participants will participate in a 6-month cardiac rehabilitation programme, consisting of struc-
tured, 60-minute, bi-weekly exercise training sessions, according to a pre-defined protocol. Institu-
tional activity will be complemented by 120 minutes of weekly home exercise prescribed by a spe-
cialist in cardiac rehabilitation. Following discharge, participants in the comparator arm will return
to the IM outpatient clinics at 2 to 4 weeks and at 3 and 6 months for consultation. These scheduled
consultations will comprise history taking, recording of any new events, physical examination, and
recommendations as clinically indicated. Target values for blood pressure and glucose control will
be in accordance with current guidelines, and special emphasis will be given to management of flu-
id retention
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Outcomes Primary outcomes: combined all-cause mortality and hospitalisations at 12 months' follow-up
Secondary clinical outcomes: will be collected during 3- and 6-month follow-up visits and will in-
clude the following: blood pressure averages; HbA1C levels; assessment of NYHA class and glob-
al clinical assessment, 6-minute walk test, and quality of life data as evaluated by the EQ-5D ques-
tionnaire; all-cause mortality endpoint [Time Frame: 12 months after randomisation]; heart fail-
ure hospitalisations [Time Frame: 12 months after randomisation]; number of HF hospitalisations
as assessed by HF specialists blinded to participant allocation. Assessment will include medical
record and hospital discharge letter review
Starting date October 2013
Contact information Dr. Robert Klempfner Heart Rehabilitation Institute, Sheba Medical Center
Notes WHO International Clinical Rrials Registry Platform states that trial is still recruiting
NCT01914315  (Continued)
 
 
Trial name or title A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF)
Methods RCT
Participants 360 participants ≥ 60 years old hospitalised with ADHF
Interventions 12-Week novel, progressive, multi-domain rehabilitation and exercise training intervention or at-
tention control. The multi-domain rehabilitation intervention will include endurance, mobility,
strength, and balance training and will be tailored according to participant performance in each of
these domains. It will begin upon randomisation during hospitalisation and will continue 3 times
per week in an outpatient setting
Outcomes All participants will undergo measures of physical function and quality of life at baseline, 1 month,
and 3 months. Clinical events will be monitored for 6 months following the index hospitalisation
Starting date September 2014
Contact information Principal investigator: Dalane W Kitzman, MD; Wake Forest University Health Sciences, Win-
ston-Salem, North Carolina, USA
Notes Estimated study completion date: November 2020
NCT02196038 
 
 
Trial name or title Effect of Pedometer-Based Walking Intervention on Functional Capacity and Neurohumoral Mod-
ulation in Patients With Chronic Heart Failure With Preserved Ejection Fraction: A Multicenter Ran-
domized Controlled Trial
Methods RCT
Participants 200 physically inactive patients with chronic heart failure with preserved or mid-range ejection
fraction
Interventions The 6-month intervention will consist of an individualised pedometer-based walking programme
with weekly step goals, monthly face-to-face sessions with the physician, and monthly telephone
NCT03041376 
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calls with the research nurse. The intervention will be based on effective behavioural principles
(goal-setting, self-monitoring, personalised feedback)
Outcomes Primary outcome: change in 6-minute walk distance at 6 months
Secondary outcomes: changes in serum biomarkers levels, pulmonary congestion assessed by ul-
trasound, average daily step count measured by accelerometry, anthropometric measures, symp-
toms of depression, health-related quality of life, self-efficacy, MAGGIC Risk Score
Starting date April 2017
Contact information Jan Belohlavek, Charles University, Czech Republic
Notes Estimated study completion date: 31 January 2020
NCT03041376  (Continued)
ADHF: acute decompensated heart failure; EQ-5D: EuroQoL Group Quality of Life Questionnaire based on 5 dimensions; HbA1C:
glycosylated haemoglobin; HF: heart failure; NYHA: New York Heart Association; RCT: randomised controlled trial; WHO: World Health
Organization.
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   All exercise interventions versus usual care
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 All-cause mortality up to 12 months' fol-
low-up
27 2596 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.66, 1.21]
2 All-cause mortality more than 12 months'
follow-up
6 2845 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.75, 1.02]
3 Hospital admission up to 12 months' fol-
low-up
21 2182 Risk Ratio (M-H, Fixed, 95% CI) 0.70 [0.60, 0.83]
4 Hospital admission more than 12 months'
follow-up
6 2691 Risk Ratio (M-H, Random, 95% CI) 0.70 [0.47, 1.05]
5 Hospital admission heart failure only 14 1114 Risk Ratio (M-H, Fixed, 95% CI) 0.59 [0.42, 0.84]
6 Health-related quality of life - MLWHF up
to 12 months' follow-up
17 1995 Mean Difference (IV, Random, 95%
CI)
-7.11 [-10.49,
-3.73]
7 Health-related quality of life - MLWHF and
other scales up to 12 months' follow-up
26 3833 Std. Mean Difference (IV, Random,
95% CI)
-0.60 [-0.82, -0.39]
8 Health-related quality of life - MLWHF
more than 12 months' follow-up
3 329 Mean Difference (IV, Random, 95%
CI)
-9.49 [-17.48,
-1.50]
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Analysis 1.1.   Comparison 1 All exercise interventions versus usual
care, Outcome 1 All-cause mortality up to 12 months' follow-up.
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Antonicelli 2016 5/170 8/173 9.72% 0.64[0.21,1.91]
Austin 2005 5/100 4/100 4.91% 1.25[0.35,4.52]
Chen 2018 0/31 2/31 3.07% 0.2[0.01,4]
Dalal 2018 4/107 4/109 4.86% 1.02[0.26,3.97]
DANREHAB 2008 4/45 3/46 3.64% 1.36[0.32,5.75]
Davidson 2010 4/53 11/52 13.62% 0.36[0.12,1.05]
Dracup 2007 9/87 8/86 9.87% 1.11[0.45,2.75]
Du 2018 1/67 1/65 1.24% 0.97[0.06,15.19]
Gary 2010 1/20 0/17 0.66% 2.57[0.11,59.3]
Gary 2010 0/18 1/19 1.79% 0.35[0.02,8.09]
Giannuzzi 2003 0/45 1/45 1.84% 0.33[0.01,7.97]
Gottlieb 1999 1/17 0/18 0.6% 3.17[0.14,72.8]
Hambrecht 1995 1/12 0/10 0.66% 2.54[0.11,56.25]
Hambrecht 1998 1/10 1/10 1.23% 1[0.07,13.87]
Hambrecht 2000 3/36 2/37 2.42% 1.54[0.27,8.69]
Jolly 2009 7/84 5/85 6.1% 1.42[0.47,4.29]
Keteyian 1996 0/21 1/19 1.93% 0.3[0.01,7.02]
McKelvie 2002 9/90 8/91 9.76% 1.14[0.46,2.82]
Mehani 2013 0/20 2/20 3.07% 0.2[0.01,3.92]
Myers 2000 1/12 0/13 0.59% 3.23[0.14,72.46]
Nilsson 2008 2/40 1/40 1.23% 2[0.19,21.18]
Norman 2012 1/22 0/20 0.64% 2.74[0.12,63.63]
Pozehl 2008 0/15 1/6 2.56% 0.15[0.01,3.16]
Wall 2010 1/9 1/10 1.16% 1.11[0.08,15.28]
Willenheimer 2001 3/27 2/27 2.45% 1.5[0.27,8.28]
Witham 2005 1/41 3/41 3.68% 0.33[0.04,3.07]
Witham 2012 3/53 2/54 2.43% 1.53[0.27,8.78]
Yeh 2011 0/50 3/50 4.29% 0.14[0.01,2.7]
   
Total (95% CI) 1302 1294 100% 0.89[0.66,1.21]
Total events: 67 (Exercise), 75 (Control)  
Heterogeneity: Tau2=0; Chi2=15.85, df=27(P=0.96); I2=0%  
Test for overall effect: Z=0.73(P=0.47)  
Favours exercise 10000.001 100.1 1 Favours control
 
 
Analysis 1.2.   Comparison 1 All exercise interventions versus usual
care, Outcome 2 All-cause mortality more than 12 months' follow-up.
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Austin 2005 31/100 38/100 13.6% 0.82[0.56,1.2]
Belardinelli 1999 9/50 20/49 7.23% 0.44[0.22,0.87]
Belardinelli 2012 4/63 10/60 3.67% 0.38[0.13,1.15]
HF ACTION 2009 189/1159 198/1171 70.51% 0.96[0.8,1.16]
Jónsdóttir 2006a 2/21 2/22 0.7% 1.05[0.16,6.77]
Mueller 2007 9/25 12/25 4.3% 0.75[0.39,1.46]
   
Favours experimental 1000.01 100.1 1 Favours control
Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
125
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total (95% CI) 1418 1427 100% 0.88[0.75,1.02]
Total events: 244 (Exercise), 280 (Control)  
Heterogeneity: Tau2=0; Chi2=7.54, df=5(P=0.18); I2=33.66%  
Test for overall effect: Z=1.69(P=0.09)  
Favours experimental 1000.01 100.1 1 Favours control
 
 
Analysis 1.3.   Comparison 1 All exercise interventions versus usual
care, Outcome 3 Hospital admission up to 12 months' follow-up.
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Antonicelli 2016 25/170 60/173 22.8% 0.42[0.28,0.64]
Austin 2005 9/100 19/100 7.28% 0.47[0.23,1]
Bocalini 2008 0/22 3/20 1.4% 0.13[0.01,2.38]
Chen 2018 11/31 8/31 3.07% 1.38[0.64,2.95]
Dalal 2018 19/107 24/109 9.12% 0.81[0.47,1.38]
Davidson 2010 23/53 36/52 13.93% 0.63[0.44,0.9]
Dracup 2007 35/87 37/86 14.27% 0.94[0.66,1.33]
Du 2018 1/67 1/65 0.39% 0.97[0.06,15.19]
Giallauria 2008 3/30 7/31 2.64% 0.44[0.13,1.55]
Giannuzzi 2003 2/45 1/45 0.38% 2[0.19,21.28]
Gielen 2003 1/10 0/10 0.19% 3[0.14,65.9]
Hambrecht 1995 0/12 1/10 0.62% 0.28[0.01,6.25]
Jolly 2009 16/84 20/85 7.62% 0.81[0.45,1.45]
Jónsdóttir 2006a 2/21 5/22 1.87% 0.42[0.09,1.93]
Keteyian 1996 0/21 1/19 0.6% 0.3[0.01,7.02]
Lang 2018 4/25 7/25 2.68% 0.57[0.19,1.71]
Mehani 2013 3/20 0/20 0.19% 7[0.38,127.32]
Passino 2006 0/44 2/41 0.99% 0.19[0.01,3.78]
Witham 2005 10/41 11/41 4.22% 0.91[0.43,1.9]
Witham 2012 14/53 11/54 4.18% 1.3[0.65,2.59]
Yeh 2011 2/50 4/50 1.53% 0.5[0.1,2.61]
   
Total (95% CI) 1093 1089 100% 0.7[0.6,0.83]
Total events: 180 (Exercise), 258 (Control)  
Heterogeneity: Tau2=0; Chi2=24.56, df=20(P=0.22); I2=18.56%  
Test for overall effect: Z=4.3(P<0.0001)  
Favours exercise 1000.01 100.1 1 Favours control
 
 
Analysis 1.4.   Comparison 1 All exercise interventions versus usual
care, Outcome 4 Hospital admission more than 12 months' follow-up.
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Belardinelli 1999 5/50 14/49 10.45% 0.35[0.14,0.9]
Belardinelli 2012 8/63 25/60 13.94% 0.3[0.15,0.62]
Cowie 2014 9/15 5/8 14.59% 0.96[0.49,1.89]
Favours exercise 100.1 50.2 20.5 1 Favours control
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Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Cowie 2014 6/15 5/8 12.18% 0.64[0.28,1.45]
HF ACTION 2009 729/1159 760/1171 25.18% 0.97[0.91,1.03]
Jónsdóttir 2006a 7/21 11/22 13.56% 0.67[0.32,1.39]
Mueller 2007 8/25 5/25 10.09% 1.6[0.61,4.22]
   
Total (95% CI) 1348 1343 100% 0.7[0.47,1.05]
Total events: 772 (Exercise), 825 (Control)  
Heterogeneity: Tau2=0.16; Chi2=17.81, df=6(P=0.01); I2=66.3%  
Test for overall effect: Z=1.73(P=0.08)  
Favours exercise 100.1 50.2 20.5 1 Favours control
 
 
Analysis 1.5.   Comparison 1 All exercise interventions versus
usual care, Outcome 5 Hospital admission heart failure only.
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Belardinelli 1999 5/50 14/49 21.14% 0.35[0.14,0.9]
Chen 2018 12/31 9/31 13.46% 1.33[0.66,2.7]
Cowie 2014 3/15 5/8 9.75% 0.32[0.1,1.01]
Cowie 2014 8/15 5/8 9.75% 0.85[0.42,1.75]
Dalal 2018 3/107 6/109 8.89% 0.51[0.13,1.98]
Giannuzzi 2003 2/45 1/45 1.5% 2[0.19,21.28]
Hambrecht 1995 0/12 1/10 2.43% 0.28[0.01,6.25]
Jolly 2009 4/84 2/85 2.97% 2.02[0.38,10.75]
Jónsdóttir 2006a 0/21 3/22 5.12% 0.15[0.01,2.73]
Lang 2018 0/25 4/25 6.73% 0.11[0.01,1.96]
Mueller 2007 2/25 3/25 4.49% 0.67[0.12,3.65]
Myers 2000 0/12 2/13 3.6% 0.22[0.01,4.08]
Passino 2006 0/44 2/41 3.87% 0.19[0.01,3.78]
Willenheimer 2001 0/23 3/27 4.83% 0.17[0.01,3.07]
Witham 2012 1/53 1/54 1.48% 1.02[0.07,15.87]
   
Total (95% CI) 562 552 100% 0.59[0.42,0.84]
Total events: 40 (Exercise), 61 (Control)  
Heterogeneity: Tau2=0; Chi2=15.81, df=14(P=0.32); I2=11.46%  
Test for overall effect: Z=2.94(P=0)  
Favours expercise 2000.005 100.1 1 Favours control
 
 
Analysis 1.6.   Comparison 1 All exercise interventions versus usual care,
Outcome 6 Health-related quality of life - MLWHF up to 12 months' follow-up.
Study or subgroup Exercise Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Antonicelli 2016 150 28.6 (12.3) 163 44.5 (12.3) 7.65% -15.9[-18.63,-13.17]
Austin 2005 85 22.9 (14.7) 94 36.9 (21.3) 6.71% -14[-19.32,-8.68]
Belardinelli 1999 48 40 (19) 46 51 (22) 5.41% -11[-19.33,-2.67]
Chen 2018 31 19.4 (12.2) 29 34.3 (14.4) 6.08% -14.9[-21.68,-8.12]
Favours expercise 4020-40 -20 0 Favours control
Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
127
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Study or subgroup Exercise Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Dalal 2018 92 24.1 (20.9) 93 27.5 (23.2) 6.26% -3.4[-9.76,2.96]
Davidson 2010 50 52.9 (15.7) 42 56.4 (18.3) 5.96% -3.5[-10.54,3.54]
Dracup 2007 86 35.7 (23.7) 87 43.2 (27.3) 5.71% -7.5[-15.12,0.12]
Du 2018 67 36.9 (21.6) 65 41 (22.4) 5.76% -4.1[-11.61,3.41]
Gary 2010 17 25.6 (19.7) 14 28.9 (29.9) 2.4% -3.3[-21.55,14.95]
Gary 2010 15 24.2 (16.3) 16 34.3 (23.6) 3.32% -10.1[-24.3,4.1]
Jolly 2009 77 37.6 (21) 80 34.9 (24.8) 5.9% 2.7[-4.48,9.88]
Koukouvou 2004 16 34.1 (13) 19 45.2 (9) 5.74% -11.1[-18.65,-3.55]
Lang 2018 22 29.2 (25.8) 23 38.7 (30.1) 2.79% -9.5[-25.86,6.86]
McKelvie 2002 57 -3.4 (18.1) 67 -3.3 (13.9) 6.52% -0.1[-5.86,5.66]
Nilsson 2008 35 23 (14) 37 28 (20) 5.57% -5[-12.94,2.94]
Passino 2006 44 32 (26.5) 41 53 (32) 3.82% -21[-33.54,-8.46]
Witham 2012 43 15.4 (14.8) 44 11.3 (12.1) 6.55% 4.1[-1.59,9.79]
Yeh 2011 50 13 (4) 50 18 (6) 7.83% -5[-7,-3]
   
Total *** 985   1010   100% -7.11[-10.49,-3.73]
Heterogeneity: Tau2=36.91; Chi2=93.22, df=17(P<0.0001); I2=81.76%  
Test for overall effect: Z=4.12(P<0.0001)  
Favours expercise 4020-40 -20 0 Favours control
 
 
Analysis 1.7.   Comparison 1 All exercise interventions versus usual care, Outcome 7
Health-related quality of life - MLWHF and other scales up to 12 months' follow-up.
Study or subgroup Exercise Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Antonicelli 2016 150 28.6 (12.3) 163 44.5 (12.3) 4.34% -1.29[-1.53,-1.05]
Austin 2005 85 22.9 (14.7) 94 36.9 (21.3) 4.21% -0.76[-1.06,-0.45]
Belardinelli 1999 48 40 (19) 46 51 (22) 3.93% -0.53[-0.94,-0.12]
Bocalini 2008 22 -87 (4) 20 -81 (6) 3.2% -1.17[-1.83,-0.51]
Chen 2018 31 19.4 (12.2) 29 34.3 (14.4) 3.54% -1.11[-1.65,-0.56]
Dalal 2018 92 24.1 (20.9) 93 27.5 (23.2) 4.25% -0.15[-0.44,0.14]
DANREHAB 2008 19 -42.7 (9.1) 15 -37.4 (11.4) 3.12% -0.51[-1.2,0.18]
Davidson 2010 50 52.9 (15.7) 42 56.4 (18.3) 3.93% -0.2[-0.62,0.21]
Dehkordi AH 2015 30 -63.3 (12.7) 31 -58.4 (8.7) 3.65% -0.45[-0.96,0.06]
Dracup 2007 86 35.7 (23.7) 87 43.2 (27.3) 4.22% -0.29[-0.59,0.01]
Du 2018 67 36.9 (21.6) 65 41 (22.4) 4.12% -0.19[-0.53,0.16]
Gary 2010 15 24.2 (16.3) 16 34.3 (23.6) 3.04% -0.48[-1.2,0.23]
Gary 2010 17 25.6 (19.7) 14 28.9 (29.9) 3.06% -0.13[-0.84,0.58]
HF ACTION 2009 828 72.8 (20.4) 784 71.4 (21.3) 4.56% 0.07[-0.03,0.16]
Jolly 2009 77 37.6 (21) 80 34.9 (24.8) 4.19% 0.12[-0.2,0.43]
Jónsdóttir 2006a 21 -47.5 (8.7) 20 -44.1 (14) 3.33% -0.29[-0.91,0.32]
Kaltsatou 2014 16 -5.7 (3) 9 0.8 (1.2) 2.06% -2.49[-3.6,-1.38]
Kaltsatou 2014 18 -6.5 (2.4) 8 0.8 (1.2) 1.72% -3.33[-4.62,-2.04]
Klocek 2005 14 -109 (23.5) 7 -71.7 (23.5) 2.2% -1.52[-2.57,-0.48]
Klocek 2005 14 -99 (23.5) 7 -71.7 (23.5) 2.34% -1.12[-2.1,-0.13]
Koukouvou 2004 16 34.1 (13) 19 45.2 (9) 3.06% -0.99[-1.69,-0.28]
Lang 2018 22 29.2 (25.8) 23 38.7 (30.1) 3.41% -0.33[-0.92,0.26]
Nilsson 2008 35 23 (14) 37 28 (20) 3.78% -0.29[-0.75,0.18]
Norman 2012 19 -81 (18.2) 18 -77.9 (11.6) 3.24% -0.2[-0.84,0.45]
Favours exercise 52.5-5 -2.5 0 Favours control
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Study or subgroup Exercise Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Passino 2006 44 32 (26.5) 41 53 (32) 3.86% -0.71[-1.15,-0.27]
Reeves 2017 12 -65 (19) 12 -63 (22) 2.8% -0.09[-0.89,0.71]
Willenheimer 2001 20 -0.7 (0.8) 17 0 (1) 3.17% -0.76[-1.44,-0.09]
Witham 2005 36 -69 (13) 32 -65 (10) 3.74% -0.34[-0.82,0.14]
Yeh 2011 50 13 (4) 50 18 (6) 3.92% -0.97[-1.39,-0.56]
   
Total *** 1954   1879   100% -0.6[-0.82,-0.39]
Heterogeneity: Tau2=0.26; Chi2=215.03, df=28(P<0.0001); I2=86.98%  
Test for overall effect: Z=5.54(P<0.0001)  
Favours exercise 52.5-5 -2.5 0 Favours control
 
 
Analysis 1.8.   Comparison 1 All exercise interventions versus usual care, Outcome
8 Health-related quality of life - MLWHF more than 12 months' follow-up.
Study or subgroup Exercise Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Austin 2005 57 35.5 (21.7) 55 37.1 (24.9) 29.99% -1.6[-10.26,7.06]
Belardinelli 1999 48 44 (21) 46 54 (22) 29.9% -10[-18.7,-1.3]
Belardinelli 2012 63 43 (12) 60 58 (14) 40.11% -15[-19.62,-10.38]
   
Total *** 168   161   100% -9.49[-17.48,-1.5]
Heterogeneity: Tau2=35.87; Chi2=7.33, df=2(P=0.03); I2=72.71%  
Test for overall effect: Z=2.33(P=0.02)  
Favours exercise 4020-40 -20 0 Favours control
 
 
A D D I T I O N A L   T A B L E S
 
Trial first
author
(year)
Fol-
low-up
Measure Outcome values (or change from baseline) at fol-
low-up
Mean (standard deviation)
Control vs exercise, between-group P value
Between-group difference
Anton-
icelli
(2016)
6 months MLWHF total 44.5 (12.3) vs 28.6 (12.3); P < 0.001 Exercise > Control
Austin
(2005/8)
6 months
5 years
MLWHF Physi-
cal
MLWHF Emo-
tional
MLWHF Total
EQ-5D
20.4 (12.2) vs 12.6 (9.7); P < 0.0001*
8.0 (7.1) vs 4.4 (10.4); P < 0.01*
36.9 (24.0) vs 22.9 (17.8); P < 0.001*
0.58 (0.19) vs 0.70 (0.16); P < 0.0001*
19.3 (23.5) vs 18.3 (11.2); P = 0.66*
7.6 (7.1) vs 7.4 (6.5); P = 0.88*
Exercise > Control
Exercise > Control
Exercise > Control
Exercise > Control
Exercise = Control
Exercise = Control
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MLWHF Physi-
cal
MLWHF Emo-
tional
MLWHF Total
EQ-5D
37.1 (24.9) vs 35.5 (21.7); P = 0.72*
0.58 (0.22) vs 0.64 (0.19); P = 0.12*
Exercise = Control
Exercise = Control
Belar-
dinelli
(1999)
2 months
15
months
29
months
MLWHF total 52 (29) vs 40 (19); P < 0.001
52 (20) vs 39 (20); P < 0.001
54 (22) vs 44 (21); P < 0.001
Exercise > Control
Exercise > Control
Exercise > Control
Belar-
dinelli
(2012)
10 years MWLHF total 58 (14) vs 43 (12); P < 0.001 Exercise > Control
Bocalini
(2008)
6 months WHOQoL
Physical
Psychological
Social
Environmental
2 (1) vs 23 (4); P < 0.0001*
1 (1) vs 20 (2); P < 0.0001*
3 (2) vs 16 (1); P < 0.0001*
2 (1) vs 15 (2); P < 0.0001*
Exercise > Control
Exercise > Control
Exercise > Control
Exercise > Control
Chen
(2018)
6 months Physical (SPPB)
MLWHF total
8.9 (2.3) vs 10.0 (2.1); P = 0.059
34.3 (14.4) vs 19.4 (12.2); P < 0.001
Exercise = Control
Exercise > Control
Dalal
(2018)
12
months
MLWHF total
Physical
Emotional
Heart QoL
Global
Heart QoL
Physical
Heart QoL Emo-
tional
EQ-5D-3L
27.5 (23.2) vs 24.1 (20.9); P = 0.025
14.5 (11.8) vs 12.2 (10.8); P = 0.016
5.5 (6.4) vs 5.1 (5.8); P = 0.273
1.9 (0.9) vs 1.9 (0.9); P = 0.823
1.7 (0.9) vs 1.8 (0.9); P = 0.869
2.3 (0.8) vs 2.3 (0.8); P = 0.683
0.739 (0.263) vs 0.752 (0.240); P = 0.487
Exercise > Control
Exercise > Control
Exercise = Control
Exercise = Control
Exercise = Control
Exercise = Control
Exercise = Control
DAN-
REHAB
(2008)
12
months
SF-36 PCS
SF-36MCS
37.4 (11.4) vs 42.7 (9.1)*; P = 0.14
50.5 (10.0) vs 49.7 (8.8)*; P = 0.81
Exercise = Control
Exercise = Control
Davidson
(2010)
12
months
MLWHF total 56.4 (18.3) vs 52.9 (15.7); P = 0.33 Exercise = Control
Dracup
(2007)
6 months MLWHF Physi-
cal
19.4 (11.5) vs 16.1 (10.0); P = 0.04*
10.5 (7.4) vs 7.8 (6.6); P = 0.01*
Exercise > Control
Exercise > Control
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MLWHF Emo-
tional
MLWHF Total
43.2 (26.5) vs 35.7 (23.7); P = 0.05 Exercise > Control
Du (2017) 6 months MLWHF total
SF-36
41 (22.4) vs 36.9 (21.59); P = 0.535
54.5 (25.31) vs 53.9 (22.78); P = 0.697
Exercise = Control
Exercise = Control
Gary
(2010)
Comp
6 months MLWHF total 34.3 (23.6) vs 24.2 (16.3); P = 0.18* Exercise = Control
Gary
(2010) Ex-
er
6 months MLWHF total 28.9 (29.9) vs 25.6 (19.7); P = 0.71* Exercise = Control
Hassen-
pour-Dehkro-
di (2015)
6 months MacNew 58.43 (8.67) vs 63.34 (12.69); P < 0.05 Exercise > Control
Gottlieb
(1999)
6 months MLWHF total
MOS PF
MOS RL
MOS GH
NR (NR) vs 22 (20); NR
NR (NR) vs 68 (28); NR
NR (NR) vs 50 (42); NR
NR (NR) vs 361 (224); NR
NR
NR
NR
NR
HF-AC-
TION
(2009)
12
months
KCCQ+ 71.4 (21.3) vs 72.8 (20.4) Exercise > Control**
Jolly
(2009)
6 months
12
months
MLWHF total
EQ-5D
MLWHF total
EQ-5D
34.5 (24.0) vs 36.3 (24.1); P = 0.30
0.62 (0.32) vs 0.66 (0.24); P = 0.004
34.9 (24.8) vs 37.6 (21.0); P = 0.80
0.69 (0.28) vs 0.68 (0.21); P = 0.07
Exercise = Control
Exercise > Control
Exercise = Control
Exercise = Control
Jónsdót-
tir (2006)
6 months Icelandic qual-
ity of life ques-
tionnaire
4.10 (14.04) vs 47.55 (8.7); P = 0.34 Exercise = Control
Kaltsatou
2014
(dance)
8 months SF-36 (physi-
cal)+
SF-36 (mental)+
SF-36 (total)+
-0.6 (0.9) vs 3.3 (1.6); P < 0.05
-0.2 (0.5) vs 3.1 (1.3); P < 0.05
-0.8 (1.2) vs 6.5 (2.4); P < 0.05
Exercise > Control
Exercise > Control
Exercise > Control
Kaltsatou
2014 (ex-
ercise)
8 months SF-36 (physi-
cal)+
SF-36 (mental)+
SF-36 (total)+
-0.6 (0.9) vs 2.9 (1.5); P < 0.05
-0.2 (0.5) vs 2.7 (2.2); P < 0.05
-0.8 (1.2) vs 5.7 (3.0); P < 0.05
Exercise > Control
Exercise > Control
Exercise > Control
Klocek
(2005)
6.5
months
PGWB total 99.0 vs 109.0 (training grp A) vs 71.7 (training grp B); P <
0.01
Exercise > Control
Table 1.   Health-related quality of life results  (Continued)
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(Const or
Prog)
Kouk-
ouvou
(2004)
6 months MLWHF total
Spritzer QLI to-
tal
34.1 (13.0) vs 45.1 (9.9); P = 0.05*
7.1 (1.1) vs 9.1 (1.1); P < 0.0001*
Exercise > Control
Exercise > Control
Lang
(2018)
6 months MLWHF total
Heart-QoL
EQ-5D-5L
29.2 (25.8) vs 38.7 (30.1); P > 0.05
2.0 (1.0) vs 1.9 (1.0); P > 0.05
0.65 (0.31) vs 0.55 (0.29); P > 0.05
Exercise = Control
Exercise = Control
Exercise = Control
McKelvie
(2002)
12
months
MLWHF total+ -3.3 (13.9) vs -3.4 (18.1); P = 0.98 Exercise = Control
Nilsson
(2008)
12
months
MLWHF total 28 (20) vs 22 (12); P = 0.003 Exercise > Control
Norman
(2012)
6 months KCCQ 77.9 (11.6) vs 81.0 (18.2); P = 0.78 Exercise = Control
Passino
(2006)
9.75
months
MLWHF total 53 (32) vs 32 (26.5); P < 0.0001* Exercise > Control
Reeves
(2017)
3 months KCCQ 63 (22) vs 65 (19); P > 0.05* Exercise = Control
Willen-
heimer
(2001)
10
months
PGAQoL 0 (1) vs 0.7 (0.9); P = 0.023 Exercise > Control
Witham
(2005)
6 months GCHFQ 69 (13) vs 65 (10); P = 0.48 Exercise = Control
Witham
(2012)***
6 months MLWHF total 15.4 (14.8) vs 11.3 (12.1); P > 0.05 Exercise = Control
Yeh
(2011)
12
months
MLWHF total 18 (6) vs 13 (4); P < 0.0001 Exercise > Control
Table 1.   Health-related quality of life results  (Continued)
*P values: calculated by authors of this Cochrane review ; +: change in outcome from baseline; **We have calculated the between P value
for this trial based on individual participant data; ***Data obtained from study authors.
EQ-5D: EuroQoL Group Quality of Life Questionnaire based on 5 dimensions; EQ-5D-3L: EuroQoL Group Quality of Life Questionnaire
based on 3-level scale; GCHFQ: Guyatt Chronic Heart Failure Questionnaire; GH: general health; KCCQ: Kansas City Cardiomyopathy
Questionnaire; MacNew: MacNew Heart Disease Health-Related Quality of Life questionnaire; MCS: Mental Component Score; MLWHF:
Minnesota Living With Heart Failure questionnaire; MOS: Medical Survey Outcome; NR: not reported; PCS: Physical Component Score; PF:
Physical functioning; PGAQoL: Patient's Global Assessment of Quality of Life; PGWB: Psychological General Well-Being index; QLI: quality of
life index; QoL: quality of life; RL: role limitation; SF-36: Short Form-36; SPPB: Short Physical Performance Battery; WHOQoL: World Health
Organization Quality of Life questionnaire.
Exercise = Control: no statistically significant diNerence (P > 0.05) in HRQoL between exercise and control groups at follow-up.
Exercise > Control: statistically significant (P ≤ 0.05) higher HRQoL in exercise group compared to control group at follow-up.
Exercise < Control: statistically significant (P ≤ 0.05) lower HRQoL in exercise group versus control group at follow-up.
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Author (year) Georgiou
(2001)
HF-ACTION
Reed (2010)
Witham (2012) Cowie
(2014)
Centre and
home
Dalal
(2018)
Lang
(2018)
Year of costs
Country
Currency
1998
US
USD
2008
US
USD
2010
UK
GBP
2013/2014
UK
GBP
2016
UK
GBP
2016
UK
GBP
Intervention cost      
Mean costs/patient 4,563 6,483 (SD 4,884) 474.75 Not report-
ed
418.39 362.61
Costs considered StaNing, space
rental, equip-
ment, pa-
tients’ lost
wages
StaNing, patient time,
travel, parking
StaNing, equip-
ment, staN and
patient travel
StaNing,
equipment,
consum-
ables*
(*home
training on-
ly)
Primary
and sec-
ondary
care, so-
cial care,
drugs,
NHS and
interven-
tion costs
StaNing,
equip-
ment,
staN travel
Cost-effectiveness      
Follow-up period 15.5 years Mean 2.5 years 6 months 5 years NR NR
Total mean healthcare
cost/patient
(exercise)
5,282* 57,338 (SD 81,343)+ 1888.24 (SD
3111)
221.58
(hospital)
and 196.53
(home)
NR NR
Total mean healthcare
costs per
patient (control)
2,055* 56,177 (SD 92,749)+ 1943.93 (SD
4551)
Not calcu-
lated
NR NR
Incremental healthcare
costs
3227* 1,161 (95% CI -6,205 to
8,404)
-447.85 (95%
CI -1696.00 to
931.00)
NR NR NR
Additional healthcare
costs
considered
Hospitalisa-
tions
Medication, procedures,
outpatient visits, emer-
gency visits, hospitalisa-
tions, tests
Inpatient and
outpatient ad-
missions, prima-
ry care contacts,
medication
NR NR NR
Mean healthcare bene-
fit (exercise)
10.24 life-
years
2.02 QALYs (SD 1.00) NR NR 0.74 QALYs
(SD 0.22)
NR
Mean health care bene-
fit (control)
7.96 life-years 1.99 QALYs (SD 1.01) NR NR 0.76 QALYs
(SD 0.21)
NR
Incremental mean
healthcare benefit
1.82 life-years 0.03 (95% CI -0.06 to
0.11)
NR NR NR NR
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Incremental cost-effec-
tiveness ratio
1,773 per life-
year saved
NR NR NR NR NR
Table 2.   Costs and cost-e:ectiveness  (Continued)
CI: confidence interval; GBP: GB pounds; NR: not reported; QALY: quality-adjusted life year; SD: standard deviation; USD: US dollars.
 
 
  All-cause
mortality
P value
All hos-
pitalisa-
tions
P value
MLWHF
P value
All HRQoL
outcomes
P value
Type of rehabilitation (exercise only vs comprehensive) 0.72 0.55 0.22 0.49
Type of exercise (aerobic training alone vs aerobic plus resistance train-
ing)
0.93 0.06 0.15 0.66
Exercise dose (number of weeks ×number of sessions/week ×average du-
ration of session in hours)
0.10 0.44 0.89 0.71
Exercise setting (hospital only, home only, both hospital and home) 0.09 0.60 0.62 0.08
Single vs multi-centre 0.46 0.60 0.09 0.06
Publication date 0.20 0.78 0.67 0.74
Risk of bias 0.28 0.05 0.01 0.01
Table 3.   Univariate meta-regression analysis 
CI: confidence interval; HRQoL: health-related quality of life; MLWHF: Minnesota Living With Heart Failure questionnaire.
 
 
Author
(year)
Outcome(s) Subgroup(s) Results (P value) Data
analysis
methods
Prede-
fined
HF AC-
TION
(O’Con-
nor 2009)
Composite prima-
ry endpoint of all-
cause mortality or
hospitalisation, me-
dian follow-up 30
months
Age (≤ 70 years vs > 70
years), gender (males
vs females), race (white
vs non-white), heart
failure aetiology (is-
chaemic vs non-is-
chaemic), baseline LVEF
(≤ 25% vs > 25%), base-
line NHYA (II vs III/IV),
previous re-vasculari-
sation, history of MI, on
ACE or beta blocker at
baseline
"there was no significant interaction of
exercise training with any of the factors
defining these subgroups" (P > 0.05)
Interac-
tion test
on hazard
ratio
Yes
HF AC-
TION
(Flynn
2009)
Kansas City Car-
diomyopathy Ques-
tionnaire (KCCQ),
overall score up to
36 months
Age, LVEF (≤ 25% or
> 25%), previous re-
vascularisation (coro-
nary artery bypass graR
surgery or percuta-
No significant subgroup interactions (P >
0.05)
Interac-
tion test
Yes
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neous coronary inter-
vention, or no previ-
ous re-vascularisation),
history of myocardial
infarction, and KCCQ
overall summary score
at baseline (0 to 50, 50
to 75, or 75 to 100)
HF AC-
TION
(Keteyian
2012)
All-cause mortality
or hospitalisation
and cardiovascular
mortality or HF hos-
pitalisation, medi-
an follow-up 28.2
months
Exercise volume de-
fined as metabolic
equivalent (MET)-hour
per week (i.e. product
of exercise intensity
(where 1 MET is 3.5 mL
VO2/kg/min) and hours
of exercise per week)
Exercise volume was linear logarithmic
predictor (P = 0.03) for all-cause mortali-
ty or hospitalisation. For cardiovascular
mortality or HF hospitalisation, exercise
volume was a significant (P < 0.001) linear
and logarithmic predictor
Moderate exercise volumes of 3 to 5
metabolic equivalent (MET)-hours and 5
to 7 MET-hours per week were associated
with reductions in subsequent risk that
exceeded 30%
Regres-
sion-based
methods
(based
only on
exercise
group da-
ta)
Post hoc
HF AC-
TION
(Pina
2013)
Kansas City Car-
diomyopathy Ques-
tionnaire
(KCCQ)
Haemoglobin …interaction…by Hgb by exercise train-
ing were not significant for the overall
summary scale (P = 0.65 for the jump
of baseline to 3 months, P = 0.56 for
the slope of 3 months to the end of the
study). Results for KCCQ subscales were
similar to results for the overall summary
scale; none of the 3-way interaction terms
were statistically significant
Interac-
tion test
Post hoc
HF AC-
TION
(Mentz
2013)
Mortality/hospi-
talisation, mortal-
ity, and CV mortal-
ity/HF hospitalisa-
tion
Chronic obstructive pul-
monary disease (COPD)
No evidence to suggest an interaction be-
tween exercise training and COPD status
for any of the clinical endpoints (all P <
0.15)
Interac-
tion test
Post hoc
HF AC-
TION
(Mentz
2013)
Mortality/hospi-
talisation, mortal-
ity, and CV mortal-
ity/HF hospitalisa-
tion/exercise ca-
pacity/HRQoL
Race (white/black/oth-
er)
No interaction between race and assign-
ment to exercise training on clinical out-
comes. However, here was evidence for
an interaction between black race and
exercise training for change in 6-minute
walk distance. No other exercise or health
status variable demonstrated a statisti-
cally significant interaction with race and
exercise training
Interac-
tion test
Post hoc
HF-AC-
TION
(Zeitler
2015)
All-cause death
or hospitalisation
Ventricular pacing sta-
tus
Interaction tests for reduction in all-cause
death and device type (P < 0.33) and re-
duction in CV death or CV hospitalisation
(P < 0.19) did not meet statistical signifi-
cance
Interac-
tion test
Post hoc
HF-AC-
TION
(Banks
2016)
6-Minute walk dis-
tance (6MWD) and
peak VO2
Diabetes mellitus No evidence of an interaction between
DM and exercise training on any clinical
outcomes
Interac-
tion test
Post hoc
Table 4.   Trial level subgroup analysis  (Continued)
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HF-AC-
TION
(Parikh
2016)
Kansas City Car-
diomyopathy Ques-
tionnaire
(KCCQ) and exer-
cise capacity
Angina pectoris Evidence of an interaction between base-
line AP and exercise training and change
in peak VO2 (interaction P < 0.019) but not
with change in HRQoL or change in 6MWD
(interaction P > 0.1). Exercise training (vs
usual care) was associated with greater
peak VO2 improvement in patients with
AP (treatment effect + 1.25 mL/kg/min,
95% CI 0.64 to 1.85) than in patients with-
out AP (treatment effect = 0.45 mL/kg/
min, 95% CI 0.18 to 0.72)
Interac-
tion test
Post hoc
HF-AC-
TION
(Luo
2017)
Mortality/hospi-
talisation, mortal-
ity, and CV mortal-
ity/HF hospitalisa-
tion/exercise ca-
pacity/HRQoL
Atrial fibrillation No significant interactions between base-
line AF status and randomisation group
for change in quality of life and function-
al capacity from baseline to 3 months. No
evidence
of a differential effect of exercise training
based on events and AF status (all inter-
actions P > 0.10)
Interac-
tion test
Post hoc
HF-AC-
TION
(Verma
2017)
Mortality/hospi-
talisation, mortal-
ity, and CV mortal-
ity/HF hospitalisa-
tion/exercise ca-
pacity/HRQoL
Having a partner, SES
(education beyond
high school, income
USD25,000, and em-
ployed)
No interaction between any of the part-
ner status or SES variables and exercise
training for outcomes (all P > 0.5)
Interac-
tion test
Post hoc
Dalal
2018
MLWHF, follow-up
12 months
Baseline NTproBNP lev-
el, presence of caregiv-
er, recruitment site, du-
ration of HF
"We found no evidence of a significant
subgroup treatment interaction on the
primary outcome at 12 months by NT-
pro-
BNP level, presence of caregiver, recruit-
ment site, or duration of HF"
Interac-
tion test
Yes
Table 4.   Trial level subgroup analysis  (Continued)
6MWD: 6-minute walking distance; ACE: angiotensin-converting enzyme; AF: atrial fibrillation; CI: confidence interval; COPD: chronic
obstructive pulmonary disease; CV: cardiovascular; DM: diabetes mellitus; HF: heart failure; HRQoL: health-related quality of life; KCCQ:
Kansas City Cardiomyopathy Questionnaire; LVEF: leR ventricular ejection fraction; MET: metabolic equivalent; MI: myocardial infarction;
MLWHF: Minnesota Living With Heart Failure questionnaire; NTproBNP: N-terminal prohormone of brain natriuretic peptide; NYHA: New
York Heart Association; SES: socioeconomic status; VO2: oxygen uptake.
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Appendix 1. Search strategy January 2018
CENTRAL
#1 MeSH descriptor: [Myocardial Ischemia] explode all trees
#2 (myocard* near isch*mi*):ti or (myocard* near isch*mi*):ab
#3 (isch*mi* near heart):ti or (isch*mi* near heart):ab
#4 MeSH descriptor: [Coronary Artery Bypass] explode all trees
#5 (coronary):ti or (coronary):ab
#6 MeSH descriptor: [Coronary Disease] explode all trees
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#7 MeSH descriptor: [Myocardial Revascularization] explode all trees
#8 MeSH descriptor: [Myocardial Infarction] explode all trees
#9 (myocard* near infarct*):ti or (myocard* near infarct*):ab
#10 (heart near infarct*):ti or (heart near infarct*):ab
#11 MeSH descriptor: [Angina Pectoris] explode all trees
#12 (angina):ti or (angina):ab
#13 MeSH descriptor: [Heart Failure] explode all trees
#14 (heart and (failure or attack)):ti or (heart and (failure or attack)):ab
#15 (Heart diseases):ti or (Heart diseases):ab
#16 MeSH descriptor: [Heart Diseases] explode all trees
#17 (heart and (disease*)):ti or (heart and (disease*)):ab
#18 (myocard*):ti or (myocard*):ab
#19 (cardiac*):ti or (cardiac*):ab
#20 (CABG):ti or (CABG):ab
#21 (PTCA):ti or (PTCA):ab
#22 (stent* and (heart or cardiac*)):ti or (stent* and (heart or cardiac*)):ab
#23 MeSH descriptor: [Heart Bypass, LeR] explode all trees
#24 (HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF REF"):ti or (HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF
REF"):ab
#25 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21
or #22 or #23 or #24
#26 MeSH descriptor: [Rehabilitation Centers] this term only
#27 MeSH descriptor: [Exercise Therapy] explode all trees
#28 MeSH descriptor: [Sports] this term only
#29 MeSH descriptor: [Physical Exertion] explode all trees
#30 (rehabilitat*):ti or (rehabilitat*):ab
#31 (physical* near (fit* or train* or therap* or activit*)):ti or (physical* near (fit* or train* or therap* or activit*)):ab
#32 MeSH descriptor: [Exercise] explode all trees
#33 (train*) near (strength* or aerobic or exercise*):ti or (train*) near (strength* or aerobic or exercise*):ab
#34 ((exercise* or fitness) near/3 (treatment or intervent* or program*)):ti or ((exercise* or fitness) near/3 (treatment or intervent* or
program*)):ab
#35 MeSH descriptor: [Rehabilitation] explode all trees
#36 MeSH descriptor: [Patient Education as Topic] this term only
#37 (patient* near/3 educat*):ti or (patient* near/3 educat*):ab
#38 ((lifestyle or life-style) near/3 (intervent* or program* or treatment*)):ti or ((lifestyle or life-style) near/3 (intervent* or program* or
treatment*)):ab
#39 MeSH descriptor: [Self Care] explode all trees
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#40 MeSH descriptor: [Ambulatory Care] explode all trees
#41 MeSH descriptor: [Psychotherapy] explode all trees
#42 (psychotherap*):ti or (psychotherap*):ab
#43 (psycholog* near intervent*):ti or (psycholog* near intervent*):ab
#44 (relax*):ti or (relax*):ab
#45 MeSH descriptor: [Mind-Body Therapies] explode all trees
#46 ((Mind or Body) and (Relaxation Techniques)):ti or ((Mind or Body) and (Relaxation Techniques)):ab
#47 MeSH descriptor: [Counseling] explode all trees
#48 (counseling or counselling):ti or (counseling or counselling):ab
#49 MeSH descriptor: [Cognitive Therapy] explode all trees
#50 MeSH descriptor: [Behavior Therapy] explode all trees
#51 ((behavio*r*) near/4 (modif* or therap* or rehab* or change)):ti or ((behavio*r*) near/4 (modif* or therap* or rehab* or change)):ab
#52 MeSH descriptor: [Stress, Psychological] explode all trees
#53 (stress near manage*):ti or (stress near manage*):ab
#54 (cognitive* near therap*):ti or (cognitive* near therap*):ab
#55 MeSH descriptor: [Meditation] explode all trees
#56 (meditat*):ti or (meditat*):ab
#57 MeSH descriptor: [Anxiety] this term only
#58 ((manage*) near (anxiety or depres*)):ti or ((manage*) near (anxiety or depres*)):ab
#59 (CBT):ti or (CBT):ab
#60 (hypnotherap*):ti or (hypnotherap*):ab
#61 (goal near/3 (setting)):ti or (goal near/3 (setting)):ab
#62 ((psycho-educat*) or (psychoeducat*)):ti ((psycho-educat*) or (psychoeducat*)):ab
#63 (motivat* near (interv*)):ti or (motivat* near (interv*)):ab
#64 MeSH descriptor: [Psychopathology] explode all trees
#65 (psychopathol*):ti or (psychopathol*):ab
#66 MeSH descriptor: [Autogenic Training] explode all trees
#67 (autogenic*):ti or (autogenic*):ab
#68 (self near (manage* or care or motivat*)):ti or (self near (manage* or care or motivat*)):ab
#69 (distress*):ti or (distress*):ab
#70 (psychosocial* or psycho-social):ti or (psychosocial* or psycho-social):ab
#71 MeSH descriptor: [Health Education] explode all trees
#72 (nutrition or diet or health near (education)):ti or (nutrition or diet or health near (education)):ab
#73 (heart manual):ti or (heart manual):ab
#74 #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37
Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
138
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
#75 #38 or #40 or #41 or #42 or #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53 or #54 or #55 or #56 or #57 or #58
or #59 or #60 or #61 or #62 or #63 or #64 or #65 or #66 or #67 or #68 or #69 or #70 or #71 or #72 or #73
#76 #74 or #75
#77 #76 and #25
#78 #77 Publication Year from 2013 to 2018, in Trials
MEDLINE
1. exp Myocardial Ischemia/
2. (myocard$4 adj5 (ischaemi$2 or ischemi$2)).ti,ab.
3. ((ischaemi$2 or ischemi$2) adj5 heart).ti,ab.
4. exp Coronary Artery Bypass/
5. coronary.ti,ab.
6. exp Coronary Disease/
7. exp Myocardial Revascularization/
8. Myocardial Infarction/
9. (myocard$5 adj5 infarct$5).ti,ab.
10. (heart adj5 infarct$5).ti,ab.
11. exp Angina Pectoris/
12. angina.ti,ab.
13. exp Heart Failure/
14. (heart adj5 failure).ti,ab.
15. (HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF REF").ti,ab.
16. or/1-15
17. exp Heart Diseases/
18. (heart adj5 disease$2).ti,ab.
19. myocard$5.ti,ab.
20. cardiac$2.ti,ab.
21. CABG.ti,ab.
22. PTCA.ti,ab.
23. (stent$4 and (heart or cardiac$4)).ti,ab.
24. Heart Bypass, LeR/ or exp Heart Bypass, Right/
25. or/17-24
26. *Rehabilitation Centers/
27. exp Exercise Therapy/
28. *Rehabilitation/
29. exp Sports/
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30. Physical Exertion/ or exertion.ti,ab.
31. exp Exercise/
32. rehabilitat$5.ti,ab.
33. (physical$4 adj5 (fit or fitness or train$5 or therap$5 or activit$5)).ti,ab.
34. (train$5 adj5 (strength$3 or aerobic or exercise$4)).ti,ab.
35. ((exercise$4 or fitness) adj5 (treatment or intervent$4 or programs$2 or therapy)).ti,ab.
36. Patient Education as Topic/
37. (patient$2 adj5 educat$4).ti,ab.
38. ((lifestyle or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
39. *Self Care/
40. (self adj5 (manage$5 or care or motivate$5)).ti,ab.
41. *Ambulatory Care/
42. exp Psychotherapy/
43. psychotherap$2.ti,ab.
44. (psycholog$5 adj5 intervent$5).ti,ab.
45. relax$6.ti,ab.
46. exp Relaxation Therapy/ or exp Mind-Body Therapies/
47. exp Counseling/
48. (counselling or counseling).ti,ab.
49. exp Cognitive Therapy/
50. exp Behavior Therapy/
51. ((behavior$4 or behaviour$4) adj5 (modify or modificat$4 or therap$2 or change)).ti,ab.
52. *Stress, Psychological/
53. (stress adj5 management).ti,ab.
54. (cognitive adj5 therap$2).ti,ab.
55. meditat$4.ti,ab.
56. *Meditation/
57. exp Anxiety/
58. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
59. CBT.ti,ab.
60. hypnotherap$5.ti,ab.
61. (goal adj5 setting).ti,ab.
62. (goal$2 adj5 setting).ti,ab.
63. (psycho-educat$5 or psychoeducat$5).ti,ab.
64. (motivat$5 adj5 (intervention or interv$3)).ti,ab.
Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
140
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
65. Psychopathology/
66. psychopathol$4.ti,ab.
67. psychosocial$4.ti,ab.
68. distress$4.ti,ab.
69. exp Health Education/
70. (health adj5 education).ti,ab.
71. (heart adj5 manual).ti,ab.
72. Autogenic Training/
73. autogenic$5.ti,ab.
74. or/26-39
75. or/40-73
76. 16 or 25
77. 74 or 75
78. 76 and 77
79. randomized controlled trial/
80. randomized controlled trial.pt.
81. controlled clinical trial.pt.
82. controlled clinical trial/
83. Random Allocation/
84. Double-Blind Method/
85. single-blind method/
86. (random$ or placebo$).ti,ab.
87. ((singl$3 or doubl$3 or tripl$3 or trebl$3) adj5 (blind$3 or mask$3)).ti,ab.
88. exp Research Design/
89. Clinical Trial.pt.
90. exp clinical trial/
91. (clinic$3 adj trial$2).ti,ab.
92. or/79-91
93. 78 and 92
94. (Animals not Humans).sh.
95. 93 not 94
96. limit 95 to yr="2013-Current"
Embase
1. exp heart disease/
2. (myocard$4 adj5 (ischaemi$2 or ischemi$2)).ti,ab.
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3. ((ischaemi$2 or ischemi$2) adj5 heart).ti,ab.
4. exp coronary artery disease/
5. transluminal coronary angioplasty/
6. (coronary adj5 (disease$2 or bypass$2 or thrombo$5 or angioplasty$2)).ti,ab.
7. exp heart infarction/
8. (myocard$5 adj5 infarct$5).ti,ab.
9. (heart adj5 infarct$5).ti,ab.
10. heart muscle revascularization/
11. exp Angina Pectoris/
12. angina.ti,ab.
13. exp congestive heart failure/
14. (heart adj5 failure).ti,ab.
15. (HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF REF").ti,ab.
16. or/1-15
17. (heart adj5 disease$2).ti,ab.
18. cardiac$2.ti,ab.
19. CABG.ti,ab.
20. PTCA.ti,ab.
21. (stent$4 and heart).ti,ab.
22. exp extracorporeal circulation/
23. or/17-22
24. 16 or 23
25. *Psychotherapy/
26. psychotherapy$2.ti,ab.
27. (psycholog$5 adj5 intervent$5).ti,ab.
28. relax$6.ti,ab.
29. relaxation training/
30. *counselling/
31. (counselling or counseling).ti,ab.
32. ((behavior$4 or behaviour$4) adj5 (modify or modificat$4 or therap$2 or change)).ti,ab.
33. stress management/
34. (stress adj5 management).ti,ab.
35. *Mediation/
36. meditat$5.ti,ab.
37. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
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38. CBT.ti,ab.
39. hypnotherap$2.ti,ab.
40. (goal$2 adj5 setting).ti,ab.
41. (psycho-educat$5 or psychoeducat$5).ti,ab.
42. (motivat$5 adj5 intervent$6).ti,ab.
43. exp psychosocial care/ or exp psychosocial rehabilitation/
44. psychosocial.ti,ab.
45. exp health education/
46. (health adj5 education).ti,ab.
47. (heart adj5 manual).ti,ab.
48. autogenic training/
49. autogenic.ti,ab.
50. *Rehabilitation/
51. rehabilitation center/
52. rehabil$.ti,ab.
53. exp Sport/
54. exp Kinesiotherapy/
55. exp Exercise/
56. exp Physiotherapy/
57. (physical$4 adj5 (fit or fitness or train$5 or therap$5 or activit$5)).ti,ab.
58. (train$5 adj5 (strength$3 or aerobic or exercise$4)).ti,ab.
59. ((exercise$4 or fitness) adj5 (treatment or intervent$4 or programs$2 or therapy)).ti,ab.
60. (aerobic$4 adj5 exercise$4).ti,ab.
61. (kinesiotherapy or physiotherapy).ti,ab.
62. patient education/
63. (patient$2 adj5 educat$4).ti,ab.
64. ((((lifestyle or life) adj1 style) or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
65. exp self care/
66. (self adj5 (manage$5 or care or motivate$5)).ti,ab.
67. exp ambulatory care/
68. (psycho-educat$5 or psychoeducat$5).ti,ab.
69. (motivat$5 adj5 intervent$6).ti,ab.
70. psychosocial care/ or psychosocial rehabilitation/
71. psychosocial.ti,ab.
72. exp health education/
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73. (health adj5 education).ti,ab.
74. (heart adj5 manual).ti,ab.
75. autogenic training/
76. autogenic$5.ti,ab.
77. (psycho-educat$5 or psychoeducat$5).ti,ab.
78. (motivat$5 adj5 intervent$6).ti,ab.
79. psychosocial care/ or psychosocial rehabilitation/
80. psychosocial.ti,ab.
81. exp health education/
82. (health adj5 education).ti,ab.
83. (heart adj5 manual).ti,ab.
84. or/25-50
85. or/51-83
86. 84 or 85
87. (random$ or placebo$).ti,ab.
88. ((singl$4 or doubl$4 or tripl$4 or trebl$4) adj5 (blind$4 or mask$4)).ti,ab.
89. (controlled adj1 clinical adj1 trial).ti,ab.
90. randomized controlled trial/
91. or/87-90
92. 24 and 86
93. 91 and 92
94. (animal$ not human$).sh,hw.
95. 93 not 94
96. limit 95 to yr="2013-Current"
CINAHL
1. TI((myocard* N5 ischaemi*) or (myocard* N5 ischemi*) or (heart N5 ischaemi*) or (heart N5 ischemi*)) OR AB((myocard* N5 ischaemi*)
or (myocard* N5 ischemi*) or (heart N5 ischaemi*) or (heart N5 ischemi*))
2. TI(coronary) or AB(coronary)
3. TI((myocard* N5 infarc*) or (heart N5 infarc*)) or AB((myocard* N5 infarc*) or (heart N5 infarc*))
4. TI(angina) OR AB(angina)
5. TI(heart N5 failure) or AB(heart N5 failure)
6. TI(heart N5 diseas*) or AB(heart N5 diseas*)
7. TI(cardiac) or AB(cardiac)
8. TI(CABG) or AB(CABG)
9. TI(PTCA) or AB(PTCA)
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10. TI(Stent* and (heart or cardiac*)) or AB(Stent* and (heart or cardiac*))
11. (MH "Myocardial Ischemia+")
12. (MH "Myocardial Infarction+")
13. (MH "Coronary Artery Bypass+")
14. (MH "Coronary Disease+")
15. TI(cardiac N5 patient*) or AB(cardiac N5 patient*)
16. TI(Cardiomyopathies) or AB(Cardiomyopathies)
17. (MH "Myocardial Revascularization+")
18. (MH "Heart Diseases+")
19. (MH "Cardiovascular Diseases+")
20. (MH "Heart Failure+")
21. (MH "Angina Pectoris+")
22. TI(HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF REF") or AB(HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF REF")
23. S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19
OR S20 OR S21 OR S22
24. (MM "Rehabilitation")
25. (MM "Sports")
26. (MM "Physical Activity")
27. (MH "Muscle Strengthening+")
28. (MH "Aerobic Exercises+")
29. (MH "Physical Fitness+")
30. (MH "Patient Education+")
31. (MH "Therapeutic Exercise+")
32. TI(rehabilitat*) or AB(rehabilitat*)
33. TI((physical* N5 fit) or (physical N5 fitness) or (physical N5 train*) or (physical N5 therap*) or (physical N5 activit*)) or AB((physical* N5
fit) or (physical N5 fitness) or (physical N5 train*) or (physical N5 therap*) or (physical N5 activit*))
34. TI((train N5 strength) or (train N5 aerobic) or (train N5 exercis*)) or AB((train N5 strength) or (train N5 aerobic) or (train N5 exercis*))
35. TI((exercise N5 treatment) or (fitness N5 treatment) or (exercise N5 intervent*) or (fitness N5 intervent*) or (exercise N5 program*) or
(fitness N5 program) or (exercise N5 therapy) or (fitness N5 therapy)) or AB((exercise N5 treatment) or (fitness N5 treatment) or (exercise
N5 intervent*) or (fitness N5 intervent*) or (exercise N5 program*) or (fitness N5 program) or (exercise N5 therapy) or (fitness N5 therapy))
36. TI(patient* N5 educat*) or AB(patient* N5 educat*)
37. TI ((lifestyle N5 intervent*) or (life-style N5 intervent*) or (lifestyle N5 program*) or (life-style N5 program*) or (lifestyle N5 treatment)
or (life-style N5 treatment)) OR AB ((lifestyle N5 intervent*) or (life-style N5 intervent*) or (lifestyle N5 program*) or (life-style N5 program*)
or (lifestyle N5 treatment) or (life-style N5 treatment))
38. (MH "Self Care+")
39. TI((self N5 manage*) or (self N5 care) or (self N5 motivat*)) or AB((self N5 manage*) or (self N5 care) or (self N5 motivat*))
40. (MM "Ambulatory Care")
Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
145
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
41. TI(aerobic) or AB(aerobic)
42. TI(resistance W1 train*) or AB(resistance W1 train*)
43. TI(muscle W1 strength*) or AB(muscle W1 strength*)
44. TI(resistance W1 train*) or AB(resistance W1 train*)
45. TI(muscle W1 strength*) or AB(muscle W1 strength*)
46. (MH "Psychotherapy+")
47. TI(psychotherap*) or AB(psychotherap*)
48. TI(psycholog* N5 intervent*) or AB(psycholog* N5 intervent*)
49. TI(relax) or AB(relax)
50. (MH "Relaxation Techniques+")
51. TI(counselling or counseling) or AB(counselling or counseling)
52. (MH "Counseling+")
53. TI((behavio?r* N5 modify) or (behavio?r* N5 modificat*) or (behavio?r* N5 therap*) or (behavio?r* N5 change)) or AB((behavio?r* N5
modify) or (behavio?r* N5 modificat*) or (behavio?r* N5 therap*) or (behavio?r* N5 change))
54. (MM "Stress Management")
55. TI(stress N5 manag*) or AB(stress N5 manag*)
56. TI(cognitive N5 therap*) or AB(cognitive N5 therap*)
57. (MM "Meditation")
58. TI(meditat*) or AB(meditat*)
59. (MH "Anxiety+")
60. TI((manage* N5 anxiety) or (manage* N5 depress*)) or AB((manage* N5 anxiety) or (manage* N5 depress*))
61. TI(CBT) or AB(CBT)
62. TI(hypnotherap*) or AB(hypnotherap*)
63. TI(goal* N5 setting) or AB(goal* N5 setting)
64. TI(psycho-educat* or psychoeducat*) or AB(psycho-educat* or psychoeducat*)
65. TI((motivat* N5 interv*) or (motivate* N5 intervent*)) or AB((motivat* N5 interv*) or (motivate* N5 intervent*))
66. TI(psychosocial*) or AB(psychosocial*)
67. (MH "Health Education+")
68. TI(health N5 educat*) or AB(health N5 educat*)
69. TI(heart W1 manual) or AB(heart W1 manual)
70. TI(autogenic*) or AB(autogenic*)
71. S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR
S41 OR S42 OR S43 OR S44 OR S45
72. S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60 OR S61 OR S62 OR S63
OR S64 OR S65 OR S66 OR S67 OR S68 OR S69 OR S70
73. S71 OR S72
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74. S23 AND S73
75. PT CLINICAL TRIAL
76. (MH "Clinical Trials+")
77. TI (random* or placebo*) or AB (random* or placebo*)
78. TI(singl* or double* or triple* or treble* and (blind* or mask*)) or AB(singl* or double* or triple* or treble* and (blind* or mask*))
79. TI(controlled w1 clinical w1 trials) or AB(controlled w1 clinical w1 trials)
80. S75 OR S76 OR S77 OR S78 OR S79
81. S74 AND S80 Publication Year: 2013-2018
PsycINFO
1. exp heart disorders/
2. *Myocardial Infarctions/
3. exp Ischemia/
4. *Heart Surgery/
5. angioplasty.ti,ab.
6. (heart adj1 bypass).ti,ab.
7. coronary.ti,ab.
8. (ischemi$3 or ischaemi$3).ti,ab.
9. (myocard$5 adj5 infarct$5).ti,ab.
10. (heart adj5 (infarct$5 or failure or attack)).ti,ab.
11. angina.ti,ab.
12. (heart adj5 disease$2).ti,ab.
13. myocard$5.ti,ab.
14. cardiac$4.ti,ab.
15. CABG.ti,ab.
16. PTCA.ti,ab.
17. (HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF REF").ti,ab.
18. or/1-17
19. exp Physical Activity/
20. exp Sports/
21. *Physical Education/
22. exp Health Behavior/
23. *Physical Fitness/
24. (physical adj1 education).ti,ab.
25. exertion$6.ti,ab.
26. rehabilitat$6.ti,ab.
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27. (physical adj5 (fit$5 or train$5 or therap$5 or activit$4)).ti,ab.
28. (train$4 adj5 (strength$4 or aerobic or exercise$2)).ti,ab.
29. ((exercise$3 or fitness) adj5 (treatment or intervent$4 or program$4 or therap$2)).ti,ab.
30. patient with education.ti,ab.
31. exp Client Education/
32. exp Health Promotion/
33. ((lifestyle or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
34. exp Outpatient Treatment/
35. or/19-34
36. exp Psychotherapy/
37. psychotherapy$2.ti,ab.
38. exp Treatment/
39. (psycholog$4 adj5 intervent$5).ti,ab.
40. exp Counseling/
41. exp Coping Behavior/
42. *Meditation/
43. *Autogenic Training/
44. exp Health Education/
45. relax$6.ti,ab.
46. (counselling or counseling).ti,ab.
47. ((behavior or behaviour) adj5 (modif$5 or therap$5 or rehabilit5 or change)).ti,ab.
48. (stress adj5 management).ti,ab.
49. meditat$5.ti,ab.
50. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
51. ((cbt or cognitive$2) adj5 therap$3).ti,ab.
52. hypnotherap$3.ti,ab.
53. (psycho-educat$6 or psychoeducat$6).ti,ab.
54. (motivat$5 adj5 intervent$5).ti,ab.
55. (self adj5 manag$6).ti,ab.
56. autogenic$3.ti,ab.
57. (goal adj5 setting).ti,ab.
58. (health adj5 education).ti,ab.
59. (heart adj1 manual).ti,ab.
60. or/36-59
61. 18 and (35 or 60)
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62. (random$5 or placebo$5).ti,ab.
63. ((single$4 or double$4 or triple$4) and (blind$4 or mask or sham$4 or dummy)).ti,ab.
64. RCT.ti,ab.
65. or/62-64
66. 61 and 65
67. limit 66 to yr="2013-Current"
Web of Science
1. TS=((myocard*) SAME (isch?emia or infarct* or revasculari?*))
2. TS=((coronary* or heart*) SAME (by?pass or disease*))
3. TS=((heart) SAME (infarct* or isch?emia or failure or attack))
4. TS=(angina or cardiac* or PTCA or CABG)
5. TS=(HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF REF")
6. #1 OR #2 OR #3 OR #4 OR #5
7. TS=(rehab* or educat*)
8. #6 AND #7
9. TS=(random* or placebo*)
10. TS=((singl* or doubl* or tripl* or trebl*) SAME (blind* or mask*))
11. TS=("clinic* trial*")
12. #9 OR #10 OR #11
13. #8 AND #12
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH Timespan=2013-2018
Appendix 2. Search strategy 2001
Cochrane Controlled Trials Register (2001, Issue 2)
1. HEART-FAILURE-CONGESTIVE*:ME
2. (HEART and FAILURE)
3. (CARDIAC and FAILURE)
4. ((#1 or #2) or #3)
5. REHABILITATION*:ME
6. EXERCISE*:ME
7. EXERCISE-THERAPY*:ME
8. SPORTS*:ME
9. PHYSICAL-EDUCATION-AND-TRAINING*:ME
10. EXERTION*:ME
11. REHABILITAT*
12. (PHYSICAL* near FIT)
13. (PHYSICAL* near FITNESS)
14. (PHYSICAL near TRAIN*)
15. (PHYSICAL* near ACTIVIT*)
16. (TRAIN* near STRENGTH*)
17. (TRAIN* near AEROBIC*)
18. (AEROBIC* near EXERCISE*)
19. KINESIOTHERAP*
20. (EXERCISE* near TRAIN*)
21. (((((((((((((((#5 or #6) or #7) or #8) or #9) or #10) or #11) or #12) or #13) or #14) or #15) or #16) or #17) or #18) or #19) or #20)
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22. (#4 and #21)
Appendix 3. Search strategies 2008
CENTRAL, in the Cochrane Library (2007, Issue 4)
#1MeSH descriptor Myocardial Ischemia explode all trees
#2(myocard* NEAR isch*mi*)
#3isch*mi* NEAR heart
#4MeSH descriptor Coronary Artery Bypass explode all trees
#5coronary
#6MeSH descriptor Coronary Disease explode all trees
#7MeSH descriptor Myocardial Revascularization explode all trees
#8MeSH descriptor Myocardial Infarction explode all trees
#9myocard* NEAR infarct*
#10heart NEAR infarct*
#11MeSH descriptor Angina Pectoris explode all trees
#12angina
#13MeSH descriptor Heart Failure, Congestive explode all trees
#14heart and (failure or attack)
#15MeSH descriptor Heart Diseases explode all trees
#16heart and disease*
#17myocard*
#18cardiac*
#19CABG
#20PTCA
#21stent* AND (heart or cardiac*)
#22MeSH descriptor Heart Bypass, LeR explode all trees
#23MeSH descriptor Heart Bypass, Right explode all trees
#24(#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR
#16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23)
#25MeSH descriptor Rehabilitation Centers, this term only
#26MeSH descriptor Exercise Therapy explode all trees
#27MeSH descriptor Sports, this term only
#28MeSH descriptor Exertion explode all trees
#29rehabilitat*
#30(physical* NEAR (fit* or train* or therap* or activit*))
#31MeSH descriptor Exercise explode all trees
#32(train*) near (strength* or aerobic or exercise*)
#33((exercise* or fitness) NEAR/3 (treatment or intervent* or program*))
#34MeSH descriptor Rehabilitation explode all trees
#35MeSH descriptor Patient Education explode all trees
#36(patient* NEAR/3 educat*)
#37((lifestyle or life-style) NEAR/3 (intervent* or program* or treatment*))
#38MeSH descriptor Self Care explode all trees
#39MeSH descriptor Ambulatory Care explode all trees
#40MeSH descriptor Psychotherapy explode all trees
#41psychotherap*
#42psycholog* NEAR intervent*
#43relax*
#44MeSH descriptor Mind-Body and Relaxation Techniques explode all trees
#45MeSH descriptor Counseling explode all trees
#46counsel*ing
#47MeSH descriptor Cognitive Therapy explode all trees
#48MeSH descriptor Behavior Therapy explode all trees
#49(behavio*r*) NEAR/4 (modif* or therap* or rehab* or change)
#50MeSH descriptor Stress, Psychological explode all trees
#51stress NEAR manage*
#52cognitive* NEAR therap*
#53MeSH descriptor Meditation explode all trees
#54meditat*
#55MeSH descriptor Anxiety, this term only
#56(manage*) NEAR (anxiety or depres*)
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#57CBT
#58hypnotherap*
#59goal NEAR/3 setting
#60(psycho-educat*) or (psychoeducat*)
#61motivat* NEAR interv*
#62MeSH descriptor Psychopathology explode all trees
#63psychopathol*
#64MeSH descriptor Autogenic Training explode all trees
#65autogenic*
#66self near (manage* or care or motivat*)
#67distress*
#68psychosocial* or psycho-social
#69MeSH descriptor Health Education explode all trees
#70(nutrition or diet or health) NEAR education
#71heart manual
#72(#25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37)
#73(#38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR #49 OR #50 OR
#51 OR #52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 OR #60 OR #61 OR #62 OR #63 OR #64 OR
#65 OR #66 OR #67 OR #68 OR #69 OR #70 OR #71)
#74(#72 OR #73)
#75(#74 AND #24)
MEDLINE dialog to week 1 2008
1. SEARCH: MYOCARDIAL-ISCHEMIA#.DE.
2. SEARCH: MYOCARD$4 NEAR (ISCHAEMI$2 OR ISCHEMI$2)
3. SEARCH: (ISCHAEMI$2 OR ISCHEMI$2) NEAR HEART
4. SEARCH: CORONARY-ARTERY-BYPASS#.DE.
5. SEARCH: CORONARY.TI,AB.
6. SEARCH: CORONARY-DISEASE#.DE.
7. SEARCH: MYOCARDIAL-REVASCULARIZATION#.DE.
8. SEARCH: MYOCARDIAL-INFARCTION#.DE.
9. SEARCH: MYOCARD$5 NEAR INFARCT$5
10. SEARCH: HEART NEAR INFARCT$5
11. SEARCH: ANGINA-PECTORIS#.DE.
12. SEARCH: ANGINA.TI,AB.
13. SEARCH: HEART-FAILURE-CONGESTIVE#.DE.
14. SEARCH: HEART NEAR FAILURE
15. SEARCH: 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14
16. SEARCH: HEART-DISEASES#.DE.
17. SEARCH: (HEART NEAR DISEASE$2).TI,AB.
18. SEARCH: MYOCARD$5.TI,AB.
19. SEARCH: CARDIAC$2.TI,AB.
20. SEARCH: CABG
21. SEARCH: PTCA
22. SEARCH: STENT$4 AND (HEART OR CARDIAC$4)
23. SEARCH: HEART-BYPASS-LEFT#.DE. OR HEART-BYPASS-RIGHT#.DE.
24. SEARCH: 16 OR 17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23
25. SEARCH: REHABILITATION-CENTERS.DE.
26. SEARCH: EXERCISE-THERAPY#.DE.
27. SEARCH: REHABILITATION.W..DE.
28. SEARCH: SPORTS#.W..DE.
29. SEARCH: EXERTION#.W..DE.
30. SEARCH: EXERCISE#.W..DE.
31. SEARCH: REHABILITAT$5.TI,AB.
32. SEARCH: PHYSICAL$4 NEAR (FIT OR FITNESS OR TRAIN$5 OR THERAP$5 OR ACTIVIT$5)
33. SEARCH: TRAIN$5 NEAR (STRENGTH$3 OR AEROBIC OR EXERCIS$4)
34. SEARCH: (EXERCISE$4 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$2 OR THERAPY)
35. SEARCH: PATIENT-EDUCATION#.DE.
36. SEARCH: PATIENT$2 NEAR EDUCAT$4
37. SEARCH: (LIFESTYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)
38. SEARCH: SELF-CARE.DE.
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39. SEARCH: SELF NEAR (MANAGE$5 OR CARE OR MOTIVAT$5)
40. SEARCH: AMBULATORY-CARE.DE.
41. SEARCH: PSYCHOTHERAPY#.W..DE.
42. SEARCH: PSYCHOTHERAP$2.TI,AB.
43. SEARCH: PSYCHOLOG$5 NEAR INTERVENT$5
44. SEARCH: RELAX$6.TI,AB.
45. SEARCH: RELAXATION-TECHNIQUES#.DE. OR MIND-BODY-AND-RELAXATION-TECHNIQUES#.DE.
46. SEARCH: COUNSELING#.W..DE.
47. SEARCH: (COUNSELLING OR COUNSELING).TI,AB.
48. SEARCH: COGNITIVE-THERAPY#.DE.
49. SEARCH: BEHAVIOR-THERAPY#.DE.
50. SEARCH: (BEHAVIOR$4 OR BEHAVIOUR$4) NEAR (MODIFY OR MODIFICAT$4 OR THERAP$2 OR CHANGE)
51. SEARCH: STRESS-PSYCHOLOGICAL#.DE.
52. SEARCH: STRESS NEAR MANAGEMENT
53. SEARCH: COGNITIVE NEAR THERAP$2
54. SEARCH: MEDITAT$4
55. SEARCH: MEDITATION#.W..DE.
56. SEARCH: ANXIETY#.W..DE.
57. SEARCH: MANAGE$5 NEAR (ANXIETY OR DEPRES$5)
58. SEARCH: CBT.TI,AB.
59. SEARCH: HYPNOTHERAP$5
60. SEARCH: GOAL NEAR SETTING
61. SEARCH: GOAL$2 NEAR SETTING
62. SEARCH: PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
63. SEARCH: MOTIVAT$5 NEAR (INTERVENTION OR INTERV$3)
64. SEARCH: PSYCHOPATHOLOGY#.W..DE.
65. SEARCH: PSYCHOPATHOL$4.TI,AB.
66. SEARCH: PSYCHOSOCIAL$4.TI,AB.
67. SEARCH: DISTRESS$4.TI,AB.
68. SEARCH: HEALTH-EDUCATION#.DE.
69. SEARCH: HEALTH NEAR EDUCATION
70. SEARCH: HEART ADJ MANUAL
71. SEARCH: AUTOGENIC-TRAINING#.DE.
72. SEARCH: AUTOGENIC$5.TI.AB.
73. SEARCH: 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38
74. SEARCH: 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47 OR 48 OR 49 OR 50 OR 51 OR 52 OR 53
OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR 63 OR 64 OR 65 OR 66 OR 67 OR 68 OR 69 OR
70 OR 71 OR 72
75. SEARCH: 15 OR 24
76. SEARCH: 73 or 74
77. SEARCH: 75 AND 76
78. SEARCH: RANDOMIZED-CONTROLLED-TRIALS#.DE.
79. SEARCH: PT=RANDOMIZED-CONTROLLED-TRIAL
80. SEARCH: PT=CONTROLLED-CLINICAL-TRIAL
81. SEARCH: CONTROLLED-CLINICAL-TRIALS#.DE.
82. SEARCH: RANDOM-ALLOCATION#.DE.
83. SEARCH: DOUBLE-BLIND-METHOD#.DE.
84. SEARCH: SINGLE-BLIND-METHOD#.DE.
85. SEARCH: (RANDOM$ OR PLACEBO$).TI,AB.
86. SEARCH: ((SINGL$3 OR DOUBL$3 OR TRIPL$3 OR TREBL$3) NEAR (BLIND$3 OR MASK$3)).TI,AB.
87. SEARCH: RESEARCH-DESIGN#.DE.
88. SEARCH: PT=CLINICAL-TRIAL#
89. SEARCH: CLINICAL-TRIALS#.DE.
90. SEARCH: (CLINIC$3 ADJ TRIAL$2).TI,AB.
91. SEARCH: 77 AND 90
92. SEARCH: (ANIMALS NOT HUMANS).SH.
93. SEARCH: 91 NOT 92
94. SEARCH: LIMIT 93 TO 2001-DATE
Embase dialog to week 1 2008
1. HEART-DISEASE#.DE.
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2. (MYOCARD$4 NEAR (ISCHAEMI$2 OR ISCHEMI$2)).TI,AB.
3. ((ISCHAEMI$2 OR ISCHEMI$2) NEAR HEART).TI,AB.
4. CORONARY-ARTERY-DISEASE#.DE.
5. TRANSLUMINAL-CORONARY-ANGIOPLASTY#.DE.
6. (CORONARY NEAR (DISEASE$2 OR BYPASS$2 OR THROMBO$5 OR ANGIOPLAST$2)).TI,AB.
7. HEART-INFARCTION#.DE.
8. (MYOCARD$4 NEAR INFARCT$5).TI,AB.
9. (HEART NEAR INFARC$5).TI,AB.
10. HEART-MUSCLE-REVASCULARIZATION#.DE.
11. ANGINA-PECTORIS#.DE.
12. ANGINA.TI,AB.
13. CONGESTIVE-HEART-FAILURE#.DE.
14. (HEART NEAR FAILURE).TI,AB.
15. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14
16. (HEART NEAR DISEASE$2).TI,AB.
17. CARDIAC$2.TI,AB.
18. CABG.TI,AB.
19. PTCA.TI,AB.
20. STENT$4.TI,AB. AND HEART.TI,AB.
21. EXTRACORPOREAL-CIRCULATION#.DE.
22. 16 OR 17 OR 18 OR 19 OR 20 OR 21
23. 15 OR 22
24. PSYCHOTHERAPY#.W..DE.
25. PSYCHOTHERAP$2.TI,AB.
26. PSYCHOLOG$5 NEAR INTERVENT$5
27. RELAX$6.TI,AB.
28. RELAXATION-TRAINING#.DE.
29. COUNSELING#.W..DE.
30. (COUNSELLING OR COUNSELING).TI,AB.
31. (BEHAVIOR$4 OR BEHAVIOUR$4) NEAR (MODIFY OR MODIFICAT$4 OR THERAPY$2 OR CHANGE)
32. STRESS-MANAGEMENT#.DE.
33. STRESS NEAR MANAGEMENT
34. MEDITATION#.W..DE.
35. MEDITAT$5.TI,AB.
36. MANAGE$5 NEAR (ANXIETY OR DEPRES$5)
37. CBT.TI,AB.
38. HYPNOTHERAP$2.TI,AB.
39. GOAL$2 NEAR SETTING
40. PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
41. MOTIVAT$5 NEAR INTERVENT$6
42. PSYCHOSOCIAL-CARE#.DE. OR PSYCHOSOCIAL-REHABILITATION#.DE.
43. PSYCHOSOCIAL.TI,AB.
44. HEALTH-EDUCATION#.DE.
45. HEALTH NEAR EDUCATION
46. HEART ADJ MANUAL
47. AUTOGENIC-TRAINING#.DE.
48. AUTOGENIC.TI,AB.
49. REHABILITATION#.W..DE.
50. REHABILITATION-CENTER#.DE.
51. REHABIL$.TI,AB.
52. SPORT#.W..DE.
53. KINESIOTHERAPY#.W..DE.
54. EXERCISE#.W..DE.
55. PHYSIOTHERAPY#.W..DE.
56. PHYSICAL$4 NEAR (FIT OR FITNESS OR TRAIN$5 OR THERAP$5 OR ACTIVIT$5)
57. TRAIN$5 NEAR (STRENGTH$3 OR AEROBIC OR EXERCIS$4)
58. (EXERCISE$4 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$2 OR THERAPY)
59. AEROBIC$4 NEAR EXERCISE$4
60. (KINESIOTHERAPY OR PHYSIOTHERAPY).TI,AB.
61. PATIENT-EDUCATION#.DE.
62. PATIENT$2 NEAR EDUCAT$4
63. (LIFESTYLE OR LIFE ADJ STYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)
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64. SELF-CARE#.DE.
65. SELF NEAR (MANAGE$5 OR CARE OR MOTIVAT$5)
66. AMBULATORY-CARE#.DE.
67. PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
68. MOTIVAT$5 NEAR INTERVENT$6
69. PSYCHOSOCIAL-CARE#.DE. OR PSYCHOSOCIAL-REHABILITATION#.DE.
70. PSYCHOSOCIAL.TI,AB.
71. HEALTH-EDUCATION#.DE.
72. HEALTH NEAR EDUCATION
73. HEART ADJ MANUAL
74. AUTOGENIC-TRAINING#.DE.
75. AUTOGENIC.TI,AB.
76. PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
77. MOTIVAT$5 NEAR INTERVENT$6
78. PSYCHOSOCIAL-CARE#.DE. OR PSYCHOSOCIAL-REHABILITATION#.DE.
79. PSYCHOSOCIAL.TI,AB.
80. HEALTH-EDUCATION#.DE.
81. HEALTH NEAR EDUCATION
82. HEART ADJ MANUAL
83. 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or
42 or 43 or 44 or 45 or 46 or 47 or 48 or 49
84 50 OR 51 OR 52 OR 53 OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR 63 OR 64 OR 65 OR
66 OR 67 OR 68 OR 69 OR 70 OR 71 OR 72 OR 73 OR 74 OR 75 OR 76 OR 77 OR 78 OR 79 OR 80 OR 81 OR 82
85. 83 OR 84
86. (RANDOM$ OR PLACEBO$).TI,AB.
87. (SINGL$4 OR DOUBLE$4 OR TRIPLE$4 OR TREBLE$4).TI,AB. AND (BLIND$4 OR MASK$4).TI,AB.
88. (CONTROLLED ADJ CLINICAL ADJ TRIAL).TI,AB.
89. RANDOMIZED-CONTROLLED-TRIAL#.DE.
90. 1 OR 2 OR 3 OR 4
91. 23 AND 85
92. 91 AND 92
93. LIMIT 92 TO 2001-2008
CINAHL dialog to week 1 2008
1. ((MYOCARD$4 OR HEART) NEAR (ISCHAEMI$2 OR ISCHEMI$2)).TI,AB.
2. CORONARY.TI,AB.
3. ((MYOCARD$4 OR HEART) NEAR INFARC$5).TI,AB.
4. ANGINA.TI,AB.
5. (HEART NEAR FAILURE).TI,AB.
6. (HEART NEAR DISEAS$2).TI,AB.
7. CARDIAC$2.TI,AB.
8. CABG
9. PTCA
10. STENT$4.TI,AB. AND (HEART OR CARDIAC$4).TI,AB.
11. MYOCARDIAL-ISCHEMIA#.DE.
12. MYOCARDIAL-INFARCTION#.DE.
13. CORONARY-ARTERY-BYPASS#.DE.
14. CORONARY-DISEASE#.DE.
15. CARDIAC-PATIENTS#.DE.
16. MYOCARDIAL-DISEASES#.DE.
17. MYOCARDIAL-REVASCULARIZATION#.DE.
18. HEART-DISEASES#.DE.
19. CARDIOVASCULAR-DISEASES#.DE.
20. HEART-FAILURE-CONGESTIVE#.DE.
21. ANGINA-PECTORIS#.DE.
22. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18
OR 19 OR 20 OR 21
23. REHABILITATION#.W..DE.
24. SPORTS#.W..DE.
25. EXERCISE#.W..DE.
26. PHYSICAL-ACTIVITY#.DE.
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27. MUSCLE-STRENGTHENING#.DE.
28. AEROBIC-EXERCISES#.DE.
29. PHYSICAL-FITNESS#.DE.
30. PATIENT-EDUCATION#.DE.
31. THERAPEUTIC-EXERCISE#.DE.
32. REHABILITAT$5.TI,AB.
33. (PHYSICAL$4 NEAR (FIT OR FITNESS OR TRAIN$4 OR THERAP$5 OR ACTIVIT$4)).TI,AB.
34. (TRAIN$4 NEAR (STRENGTH$3 OR AEROBIC OR EXERCIS$4)).TI,AB.
35. ((EXERCISE$4 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$2 OR THERAPY)).TI,AB.
36. (PATIENT$2 NEAR EDUCAT$4).TI,AB.
37. ((LIFESTYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)).TI,AB.
38. SELF-CARE#.DE.
39. (SELF NEAR (MANAGE$5 OR CARE OR MOTIVAT$5)).TI,AB.
40. AMBULATORY-CARE#.DE.
41 AEROBIC.TI,AB.
42. RESISTANCE ADJ TRAIN$4
43. MUSCLE ADJ STRENGTH$5
44. AEROBIC.TI,AB.
45. RESISTANCE ADJ TRAIN$4
46. MUSCLE ADJ STRENGTH$5
47. PSYCHOTHERAPY#.W..DE.
48. PSYCHOTHERAP$2.TI,AB.
49. (PSYCHOLOG$5 NEAR INTERVENT$5).TI,AB.
50. RELAX.TI,AB.
51. RELAXATION-TECHNIQUES#.DE.
52. (COUNSELLING OR COUNSELING).TI,AB.
53. COUNSELING#.W..DE.
54. ((BEHAVIOR$4 OR BEHAVIOUR$4) NEAR (MODIFY OR MODIFICAT$4 OR THERAP$2 OR CHANGE)).TI,AB.
55. STRESS-MANAGEMENT#.DE.
56. (STRESS NEAR MANAG$5).TI,AB.
57. (COGNITIVE NEAR THERAP$2).TI,AB.
58. MEDITATION#.W..DE.
59. MEDITAT$5.TI,AB.
60. ANXIETY#.W..DE.
61. (MANAGE$5 NEAR (ANXIETY OR DEPRESS$5)).TI,AB.
62. CBT.TI,AB.
63. HYPNOTHERAP$5.TI,AB.
64. (GOAL$2 NEAR SETTING).TI,AB.
65. (PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5).TI,AB.
66. (MOTIVAT$5 NEAR (INTERV$3 OR INTERVENT$5)).TI,AB.
67. PSYCHOSOCIAL$4.TI,AB.
68. HEALTH-EDUCATION#.DE.
69. (HEALTH NEAR EDUCAT$5).TI,AB.
70. HEART ADJ MANUAL
71. AUTOGENIC$3.TI,AB.
72. 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38 OR
39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46
73. 47 OR 48 OR 49 OR 50 OR 51 OR 52 OR 53 OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR
63 OR 64 OR 65 OR 66 OR 67 OR 68 OR 69 OR 70 OR 71
74. 72 OR 73
75. 22 AND 74
76. PT=CLINICAL-TRIAL
77. CLINICAL-TRIALS#.DE.
78. (RANDOM$5 OR PLACEBO$2).TI,AB.
79. (SINGL$ OR DOUBLE$ OR TRIPLE$ OR TREBLE$).TI,AB. AND (BLIND$ OR MASK$).TI,AB.
80. CONTROLLED ADJ CLINICAL ADJ TRIALS
81. 76 OR 77 OR 78 OR 79 OR 80
82. 75 AND 81
83. LIMIT 82 TO 2001-2008
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PsycINFO dialog to January week 1 2008
1. SEARCH: HEART-DISORDERS#.DE.
2. SEARCH: MYOCARDIAL-INFARCTIONS.DE.
3. SEARCH: ISCHEMIA#.W..DE.
4. SEARCH: HEART-SURGERY.DE.
5. SEARCH: ANGIOPLASTY
6. SEARCH: HEART ADJ BYPASS
7. SEARCH: CORONARY.TI,AB.
8. SEARCH: (ISCHEMI$3 OR ISCHAEMI$3).TI,AB.
9. SEARCH: (MYOCARD$5 NEAR INFARCT$5).TI,AB.
10. SEARCH: (HEART NEAR (INFARC$5 OR FAILURE OR ATTACK)).TI,AB.
11. SEARCH: ANGINA.TI,AB.
12. SEARCH: (HEART NEAR DISEASE$2).TI,AB.
13. SEARCH: MYOCARD$5.TI,AB.
14. SEARCH: CARDIAC$4.TI,AB.
15. SEARCH: CABG.TI,AB.
16. SEARCH: PTCA.TI,AB.
17. SEARCH: 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16
18. SEARCH: PHYSICAL-ACTIVITY#.DE.
19. SEARCH: SPORTS#.W..DE.
20. SEARCH: PHYSICAL-EDUCATION.DE.
21. SEARCH: HEALTH-BEHAVIOR#.DE.
22. SEARCH: PHYSICAL-FITNESS.DE.
23. SEARCH: (PHYSICAL ADJ EDUCATION).TI,AB.
24 SEARCH: EXERTION.TI,AB.
25. SEARCH: REHABILITAT$6.TI,AB.
26. SEARCH: (PHYSICAL NEAR (FIT$5 OR TRAIN$5 OR THERAP$5 OR ACTIVIT$4)).TI,AB.
27. SEARCH: (TRAIN$4 NEAR (STRENGTH$4 OR AEROBIC OR EXERCISE$2)).TI,AB.
28. SEARCH: ((EXERCISE$3 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$4 OR
THERAP$2)).TI,AB.
29. SEARCH: (PATIENT WITH EDUCATION).TI,AB.
30. SEARCH: CLIENT-EDUCATION#.DE.
31. SEARCH: HEALTH-PROMOTION#.DE.
32. SEARCH: ((LIFESTYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)).TI,AB.
33. SEARCH: OUTPATIENT-TREATMENT#.DE.
34. SEARCH: 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32
OR 33
35. SEARCH: PSYCHOTHERAPY#.W..DE.
36 SEARCH: PSYCHOTHERAP$2.TI,AB.
37 SEARCH: TREATMENT#.W..DE.
38 SEARCH: (PSYCHOLOG$4 NEAR INTERVENT$5).TI,AB.
39 SEARCH: COUNSELING#.W..DE.
40 SEARCH: COPING-BEHAVIOR#.DE.
41 SEARCH: MEDITATION.W..DE.
42 SEARCH: AUTOGENIC-TRAINING.DE.
43 SEARCH: HEALTH-EDUCATION#.DE.
44. SEARCH: RELAX$6.TI,AB.
45. SEARCH: (COUNSELLING OR COUNSELING).TI,AB.
46. SEARCH: ((BEHAVIOUR OR BEHAVIOR) NEAR (MODIF$5 OR THERAP$5 OR REHABILIT$5 OR CHANGE)).TI,AB.
47. SEARCH: (STRESS NEAR MANAGE$5).TI,AB.
48. SEARCH: MEDITAT$5.TI,AB.
49. SEARCH: (MANAGE$5 NEAR (ANXIETY OR DEPRES$5)).TI,AB.
50. SEARCH: (CBT OR COGNITIV$2 NEAR THERAP$3).TI,AB.
51. SEARCH: HYPNOTHERAP$3.TI,AB.
52. SEARCH: (PSYCHO-EDUCAT$6 OR PSYCHOEDUCAT$6).TI,AB.
53. SEARCH: (MOTIVAT$5 NEAR INTERVENT$5).TI,AB.
54. SEARCH: (SELF NEAR MANAG$6).TI,AB.
55. SEARCH: AUTOGENIC$3.TI,AB.
56. SEARCH: (GOAL NEAR SETTING).TI,AB.
57. SEARCH: (HEALTH NEAR EDUCATION).TI,AB.
58. SEARCH: (HEART ADJ MANUAL).TI,AB.
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59. SEARCH: 35 OR 36 OR 37 OR 38 OR 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47 OR 48 OR 49
OR 50 OR 51 OR 52 OR 53 OR 54 OR 55 OR 56 OR 57 OR 58
60. SEARCH: 17 AND (34 OR 59)
61. SEARCH: (RANDOM$5 OR PLACEBO$5).TI,AB.
62. SEARCH: (DOUBLE$4 OR SINGLE$4 OR TRIPLE$4).TI,AB. AND (BLIND$4 OR MASK OR SHAM$4 OR
DUMMY).TI,AB.
63. SEARCH: RCT.TI,AB.
64. SEARCH: AT=TREATMENT$
65. SEARCH: 61 OR 62 OR 63 OR 64
66. SEARCH: 60 AND 66
67. SEARCH: LIMIT 66 TO YRS=2001-2008
ISI Proceedings, search date 1 April 2008
 # 7 807 #5 and #6
Databases=STP Timespan=2001-2008
# 6 29,517 TS=(rehab* or educat*)
Databases=STP Timespan=2001-2008
# 5 52,687 #4 OR #3 OR #2 OR #1
Databases=STP Timespan=2001-2008
# 4 27,506 TS=(angina or cardiac* or PTCA or CABG)
Databases=STP Timespan=2001-2008
# 3 11,226 TS=((heart) SAME (infarct* or isch?emia or failure or attack))
Databases=STP Timespan=2001-2008
# 2 12,618 TS=((coronary* or heart*) SAME (by?pass or disease*))
Databases=STP Timespan=2001-2008
# 1 11,809 TS=((myocard*) SAME (isch?emia or infarct* or revasculari?*))
Databases=STP Timespan=2001-2008
Appendix 4. Search strategies 2013
CENTRAL in the Cochrane Library (2013, Issue 1)
1.    MeSH descriptor: [Myocardial Ischemia] explode all trees
2.    (myocard* near isch*mi*):ti or (myocard* near isch*mi*):ab
3.    (isch*mi* near heart):ti or (isch*mi* near heart):ab
4.    MeSH descriptor: [Coronary Artery Bypass] explode all trees
5.    (coronary):ti or (coronary):ab
6.    MeSH descriptor: [Coronary Disease] explode all trees
7.    MeSH descriptor: [Myocardial Revascularization] explode all trees
8.    MeSH descriptor: [Myocardial Infarction] explode all trees
9.   (myocard* near infarct*):ti or (myocard* near infarct*):ab
10. (heart near infarct*):ti or (heart near infarct*):ab
11. MeSH descriptor: [Angina Pectoris] explode all trees
12. (angina):ti or (angina):ab
13. MeSH descriptor: [Heart Failure] explode all trees
14. (heart and (failure or attack)):ti or (heart and (failure or attack)):ab
15. (Heart diseases):ti or (Heart diseases):ab
16. MeSH descriptor: [Heart Diseases] explode all trees        
17. (heart and (disease*)):ti or (heart and (disease*)):ab        
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18. (myocard*):ti or (myocard*):ab           
19. (cardiac*):ti or (cardiac*):ab    
20. (CABG):ti or (CABG):ab          
21. (PTCA):ti or (PTCA):ab           
22. (stent* and (heart or cardiac*)):ti or (stent* and (heart or cardiac*)):ab   
23. MeSH descriptor: [Heart Bypass, LeR] explode all trees   
24. (HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF REF"):ti or (HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF
REF"):ab          
25. (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21
or #22 or #23 or #24)
26. MeSH descriptor: [Rehabilitation Centers] this term only
27. MeSH descriptor: [Exercise Therapy] explode all trees    
28. MeSH descriptor: [Sports] this term only     
29. MeSH descriptor: [Physical Exertion] explode all trees    
30. (rehabilitat*):ti or (rehabilitat*):ab      
31. (physical* near (fit* or train* or therap* or activit*)):ti or (physical* near (fit* or train* or therap* or activit*)):ab        
32. MeSH descriptor: [Exercise] explode all trees        
33. (train*) near (strength* or aerobic or exercise*):ti or (train*) near (strength* or aerobic or exercise*):ab     
34. ((exercise* or fitness) near/3 (treatment or intervent* or program*)):ti or ((exercise* or fitness) near/3 (treatment or intervent* or
program*)):ab     
35. MeSH descriptor: [Rehabilitation] explode all trees          
36. MeSH descriptor: [Patient Education as Topic] this term only     
37. (patient* near/3 educat*):ti or (patient* near/3 educat*):ab           
38. ((lifestyle or life-style) near/3 (intervent* or program* or treatment*)):ti or ((lifestyle or life-style) near/3 (intervent* or program* or
treatment*)):ab    
39. MeSH descriptor: [Self Care] explode all trees       
40. MeSH descriptor: [Ambulatory Care] explode all trees     
41. MeSH descriptor: [Psychotherapy] explode all trees         
42. (psychotherap*):ti or (psychotherap*):ab
43. (psycholog* near intervent*):ti or (psycholog* near intervent*):ab
44. (relax*):ti or (relax*):ab
45. MeSH descriptor: [Mind-Body Therapies] explode all trees
46. ((Mind or Body) and (Relaxation Techniques)):ti or ((Mind or Body) and (Relaxation Techniques)):ab     
47. MeSH descriptor: [Counseling] explode all trees  
48. (counseling or counselling):ti or (counseling or counselling):ab           
49. MeSH descriptor: [Cognitive Therapy] explode all trees   
50. MeSH descriptor: [Behavior Therapy] explode all trees    
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51. ((behavio*r*) near/4 (modif* or therap* or rehab* or change)):ti or ((behavio*r*) near/4 (modif* or therap* or rehab* or change)):ab      
52. MeSH descriptor: [Stress, Psychological] explode all trees         
53. (stress near manage*):ti or (stress near manage*):ab
54. (cognitive* near therap*):ti or (cognitive* near therap*):ab
55. MeSH descriptor: [Meditation] explode all trees     
56. (meditat*):ti or (meditat*):ab    
57. MeSH descriptor: [Anxiety] this term only
58. ((manage*) near (anxiety or depres*)):ti or ((manage*) near (anxiety or depres*)):ab
59. (CBT):ti or (CBT):ab
60. (hypnotherap*):ti or (hypnotherap*):ab
61. (goal near/3 (setting)):ti or (goal near/3 (setting)):ab
62. ((psycho-educat*) or (psychoeducat*)):ti ((psycho-educat*) or (psychoeducat*)):ab
63. (motivat* near (interv*)):ti or (motivat* near (interv*)):ab
64. MeSH descriptor: [Psychopathology] explode all trees    
65. (psychopathol*):ti or (psychopathol*):ab
66. MeSH descriptor: [Autogenic Training] explode all trees 
67. (autogenic*):ti or (autogenic*):ab
68. (self near (manage* or care or motivat*)):ti or (self near (manage* or care or motivat*)):ab
69. (distress*):ti or (distress*):ab  
70. (psychosocial* or psycho-social):ti or (psychosocial* or psycho-social):ab
71. MeSH descriptor: [Health Education] explode all trees
72. (nutrition or diet or health near (education)):ti or (nutrition or diet or health near (education)):ab   
73. (heart manual):ti or (heart manual):ab
74. (#26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37)
75. (#38 or #40 or #41 or #42 or #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53 or #54 or #55 or #56 or #57 or #58
or #59 or #60 or #61 or #62 or #63 or #64 or #65 or #66 or #67 or #68 or #69 or #70 or #71 or #72 or #73)
76. (#74 or #75)
77. (#76 and #25)
78. #77 from 2008, in Trials
MEDLINE Ovid 1946 to January week 4 2013
1.    exp Myocardial Ischemia/
2.    (myocard$4 adj5 (ischaemi$2 or ischemi$2)).ti,ab.
3.    ((ischaemi$2 or ischemi$2) adj5 heart).ti,ab.
4.    exp Coronary Artery Bypass/
5.    coronary.ti,ab.
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6.    exp Coronary Disease/
7.    exp Myocardial Revascularization/
8.    Myocardial Infarction/
9.    (myocard$5 adj5 infarct$5).ti,ab.
10. (heart adj5 infarct$5).ti,ab.
11. exp Angina Pectoris/
12. angina.ti,ab.
13. exp Heart Failure/
14. (heart adj5 failure).ti,ab.
15. (HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF REF").ti,ab.
16. or/1-15
17. exp Heart Diseases/
18. (heart adj5 disease$2).ti,ab.
19. myocard$5.ti,ab.
20. cardiac$2.ti,ab.
21. CABG.ti,ab.
22. PTCA.ti,ab.
23. (stent$4 and (heart or cardiac$4)).ti,ab.
24. Heart Bypass, LeR/ or exp Heart Bypass, Right/
25. or/17-24
26. *Rehabilitation Centers/
27. exp Exercise Therapy/
28. *Rehabilitation/
29. exp Sports/
30. Physical Exertion/ or exertion.ti,ab.
31. exp Exercise/
32. rehabilitat$5.ti,ab.
33. (physical$4 adj5 (fit or fitness or train$5 or therap$5 or activit$5)).ti,ab.
34. (train$5 adj5 (strength$3 or aerobic or exercise$4)).ti,ab.
35. ((exercise$4 or fitness) adj5 (treatment or intervent$4 or programs$2 or therapy)).ti,ab.
36. Patient Education as Topic/
37. (patient$2 adj5 educat$4).ti,ab.
38. ((lifestyle or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
39. *Self Care/
40. (self adj5 (manage$5 or care or motivate$5)).ti,ab.
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41. *Ambulatory Care/
42. exp Psychotherapy/
43. psychotherap$2.ti,ab.
44. (psycholog$5 adj5 intervent$5).ti,ab.
45. relax$6.ti,ab.
46. exp Relaxation Therapy/ or exp Mind-Body Therapies/
47. exp Counseling/
48. (counselling or counseling).ti,ab.
49. exp Cognitive Therapy/
50. exp Behavior Therapy/
51. ((behavior$4 or behaviour$4) adj5 (modify or modificat$4 or therap$2 or change)).ti,ab.
52. *Stress, Psychological/
53. (stress adj5 management).ti,ab.
54. (cognitive adj5 therap$2).ti,ab.
55. meditat$4.ti,ab.
56. *Meditation/
57. exp Anxiety/
58. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
59. CBT.ti,ab.
60. hypnotherap$5.ti,ab.
61. (goal adj5 setting).ti,ab.
62. (goal$2 adj5 setting).ti,ab.
63. (psycho-educat$5 or psychoeducat$5).ti,ab.
64. (motivat$5 adj5 (intervention or interv$3)).ti,ab.
65. Psychopathology/
66. psychopathol$4.ti,ab.
67. psychosocial$4.ti,ab.
68. distress$4.ti,ab.
69. exp Health Education/
70. (health adj5 education).ti,ab.
71. (heart adj5 manual).ti,ab.
72. Autogenic Training/
73. autogenic$5.ti,ab.
74. or/26-39
75. or/40-73
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76. 16 or 25
77. 74 or 75
78. 76 and 77
79. randomized controlled trial/
80. randomized controlled trial.pt.
81. controlled clinical trial.pt.
82. controlled clinical trial/
83. Random Allocation/
84. Double-Blind Method/
85. single-blind method/
86. (random$ or placebo$).ti,ab.
87. ((singl$3 or doubl$3 or tripl$3 or trebl$3) adj5 (blind$3 or mask$3)).ti,ab.
88. exp Research Design/
89. Clinical Trial.pt.
90. exp clinical trial/
91. (clinic$3 adj trial$2).ti,ab.
92. or/79-91
93. 78 and 92
94. (Animals not Humans).sh.
95. 93 not 94
96. limit 95 to yr="2008 -Current"
MEDLINE In-Process and Other Non-Indexed Citations Ovid 5 February 2013
1.    (myocard$4 adj5 (ischaemi$2 or ischemi$2)).ti,ab.
2.    ((ischaemi$2 or ischemi$2) adj5 heart).ti,ab.
3.    coronary.ti,ab.
4.    (myocard$5 adj5 infarct$5).ti,ab.
5.    (heart adj5 infarct$5).ti,ab.
6.    angina.ti,ab.
7.    (heart adj5 failure).ti,ab.
8.    (HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF REF").ti,ab.
9.    or/1-8
10. (heart adj5 disease$2).ti,ab.
11. myocard$5.ti,ab.
12. cardiac$2.ti,ab.
13. CABG.ti,ab.
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14. PTCA.ti,ab.
15. (stent$4 and (heart or cardiac$4)).ti,ab.
16. or/10-15
17. Physical Exertion/ or exertion.ti,ab.
18. rehabilitat$5.ti,ab.
19. (physical$4 adj5 (fit or fitness or train$5 or therap$5 or activit$5)).ti,ab.
20. (train$5 adj5 (strength$3 or aerobic or exercise$4)).ti,ab.
21. ((exercise$4 or fitness) adj5 (treatment or intervent$4 or programs$2 or therapy)).ti,ab.
22. (patient$2 adj5 educat$4).ti,ab.
23. ((lifestyle or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
24. (self adj5 (manage$5 or care or motivate$5)).ti,ab.
25. psychotherap$2.ti,ab.
26. (psycholog$5 adj5 intervent$5).ti,ab.
27. relax$6.ti,ab.
28. (counselling or counseling).ti,ab.
29. ((behavior$4 or behaviour$4) adj5 (modify or modificat$4 or therap$2 or change)).ti,ab.
30. (stress adj5 management).ti,ab.
31. (cognitive adj5 therap$2).ti,ab.
32. meditat$4.ti,ab.
33. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
34. CBT.ti,ab.
35. hypnotherap$5.ti,ab.
36. (goal adj5 setting).ti,ab.
37. (goal$2 adj5 setting).ti,ab.
38. (psycho-educat$5 or psychoeducat$5).ti,ab.
39. (motivat$5 adj5 (intervention or interv$3)).ti,ab.
40. psychopathol$4.ti,ab.
41. psychosocial$4.ti,ab.
42. distress$4.ti,ab.
43. (health adj5 education).ti,ab.
44. (heart adj5 manual).ti,ab.
45. autogenic$5.ti,ab.
46. or/17-45
47. 9 or 16
48. 46 and 47
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49. (random$ or placebo$).ti,ab.
50. ((singl$3 or doubl$3 or tripl$3 or trebl$3) adj5 (blind$3 or mask$3)).ti,ab.
51. (clinic$3 adj trial$2).ti,ab.
52. 49 or 50 or 51
53. 48 and 52
54. limit 53 to yr="2008 -Current"
Embase Ovid 1980 to 2013 week 5
1.    exp heart disease/
2.    (myocard$4 adj5 (ischaemi$2 or ischemi$2)).ti,ab.
3.    ((ischaemi$2 or ischemi$2) adj5 heart).ti,ab.
4.    exp coronary artery disease/
5.    transluminal coronary angioplasty/
6.    (coronary adj5 (disease$2 or bypass$2 or thrombo$5 or angioplasty$2)).ti,ab.
7.    exp heart infarction/
8.    (myocard$5 adj5 infarct$5).ti,ab.
9.    (heart adj5 infarct$5).ti,ab.
10. heart muscle revascularization/
11. exp Angina Pectoris/
12. angina.ti,ab.
13. exp congestive heart failure/
14. (heart adj5 failure).ti,ab.
15. (HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF REF").ti,ab.
16. or/1-15
17. (heart adj5 disease$2).ti,ab.
18. cardiac$2.ti,ab.
19. CABG.ti,ab.
20. PTCA.ti,ab.
21. (stent$4 and heart).ti,ab.
22. exp extracorporeal circulation/
23. or/17-22
24. 16 or 23
25. *Psychotherapy/
26. psychotherapy$2.ti,ab.
27. (psycholog$5 adj5 intervent$5).ti,ab.
28. relax$6.ti,ab.
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29. relaxation training/
30. *counselling/
31. (counselling or counseling).ti,ab.
32. ((behavior$4 or behaviour$4) adj5 (modify or modificat$4 or therap$2 or change)).ti,ab.
33. stress management/
34. (stress adj5 management).ti,ab.
35. *Mediation/
36. meditat$5.ti,ab.
37. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
38. CBT.ti,ab.
39. hypnotherap$2.ti,ab.
40. (goal$2 adj5 setting).ti,ab.
41. (psycho-educat$5 or psychoeducat$5).ti,ab.
42. (motivat$5 adj5 intervent$6).ti,ab.
43. exp psychosocial care/ or exp psychosocial rehabilitation/
44. psychosocial.ti,ab.
45. exp health education/
46. (health adj5 education).ti,ab.
47. (heart adj5 manual).ti,ab.
48. autogenic training/
49. autogenic.ti,ab.
50. *Rehabilitation/
51. rehabilitation center/
52. rehabil$.ti,ab.
53. exp Sport/
54. exp Kinesiotherapy/
55. exp Exercise/
56. exp Physiotherapy/
57. (physical$4 adj5 (fit or fitness or train$5 or therap$5 or activit$5)).ti,ab.
58. (train$5 adj5 (strength$3 or aerobic or exercise$4)).ti,ab.
59. ((exercise$4 or fitness) adj5 (treatment or intervent$4 or programs$2 or therapy)).ti,ab.
60. (aerobic$4 adj5 exercise$4).ti,ab.
61. (kinesiotherapy or physiotherapy).ti,ab.
62. patient education/
63. (patient$2 adj5 educat$4).ti,ab.
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64. ((((lifestyle or life) adj1 style) or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
65. exp self care/
66. (self adj5 (manage$5 or care or motivate$5)).ti,ab.
67. exp ambulatory care/
68. (psycho-educat$5 or psychoeducat$5).ti,ab.
69. (motivat$5 adj5 intervent$6).ti,ab.
70. psychosocial care/ or psychosocial rehabilitation/
71. psychosocial.ti,ab.
72. exp health education/
73. (health adj5 education).ti,ab.
74. (heart adj5 manual).ti,ab.
75. autogenic training/
76. autogenic$5.ti,ab.
77. (psycho-educat$5 or psychoeducat$5).ti,ab.
78. (motivat$5 adj5 intervent$6).ti,ab.
79. psychosocial care/ or psychosocial rehabilitation/
80. psychosocial.ti,ab.
81. exp health education/
82. (health adj5 education).ti,ab.
83. (heart adj5 manual).ti,ab.
84. or/25-50
85. or/51-83
86. 84 or 85
87. (random$ or placebo$).ti,ab.
88. ((singl$4 or doubl$4 or tripl$4 or trebl$4) adj5 (blind$4 or mask$4)).ti,ab.
89. (controlled adj1 clinical adj1 trial).ti,ab.
90. randomized controlled trial/
91. or/87-90
92. 24 and 86
93. 91 and 92
94. (animal$ not human$).sh,hw.
95. 93 not 94
96. limit 95 to yr="2008 -Current"
PsycINFO Ovid 1806 to January week 5 2013
1.    exp heart disorders/
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2.    *Myocardial Infarctions/
3.    exp Ischemia/
4.    *Heart Surgery/
5.    angioplasty.ti,ab.
6.    (heart adj1 bypass).ti,ab.
7.    coronary.ti,ab.
8.    (ischemi$3 or ischaemi$3).ti,ab.
9.    (myocard$5 adj5 infarct$5).ti,ab.
10. (heart adj5 (infarct$5 or failure or attack)).ti,ab.
11. angina.ti,ab.
12. (heart adj5 disease$2).ti,ab.
13. myocard$5.ti,ab.
14. cardiac$4.ti,ab.
15. CABG.ti,ab.
16. PTCA.ti,ab.
17. (HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF REF").ti,ab.
18. or/1-17
19. exp Physical Activity/
20. exp Sports/
21. *Physical Education/
22. exp Health Behavior/
23. *Physical Fitness/
24. (physical adj1 education).ti,ab.
25. exertion$6.ti,ab.
26. rehabilitat$6.ti,ab.
27. (physical adj5 (fit$5 or train$5 or therap$5 or activit$4)).ti,ab.
28. (train$4 adj5 (strength$4 or aerobic or exercise$2)).ti,ab.
29. ((exercise$3 or fitness) adj5 (treatment or intervent$4 or program$4 or therap$2)).ti,ab.
30. patient with education.ti,ab.
31. exp Client Education/
32. exp Health Promotion/
33. ((lifestyle or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
34. exp Outpatient Treatment/
35. or/19-34
36. exp Psychotherapy/
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37. psychotherapy$2.ti,ab.
38. exp Treatment/
39. (psycholog$4 adj5 intervent$5).ti,ab.
40. exp Counseling/
41. exp Coping Behavior/
42. *Meditation/
43. *Autogenic Training/
44. exp Health Education/
45. relax$6.ti,ab.
46. (counselling or counseling).ti,ab.
47. ((behavior or behaviour) adj5 (modif$5 or therap$5 or rehabilit5 or change)).ti,ab.
48. (stress adj5 management).ti,ab.
49. meditat$5.ti,ab.
50. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
51. ((cbt or cognitive$2) adj5 therap$3).ti,ab.
52. hypnotherap$3.ti,ab.
53. (psycho-educat$6 or psychoeducat$6).ti,ab.
54. (motivat$5 adj5 intervent$5).ti,ab.
55. (self adj5 manag$6).ti,ab.
56. autogenic$3.ti,ab.
57. (goal adj5 setting).ti,ab.
58. (health adj5 education).ti,ab.
59. (heart adj1 manual).ti,ab.
60. or/36-59
61. 18 and (35 or 60)
62. (random$5 or placebo$5).ti,ab.
63. ((single$4 or double$4 or triple$4) and (blind$4 or mask or sham$4 or dummy)).ti,ab.
64. RCT.ti,ab.
65. or/62-64
66. 61 and 65
67. limit 66 to yr="2008 -Current"
CINAHL EBSCOhost, search date 5 February 2013
1.    TI((myocard* N5 ischaemi*) or (myocard* N5 ischemi*) or (heart N5 ischaemi*) or (heart N5 ischemi*)) OR AB((myocard* N5 ischaemi*)
or (myocard* N5 ischemi*) or (heart N5 ischaemi*) or (heart N5 ischemi*))
2.    TI(coronary) or AB(coronary)
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3.    TI((myocard* N5 infarc*) or (heart N5 infarc*)) or AB((myocard* N5 infarc*) or (heart N5 infarc*))
4.    TI(angina) OR AB(angina)
5.    TI(heart N5 failure) or AB(heart N5 failure)
6.    TI(heart N5 diseas*) or AB(heart N5 diseas*)
7.    TI(cardiac) or AB(cardiac)
8.    TI(CABG) or AB(CABG)
9.    TI(PTCA) or AB(PTCA)
10. TI(Stent* and (heart or cardiac*)) or AB(Stent* and (heart or cardiac*))
11. (MH "Myocardial Ischemia+")
12. (MH "Myocardial Infarction+")
13. (MH "Coronary Artery Bypass+")
14. (MH "Coronary Disease+")
15. TI(cardiac N5 patient*) or AB(cardiac N5 patient*)
16. TI(Cardiomyopathies) or AB(Cardiomyopathies)
17. (MH "Myocardial Revascularization+")
18. (MH "Heart Diseases+")
19. (MH "Cardiovascular Diseases+")
20. (MH "Heart Failure+")
21. (MH "Angina Pectoris+")
22. TI(HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF REF") or AB(HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF REF")
23. S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19
OR S20 OR S21 OR S22
24. (MM "Rehabilitation")
25. (MM "Sports")
26. (MM "Physical Activity")
27. (MH "Muscle Strengthening+")
28. (MH "Aerobic Exercises+")
29. (MH "Physical Fitness+")
30. (MH "Patient Education+")
31. (MH "Therapeutic Exercise+")
32. TI(rehabilitat*) or AB(rehabilitat*)
33. TI((physical* N5 fit) or (physical N5 fitness) or (physical N5 train*) or (physical N5 therap*) or (physical N5 activit*)) or AB((physical* N5
fit) or (physical N5 fitness) or (physical N5 train*) or (physical N5 therap*) or (physical N5 activit*))
34. TI((train N5 strength) or (train N5 aerobic) or (train N5 exercis*)) or AB((train N5 strength) or (train N5 aerobic) or (train N5 exercis*))
35. TI((exercise N5 treatment) or (fitness N5 treatment) or (exercise N5 intervent*) or (fitness N5 intervent*) or (exercise N5 program*) or
(fitness N5 program) or (exercise N5 therapy) or (fitness N5 therapy)) or AB((exercise N5 treatment) or (fitness N5 treatment) or (exercise
N5 intervent*) or (fitness N5 intervent*) or (exercise N5 program*) or (fitness N5 program) or (exercise N5 therapy) or (fitness N5 therapy))
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36. TI(patient* N5 educat*) or AB(patient* N5 educat*)
37. TI ((lifestyle N5 intervent*) or (life-style N5 intervent*) or (lifestyle N5 program*) or (life-style N5 program*) or (lifestyle N5 treatment)
or (life-style N5 treatment)) OR AB ((lifestyle N5 intervent*) or (life-style N5 intervent*) or (lifestyle N5 program*) or (life-style N5 program*)
or (lifestyle N5 treatment) or (life-style N5 treatment))
38. (MH "Self Care+")
39. TI((self N5 manage*) or (self N5 care) or (self N5 motivat*)) or AB((self N5 manage*) or (self N5 care) or (self N5 motivat*))
40. (MM "Ambulatory Care")
41. TI(aerobic) or AB(aerobic)
42. TI(resistance W1 train*) or AB(resistance W1 train*)
43. TI(muscle W1 strength*) or AB(muscle W1 strength*)
44. TI(resistance W1 train*) or AB(resistance W1 train*)
45. TI(muscle W1 strength*) or AB(muscle W1 strength*)
46. (MH "Psychotherapy+")
47. TI(psychotherap*) or AB(psychotherap*)
48. TI(psycholog* N5 intervent*) or AB(psycholog* N5 intervent*)
49. TI(relax) or AB(relax)
50. (MH "Relaxation Techniques+")
51. TI(counselling or counseling) or AB(counselling or counseling)
52. (MH "Counseling+")
53. TI((behavio?r* N5 modify) or (behavio?r* N5 modificat*) or (behavio?r* N5 therap*) or (behavio?r* N5 change)) or AB((behavio?r* N5
modify) or (behavio?r* N5 modificat*) or (behavio?r* N5 therap*) or (behavio?r* N5 change))
54. (MM "Stress Management")
55. TI(stress N5 manag*) or AB(stress N5 manag*)
56. TI(cognitive N5 therap*) or AB(cognitive N5 therap*)
57. (MM "Meditation")
58. TI(meditat*) or AB(meditat*)
59. (MH "Anxiety+")
60. TI((manage* N5 anxiety) or (manage* N5 depress*)) or AB((manage* N5 anxiety) or (manage* N5 depress*))
61. TI(CBT) or AB(CBT)
62. TI(hypnotherap*) or AB(hypnotherap*)
63. TI(goal* N5 setting) or AB(goal* N5 setting)
64. TI(psycho-educat* or psychoeducat*) or AB(psycho-educat* or psychoeducat*)
65. TI((motivat* N5 interv*) or (motivate* N5 intervent*)) or AB((motivat* N5 interv*) or (motivate* N5 intervent*))
66. TI(psychosocial*) or AB(psychosocial*)
67. (MH "Health Education+")
68. TI(health N5 educat*) or AB(health N5 educat*)
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69. TI(heart W1 manual) or AB(heart W1 manual)
70. TI(autogenic*) or AB(autogenic*)
71. S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR
S41 OR S42 OR S43 OR S44 OR S45
72. S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60 OR S61 OR S62 OR S63
OR S64 OR S65 OR S66 OR S67 OR S68 OR S69 OR S70
73. S71 OR S72
74. S23 AND S73
75. PT CLINICAL TRIAL
76. (MH "Clinical Trials+")
77. TI (random* or placebo*) or AB (random* or placebo*)
78. TI(singl* or double* or triple* or treble* and (blind* or mask*)) or AB(singl* or double* or triple* or treble* and (blind* or mask*))
79. TI(controlled w1 clinical w1 trials) or AB(controlled w1 clinical w1 trials)
80. S75 OR S76 OR S77 OR S78 OR S79
81. S74 AND S80 date limit=2008-current
Web of Science, search date 6 February 2013
1.    TS=((myocard*) SAME (isch?emia or infarct* or revasculari?*))
2.    TS=((coronary* or heart*) SAME (by?pass or disease*))
3.    TS=((heart) SAME (infarct* or isch?emia or failure or attack))
4.    TS=(angina or cardiac* or PTCA or CABG)
5.    TS=(HFNEF or HFPEF or HFREF or "HF NEF" or "HF PEF" or "HF REF")
6.    #1 OR #2 OR #3 OR #4 OR #5
7.    TS=(rehab* or educat*)
8.    #6 AND #7
9.    TS=(random* or placebo*)
10. TS=((singl* or doubl* or tripl* or trebl*) SAME (blind* or mask*))
11. TS=("clinic* trial*")
12. #9 OR #10 OR #11
13. #8 AND #12
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH Timespan=2008-2013
W H A T ' S   N E W
 
Date Event Description
1 June 2018 New citation required but conclusions
have not changed
Eleven new studies (29 publications) were included in the up-
date. The study population included adults with evidence of HF -
either HFrEF or HFpEF. We based our search strategy on the Jan-
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Date Event Description
uary 2013 search strategy, which was made to reflect more re-
cent use of the terms 'HFpEF' and 'HFrEF'. The search for this cur-
rent review update was updated from the 2013 search (January
2013 to 29 January 2018), with date limits applied to our latest
search to identify only those records that have been newly added
to the databases since the last search. Review conclusions re-
main unchanged
31 May 2018 New search has been performed We updated this review with trials identified by the update
search, which we ran on 29 January 2018
 
H I S T O R Y
Protocol first published: Issue 4, 2001
Review first published: Issue 3, 2004
 
Date Event Description
1 November 2013 New citation required but conclusions
have not changed
For this review update, we identified 14 additional trials.
Whilst conclusions of the review have not changed, this update
provides a broader body of evidence of the benefits of exer-
cise-based interventions, which includes patients with HFpEF
and delivery in a home-based setting
14 February 2013 New search has been performed Searches were updated
18 May 2004 New citation required and conclusions
have changed
Substantive amendments were made
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